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A.  Abstract 
 
Huntington’s disease (HD), a genetically inherited neurodegenerative disease caused by CAG 
trinucleotide repeat expansion, is characterised by movement disorders, cognitive impairment, 
and behavioural disorders. Saccadic and manual dexterity abnormalities are established deficits 
in manifest HD but short-term changes (i.e. 12 months) in saccades and eye-hand coordination 
have not been well-explored.  
 
Given the progressive nature of cognitive, saccadic, and manual dexterity abnormalities, it is 
hypothesized that measurement of these abnormalities can be useful progression markers for 
monitoring short-term longitudinal disease changes in manifest HD. The overarching aim of 
the thesis work is to identify potentially objective biomarkers for measuring HD status and 
short-term progression that could be employed in clinical research, therapeutic trials, and 
clinics. 
 
Saccades and eye-hand coordination in 22 manifest HD patients (stage 1 – 4) and 22 
demographically-matched controls were measured using high-speed video-oculography and an 
electromagnetic motion detection system at baseline and after 12 months. Saccadic and eye-
hand coordination tasks consisted of a series of visually-guided reflexive, rhythmical, and 
complex movement tasks. A comprehensive neuropsychological battery was used to assess 
cognition in both groups whereas the HD group alone was also assessed using the full Unified 
Huntington’s Disease Rating Scale (UHDRS) at both time points. The relationships between 
saccades and eye-hand coordination, and current disease status in the HD group were also 
examined. 
 
Linear mixed-effect models showed that, in general, there was a strong effect of HD upon 
almost all cognitive measures, and saccadic and eye-hand parameters at baseline. This study 
also revealed that there was an impairment in the predictive behaviour of oculomotor and 
somatomotor movements in HD. Most of the saccadic and eye-hand parameters correlated well 
with cognitive status and motor scores of HD patients. Performance of reflexive saccades in a 
2D (combined horizontal and vertical) task and self-paced eye-hand movement were sensitive 
measures of disease severity and progression over 12 months. The basal ganglia are involved 
in regulating rhythmical movement and the decline in performance in self-paced eye-hand task 
at follow-up may reflect short-term neuropathological changes in the basal ganglia in HD. There 
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were no significant differences, in terms of 12 month longitudinal changes, in a majority of the 
other saccadic and eye-hand parameters, between the HD and control group after 12 months. 
These findings suggest that there is a slow and heterogeneous disease progression and also a 
compensating mechanism to maintain behavioural performance over short-time intervals in 
HD.  
 
Saccades may provide a better measurement of disease severity and short-term disease changes 
than somatomotor parameters in manifest HD. In summary, this study provided novel 
perspectives on eye-hand coordination in HD.  Several potential useful markers for monitoring 
short-term disease changes, which could be easily adapted for use in longitudinal research 
studies, clinical trials, and clinics, were also identified. Due to the exploratory nature of this 
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I.1. Huntington’s disease 
I.1.1. Disease overview 
The origin of Huntington’s disease (HD) can be traced back to the 1600s in what was then Great 
Britain, where it was reported that there was a widespread yet unknown malady featuring 
choreic-type movements. The disease characteristics of HD were purportedly first described in 
the medical literature by Dr. Charles Waters via his correspondence to Professor Dunglison in 
the early 1840s (Duff et al., 2007b; Dunglison, 1842). However, it was not another 30 years 
before it was given the name, Huntington’s disease, named after Dr George Huntington, an 
American physician who had given a detailed clinical description of the disease in his academic 
essay (Critchley, 1973; Huntington, 1872).  
 
HD is an autosomal dominant progressive neurodegenerative disease. The clinical features (to 
be discussed in the following sections) include motor deficits, cognitive impairment, and 
 
2 
psychiatric disorders.  Prevalence varies across the world, ranging from around 0.5 per 100,000 
in Asian and African nations to 5 – 10 per 100,000 in western populations (Walker, 2007). The 
disease typically presents itself in mid-life, i.e. in the third or fourth decade of life. However, 
seven percent of all HD cases occur in the paediatric age group, known as juvenile form HD, 
while 25 percent are categorised as late-onset HD, with onset of symptoms at the age of 60 
years and above (Guitton et al., 1985; Kirkwood et al., 2001; Lipe & Bird, 2009; Myers et al., 
1985; Nance & Myers, 2001; Ribai et al., 2007). HD tends to have an insidious onset and 
gradually worsens over 15 – 20 years (Butler et al., 1999; Guitton et al., 1985; O'Keeffe et al., 
2009). By contrast, disease progression is usually faster in juvenile HD whereas in late-onset 
HD, it assumes a slower and less aggressive disease course (Foroud et al., 1999). The relatively 
young age of most symptomatic patients contributes to a low incidence of comorbid medical 
conditions in HD (Nance, 1998). Nance & Saunders (1996) noted that the cause of death in 
45% of all HD cases is directly linked to terminal infection, most notably aspiration pneumonia 
contributed by dysphagia (Heemskerk & Roos, 2012). 
 
 
I.1.2. An overview of neuropathology in HD 
The basal ganglia and cerebral cortex are the two key areas affected in the neuropathology of 
HD (Vonsattel et al., 2011). A detailed discussion of HD pathology in the basal ganglia is 
provided in section I.2.4 of this chapter. Most symptoms observed in manifest HD are directly 
attributed to degenerative changes in the basal ganglia (Vonsattel & DiFiglia, 1998). However, 
some of these symptoms, especially those presenting in early HD, are linked to physiological 
changes at the cellular level in the cerebral cortex (Raymond et al., 2011). Raymond et al. 
(2011) also noted that pyramidal neurons in layers III, IV, and VI of the cortex are susceptible 
to degeneration in HD. Topological changes in the cerebral cortex, regional degeneration of the 
cortex, and reduction in the cerebral cortex volume are consistently reported in structural 
neuroimaging studies (Montoya et al., 2006; Rosas et al., 2002; Rosas et al., 2008; Tabrizi et 
al., 2010). Changes in the cerebral cortex are closely associated with cognitive impairment in 
manifest HD (Backman et al., 1997; Bohanna et al., 2008; Poudel et al., 2014; Rosas et al., 
2005), and also with the heterogeneity and complexity of clinical presentations in this disease 
(Rosas et al., 2008). Further, Thu et al. (2010) reported that the degree of degeneration in the 
primary motor cortex reflects the severity of motor impairment. HD neuropathology extends 
beyond these structures, whereby thalamus, hypothalamus, and cerebellum are also affected 
(Raymond et al., 2011).  
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I.1.3. Clinical presentation 
I.1.3.1. Motor deficits 
The presence of motor symptoms is often a key element in determining the phenoconversion of 
at-risk individual to manifest HD. Motor deficits in HD can be broadly divided into two main 
categories: (1) involuntary movements; and (2) disturbances in voluntary movements. 
Involuntary movements in HD, most notably ‘chorea’, are arrhythmic, irregular and often 
ballistic in nature (Walker, 2007). In early stages of manifest HD, affected individuals often 
present with subtle changes in motor function, such as restlessness or fidgetiness, resulting in 
some being misdiagnosed as having restless legs syndrome (Nance, 1998). Most patients with 
mild chorea can often hold on to a normal life (Bates et al., 2002).  In most patients, however, 
chorea becomes increasingly prominent and disabling with disease progression. Chorea 
however, is absent in some HD patients, especially those with juvenile onset HD, in whom 
rigidity and akinesia are the predominant motor symptoms (Nance & Myers, 2001). 
Bradykinesia and rigidity, i.e. parkinsonism, are usually the dominating symptoms in late stage 
HD (Phillips et al., 2008) and these symptoms often preclude patients from engaging in 
vocational activities and other activities of daily living (Bates et al., 2014b). The control of 
volitional movements requires the integration of multiple cognitive processes (Nance, 1998). 
In light of this, Nance (1998) suggested that impairment in volitional movements is closely 




I.1.3.2. Cognitive deficits 
Cognitive impairment in HD, especially in early HD, is clinically distinct from Alzheimer’s 
disease (AD) (Aretouli & Brandt, 2010; Brandt et al., 1988; Paulsen et al., 1995). AD primarily 
affects language comprehension, naming ability, and memory disturbances whereas in HD, the 
main cognitive deficits are decline in executive function and information processing, and 
language comprehension and naming ability is usually preserved until advanced stages (Nance, 
1998). The dementia syndrome in HD is often termed ‘subcortical dementia’ because the pattern 
of cognitive impairment is related to dysfunctional frontal-subcortical circuits (Zakzanis, 1998). 
Cognitive impairment in HD usually begins with short-term memory loss and with progression, 
other cognitive processes such as executive function, processing speed, and visuospatial 
function are affected (Zakzanis, 1998), eventually leading to profound global dementia in end 




I.1.3.3. Psychiatric disorders 
In HD, major psychiatric changes are often claimed to precede motor symptoms (Chin et al., 
1996) and cognitive impairment (Julien et al., 2007). Affective disorders (typically depression), 
anxiety disorders (e.g. generalised anxiety and panic disorder), and personality disorder (e.g. 
obsessive compulsive disorder) are commonly reported in premanifest (Duff et al., 2007b; 
Julien et al., 2007) and manifest HD (Paulsen et al., 2001). Depression is one of the most 
prevalent psychiatric disorders in manifest HD, affecting about 30% of patients (Slaughter et 
al., 2001). It is hypothesized that the neurodegeneration of the structures in the basal ganglia 
circuit, particularly the dorsolateral-prefrontal, anterior cingulate, and orbitofrontal circuits, 
which contribute to the control of behaviour, is likely to contribute to the development of 
psychiatric disorders in HD (Bonelli & Cummings, 2007; Paulsen et al., 2001). In addition, 
depression is thought to be a contributing factor for an increased suicide risk in HD (Walker, 
2007). 
 
I.1.4. The mutant HD gene 
In 1983, HD became one of the first diseases to be mapped (to the short arm of chromosome 4) 
via linkage analyses of polymorphic DNA (Gusella et al., 1983). However, it took the HD 
Collaborative Research Group, a specialised study group established by the Hereditary Disease 
Foundation, another ten years to isolate the defective gene, IT-15, located between D4S127 and 
D4S180 of chromosome 4p16.3 (The Huntington's Disease Collaborative Research Group, 
1993). 
Table I.1  CAG repeat number and HD clinical outcomes (Myers, 2004) 
CAG repeat number Clinical outcomes 
< 27 No disease expression 
  
27 – 35 
Unlikely to have disease expression 
Offspring might get CAG expansion 
  
36 – 39 
Reduced disease penetrance 
Possible disease expression 
  
> 39 
Full disease penetrance 
Full disease expression 
 
The IT-15 gene causes the disproportionate expansion of trinucleotide (CAG) repeats which in 
turn, results in the excessive production of mutant huntingtin (htt) protein. Analyses of the IT-
15 gene have revealed that those with the defective gene usually have a CAG trinucleotide 
repeat number of greater than 40, whereas the wild-type variant is usually 30 or less (The 
Huntington's Disease Collaborative Research Group, 1993; Watts & Koller, 1997). The CAG 
trinucleotide repeat has direct influence on disease onset timing and progression (Table I.1). 
Individuals with juvenile onset HD tend to have a higher number of CAG trinucleotide repeats 
and faster disease progression than late-onset HD patients, who by contrast have a smaller 
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repeat size (Brinkman et al., 1997; Nance & Myers, 2001; Rosenblatt et al., 2012; Rosenblatt 
et al., 2006). The mode of gene transmission (paternal or maternal transmission) and gender of 
the offspring can also influence the CAG repeats size (Duyao et al., 1993; Ranen et al., 1995; 
Trottier et al., 1994; Wheeler et al., 2007). 
 
 
I.1.5. The role of mutant htt protein in HD pathology 
The wild-type htt protein, which has a relatively long half-life of 24 hours (Persichetti et al., 
1996), can be found in the cell nucleus and also cytoplasm. This protein is thought to function 
as a nucleocytoplasmic shuttling protein (Truant et al., 2007). The mutant htt protein, compared 
to its wild-type counterpart, has an even longer half-life and a propensity to accumulate within 
cells (Kaytor et al., 2004). In addition, there is a tendency for the mutant htt protein to misfold 
and form insoluble aggregates intracellularly (Davies et al., 1997), known as mutant htt 
inclusion bodies or aggregates. It was found that the presence and rate at which these aggregates 
occur is closely related to the CAG repeat size of affected individuals (Becher et al., 1998; 
Scherzinger et al., 1999). Further, these aggregates can also increase in size with disease 
progression (Gutekunst et al., 1999).  These mutant htt aggregates, which are present both 
within (DiFiglia et al., 1997) and outside the central nervous system (Moffitt et al., 2009; 
Tabrizi et al., 2000), are extensively branched and are not separated from their surroundings by 
any membranes (Dahlgren et al., 2005; DiFiglia et al., 1997).  
 
Despite the presence of a direct link between HD and the mutant htt aggregates, current animal 
models of HD have yet to reach a consensus on the exact role of these aggregates in the 
pathogenesis of HD. One study found that the mutant htt aggregates, when introduced into cell 
culture, induce cell death (Yang et al., 2002) while another showed that switching off the mutant 
htt gene reverses aggregate formation and also phenotype expression (Yamamoto et al., 2000), 
suggesting that mutant htt aggregates can have damaging effects on neuronal cells. On the 
contrary, other studies suggested that these aggregates may actually have protective effects on 
neurons in HD. This was shown in one study, in which a reduction in mutant htt inclusions 
resulted in an increase in neuronal cell death (Okamoto et al., 2009), while it was demonstrated 
in another study that there is an enhancement of mutant htt clearance in affected cells in the 
presence of mutant htt aggregates (Ravikumar et al., 2004). 
 
There are different ways of which mutant htt protein can interfere with cell physiology, either 
by disrupting the degradation process of proteins or hampering the vesicular transport system. 
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There are two main pathways for the degradation of proteins at cellular level: (1) the ubiquitin-
proteasome system (UPS) for smaller sized cytoplastic and nuclear proteins (Schwartz & 
Ciechanover, 2009); and (2) the autophagy pathway for protein complexes that are too large to 
pass through the proteasome pore of the UPS. Both mouse (Davies et al., 1997) and human 
(DiFiglia et al., 1997) models of HD have shown that mutant htt protein can cause a disruption 
of the protein degradation pathway in the UPS. Although mutant htt protein is capable of 
inducing its own autophagic clearance to reduce its toxicity within cells (Sarkar & Rubinsztein, 
2008), there is evidence to suggest that mutant htt protein interferes with the cargo loading 
process of other protein products into the autophagic vacuoles, hence affecting the operation of 
autophagy pathways, which in turn has a negative effect on cell integrity (Martinez-Vicente et 
al., 2010).  
 
Wild-type htt protein has been shown to interact with other proteins to induce vesicular 
trafficking activity within cells (DiFiglia et al., 1995). The mutant htt protein, despite being 
malformed, still assumes the role of its wild-type counterpart. However, the mutant protein was 
found to reduce the efficiency of the vesicular transport system by abnormally interacting with 
other proteins (Kaltenbach et al., 2007; Modregger et al., 2002; Singaraja et al., 2002) or 
causing physical obstruction to other proteins (Gutekunst et al., 1995; Smith et al., 2009).  An 
efficient intracellular transport system is essential for supporting the physiological processes 
for the maintenance of neuronal architecture and promotion of neuronal growth (Gauthier et al., 
2004; Trushina et al., 2004). Given this, the interference of mutant htt protein on the vesicular 
transport system may well contribute to neuronal cell death in HD.   
 
Overstimulation of neurons by excessive glutamate intake has been implicated to be one of the 
key processes in HD pathology (Coyle & Schwarcz, 1976; McGeer & McGeer, 1976). Several 
lines of evidence propose that the overstimulation of glutamatergic receptors, likely to be an 
effect of an impaired glutamate transport system, results in the disruption of Ca2+ homeostasis 
in the mitochondria, leading to increased mitochondrial stress and eventually neuronal cell 
death (Tang et al., 2005; Wu et al., 2006). Mutant htt protein has been implicated to cause 
impairment in glutamate transport system by altering the function of one major glutamate 
transporter, the glial glutamate transporter 1 (GLT-1) (Sari, 2011). 
 
There is no consensus on which of the proposed disease mechanisms predominates in HD, or 
if they occur concurrently in the disease process. The proposed disease mechanisms may be 
different but all of them share two common end-points, i.e. the loss of cell integrity and cell 
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death, which initially occur in the striatal medium spiny neurons and later, in other neurons of 
the central nervous system.  
 
I.1.6. Current clinical management in HD 
The management for manifest HD can be classified into three broad categories: (1) 
pharmacological; (2) non-pharmacological; and (3) palliative care for end stage HD. 
Pharmacological therapy in HD can be further sub-categorized into four main groups, with each 
group targeting a specific disease symptom, i.e. motor symptoms, cognitive impairment, 
psychiatric symptoms, and miscellaneous symptoms. 
 
Several antipsychotics and neuroleptics are widely used with varied effects for managing chorea 
in HD. Antipsychotics may also be useful in controlling choreic movements in HD but they are 
usually only effective when given in high doses, which inevitably increase the risk for adverse 
effects – especially extrapyramidal symptoms (van Vugt et al., 1997). Tetrabenazine, a 
dopamine depleter, has good efficacy in managing hyperkinesia but the judicial use of the drug 
must be considered against the increased risk of developing parkinsonism and worsening of 
psychiatric symptoms (Kenney et al., 2006; Kenney & Jankovic, 2006).  
 
Acetylcholinesterase inhibitors, such as rivastigmine and donezepil, have been shown to be 
effective in managing cognitive symptoms in AD and Lewy body disease (Burns et al., 2006) 
but their efficacy in improving cognition is rather ambiguous in HD (Cubo et al., 2006; de 
Tommaso et al., 2007). Psychiatric disturbance in HD can be very distressing for patients and 
family members alike. There are evidences to suggest that commonly-prescribed mood 
modifying medications, e.g. fluoxetine, venlafaxine, carbamazepine, and sodium valproate are 
effective for managing these psychiatric symptoms in HD (Holl et al., 2010; Patel et al., 1996; 
Phillips et al., 2008; Ross & Tabrizi, 2011; Stewart et al., 1987). 
 
Sleep-wake cycle disruption and weight loss are the two most common physiological 
manifestations in HD (Silvestri et al., 1995; Trejo et al., 2004), both being considered as 
miscellaneous symptoms in HD. Hypnotics such as zopiclone and eszopliclone are helpful in 
managing sleep disturbance in HD (Phillips et al., 2008). Weight loss is best controlled with 
customized nutritional care plans and dietary supplementations (Brotherton et al., 2012).   
 
Physiotherapy, speech therapy, and occupational therapy are often used as non-
pharmacological therapies of HD but disappointingly, none have shown strong evidence for 
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improving HD symptoms (Bilney et al., 2003). Palliative care provided at nursing home or at 
patients’ own homes, allied with multidisciplinary team input into patient and family member 
care, is considered appropriate for managing end-stage HD (Phillips et al., 2008).  
Reviews on pharmacological management stress that there is limited evidence to support the 
use of the majority of commonly-prescribed medications for HD (Bonelli & Wenning, 2006), 
with the exception of tetrabenazine and some mood stabilizing drugs (Mestre et al., 2009). 
Nevertheless, therapies aiming at disease modification and neuro-protection have shown some 
promising results in animal models of HD and these therapies may potentially be useful for HD 
patients (Abdulrahman, 2011).   
 
 
I.2. The basal ganglia 
I.2.1. Anatomy of the basal ganglia 
The basal ganglia are functional grey matter entities that consist of collections of closely 
interconnected brain structures (Figure I.1) distributed in the telencephalon, the diencephalon, 




Figure I.1 A graphical representation of the basal ganglia and the brain. [Adapted from Gillies (2013) under the 
terms of the GNU Free Documentation Licence] 
 
The caudate nucleus (CN), putamen, nucleus accumbens, and globus pallidus, which derive 
from the telencephalon, are collectively known as the corpus striatum.  The CN, putamen, and 
nucleus accumbens, which share similar histological and neurochemical characteristics, and 
also patterns of connectivity in the basal ganglia, are usually known as the striatum (Mendoza 
& Foundas, 2008). The caudate nucleus, a C-shaped structure found on the lateral wall of the 
lateral ventricle, plays a key role in various cortico-striatal loops that serve to control cognition, 
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separated from the caudate nucleus by the anterior limb of the internal capsule and is involved 
in learning and the control of motor movements. The nucleus accumbens, which plays a role in 
reward circuitry (Ikemoto, 2007), is located where the head of caudate meets the anterior part 
of putamen, just lateral to the septum pellucidum. The striatum, which consists mainly of 
medium spiny neurons, is the main receiving centre for all inputs from the motor areas of the 
cerebral cortex and the thalamus (Hikosaka et al., 2000).  
 
The putamen and the globus pallidus are wedged together in the corpus striatum, and due to 
this appearance, are recognised as the lentiform nucleus of the corpus striatum. There are two 
main segments to the globus pallidus, the globus pallidus interna (GPi) and the globus pallidus 
externa (GPe), both named according to their position within the structure (Figure I.1). Both 
segments receive input from the caudate nucleus and putamen and communicate with 
subthalamic nucleus (STN). The STN, a small lens-shaped structure found ventral to the 
thalamus (as implied by its name), is part of the diencephalon and the only structure in the basal 
ganglia that produces glutamate, an excitatory neurotransmitter. It was once considered a relay 
station of the basal ganglia-thalamocortical circuitry but new evidence suggest that it has a role 
in the regulation of associative and limbic functions in the basal ganglia (Temel et al., 2005). 
The substantia nigra, which is divided into substantia nigra pars reticulata (SNr) and substantia 
nigra pars compacta (SNc), is part of the mesencephalon (Figure I.1) and is crucial to the control 
of brain functions such as reward-seeking, learning, and movement control. Both parts acquire 
input from caudate and putamen but only SNc sends information back to those structures. The 
SNc, which produces dopamine, is critical in the development of Parkinson’s disease (PD). The 
SNr together with GPi are the main output centres of the basal ganglia control system and 
significant projections are sent from them to the thalamus and superior colliculus.  
 
I.2.2. The basal ganglia circuitry  
The basal ganglia are integral to the smooth execution and control of voluntary movements 
(DeLong & Georgopoulos, 1981; Phillips et al., 1993). Thus the cardinal clinical signs observed 
in diseases with defective basal ganglia, such as HD and PD, are related to difficulties in 
movement initiation and disinhibition of involuntary movements (Aylward et al., 1997; 
Moisello et al., 2011). 
 
Nuclei within the basal ganglia have their own distinctive roles in the control of voluntary and 
involuntary movements. They can be physiologically divided into three main functional groups 
– input stations, modulators, and output stations. The two main input stations of the basal 
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ganglia are the CN and putamen. They receive direct input from different areas of the cortex 
and also the thalamus. The STN, GPe, and SNc are interconnected to other nuclei of the basal 
ganglia and they mainly act as the modulators of this intricate system.  The GPi and the SNr, 
which are the major output stations of the basal ganglia, provide electro-chemical signals to the 
thalamus and brainstem depending on the type of movement required (Hikosaka et al., 2000).  
 
Neural structures both within and outside the basal ganglia rely on neurotransmitters, which 
either have inhibitory or excitatory effect, to exert influence on another neural structures. There 
are three main types of neurotransmitter in the basal ganglia-thalamocortical system: (1) 
gamma-amino butyric acid (GABA), an inhibitory neurotransmitter; (2) glutamate (glu), an 
excitatory neurotransmitter; and (3) dopamine (DA), an excitatory neurotransmitter for 
dopamine type 1 (D1) receptors and an inhibitory neurotransmitter for dopamine type 2 (D2) 
receptors (Hikosaka, 1994; Hikosaka et al., 2000; Watts & Koller, 2004). 
 
The striatum is activated by convergent inputs from the cerebral cortex and thalamus 
(Groenewegen, 2003). Different populations of the striatal output neurons can be stimulated 
based on the type of signals received by the striatum, giving rise to the activation of the ‘direct’ 
or ‘indirect’ pathways of the basal ganglia circuitry (Figure I.2). The two pathways have 
opposing net effects on the final output of the basal ganglia circuitry. At resting state, when 
neither pathway is activated more than the other, the output structures exert a tonically active 
inhibitory effect on the thalamic and SNr target structures (Knierim, 2010). Since dopamine has 
differential effects on the two type of dopamine receptors, nigro-striatal neurons can 
simultaneously activate the ‘direct’ pathway and suppress the ‘indirect’ pathway or vice versa 
to produce a net effect of cortical excitation or inhibition.  
  
Nigro-striatal output neurons activate the ‘direct’ pathway via D1 receptors and in this pathway, 
the striatum directly innervates the output stations of the basal ganglia via the striatal-pallidal 
and striatal-nigral projections. Activation of the ‘direct’ pathway produces a ‘double negative’ 
effect, resulting in a reduction of tonic inhibitory effects on thalamus and SNr, thereby 
facilitating movement initiation (Gerfen & Wilson, 1996). When the ‘direct’ pathway is 
activated, cortical projections to the striatum use glutamate, an excitatory neurotransmitter, to 
excite the striatal neurons resulting in the excitation of the striatal neurons. Striatal neurons, 
upon excitation, release inhibitory neurotransmitters, GABA and substance P, to reduce the 
activity of neurons in the GPi and SNr complex, which in turn reduces the inhibitory effect of 
the GPi and SNr complex on thalamus. The final outcome of this pathway is a reduction in the 
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inhibition on thalamus and to enhance the excitatory drive from the thalamus to the cortex to 













Figure I.2 A schematic illustration of the basal ganglia-thalamocortical circuits and its neurotransmitters. Both 
the ‘direct’ (yellow) and ‘indirect’ (blue) pathways are shown. Red arrow indicates excitatory output and black, inhibitory 
output. Structures illustrated are: GPe, globus pallidus externa; STN, subthalamic nucleus; SNc, substantia nigra pars compacta; 
GPi/SNr, globus pallidus interna and substantia nigra pars reticulata complex; and PPN, pedunculopontine nucleus. 
Neurotransmitters involved are: GABA, gamma-amino butyric acid; glu, glutamate; enk, enkephalin; subs P, substance P; and 
DA, dopamine. The two sub-type of DA receptors are represented as D1 and D2 respectively. Illustration adapted with 
permission from Watts & Koller (1997, p. 240) and Hikosaka et al., (2000).  
 
In the ‘indirect’ pathway, the input and output stations are interposed by the GPe and STN. The 
predominant dopamine receptor expressed by the striatal output neurons in the ‘indirect’ 
pathway is the D2 receptor whilst the two main neurotransmitters in this pathway are GABA 
and enkephalin (Alexander, 1994; Groenewegen, 2003; Watts & Koller, 2004). The activation 
of the ‘indirect’ pathway excites the striatal neurons that project to GPe. This results in an 
increase in GABAergic activity (inhibitory effect) of the striatal neurons on the GPe, hence 
reducing the activity in the GPe. At resting state, the GABAergic neurons in GPe exert an 
inhibitory influence on the neurons in STN. Therefore, a decrease in the inhibitory activity in 
GPe consequentially leads to less inhibition on the STN, which in turn enhances the inhibitory 
effects of GPi on thalamus. The end result of the ‘indirect’ pathway is a reduction in motor 
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It is clear that the integrity of the basal ganglia and its associated pathways are crucial in the 
initiation and control of all movement generated in the thalamo-cortical and the brainstem 
networks (Hikosaka et al., 2000). Therefore, it is not unexpected that different pathologies of 
the basal ganglia (e.g. HD and PD) can lead to distinct motor signs and symptoms.   
 
 
I.2.3. The basal ganglia and cognition  
The functionality of the basal ganglia goes beyond the scope of being a modulator of the motor 
system, as it is also capable of receiving inputs with affective meaning and abstract in nature 
such as sensation, motivation, and etc. (Aylward et al., 1997; Huntington Disease Collaborative 
Research Group, 1993). For that reason, this structure participates in working memory, 
associative learning, modifying learned behaviour, and the control of affective functions.  
 
Although there is no consensus on the exact pathways by which the basal ganglia influence 
cognitive function, it has been proposed that they utilise similar mechanisms to the motor 
pathways, i.e. disinhibition and inhibition mechanisms, to determine what information is to be 
selected and relayed to the frontal cortex for further processing (Stocco et al., 2010). In support 
of this notion, an animal study found that the prefrontal cortex projections to the striatum are 
essential in the inhibition and modification of learned behaviour (Graves et al., 2004). Further, 
DA, a key neurotransmitter in the basal ganglia, participates in processes involving associative 
and reinforcement learning (Jahanshahi et al., 1993) and the infusion of dopamine into striatum 
improves learned behaviour performance (Stocco et al., 2010).  
 
 
I.2.4. The basal ganglia and motor symptoms of HD 
Huntington’s disease is characterised by atrophy of the striatum, i.e. caudate nucleus and 
putamen. Longitudinal imaging has shown that in addition to a reduction in striatal volume, 
total basal ganglia volume also decreases over time in HD (Aylward et al., 1997). The main 
pathological manifestation of HD in the basal ganglia is the degeneration of striatal medium 
spiny neurons accompanied by fibrillary astrocytosis and relative preservation of aspiny 
neurons (Li & Li, 2006; Watts & Koller, 1997). There are two distinct populations of striatal 
medium spiny neurons, the D2 receptor-expressing striato-GPe neurons that are enriched with 
enkephalin, and the D1 receptor-expressing striato-GPi neurons that are enriched with 
substance P.  
 































Figure I.3 Functional circuitry of the basal ganglia in HD. Predicted changes in the basal ganglia consequent to: 
(A) a selective loss of D2 receptor striatal neurons resulting in chorea; and (B) additional loss of D1 receptor striatal neurons 
leading to akinesia and rigidity. Increased activity is shown by thick lines, normal by normal sized lines, and reduced activity 
by dashed lines. GPe, globus pallidus externa; STN, subthalamic nucleus; SNc, substantia nigra pars compacta; GPi/SNr, 
globus pallidus interna and substantia nigra pars reticulata complex; and PPN, pedunculopontine nucleus. Neurotransmitters 
involved are: GABA, gamma-amino butyric acid; glu, glutamate; enk, enkephalin; subs P, substance P; and DA, dopamine. 
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Chorea in HD: Preferential loss of D-2 receptor striatal neurons 
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Current evidence suggest that there is a differential pattern of striatal neuron degeneration in 
early HD, with striato-GPe neurons being preferentially degenerated compared to striato-GPi 
neurons (Albin et al., 1992; Glass et al., 2000; Reiner et al., 1988; Richfield et al., 1995). These 
findings provide a convenient explanation for the occurrence of chorea, which is usually the 
first reported motor symptom in manifest HD (Kirkwood et al., 2001). Based on the current 
model of basal ganglia function, a selective loss of striatal neurons that project to the GPe 
translates to a deficit in the ‘indirect’ pathway (Figure I.3A). This results in the enhancement 
of the inhibitory effects of the GPe on STN and GPi and SNr complex, which in turn reduces 
GPi and SNr complex inhibition on the thalamus, leading to an increased tendency of 
thalamocortical structures to discharge spontaneously, and hence the occurrence of involuntary 
movement (DeLong, 1990; Reiner et al., 1988). 
 
As the disease progresses, striatal neurons that project to the GPi and SNr complex, which are 
relatively preserved in early HD, are also affected, resulting in widespread loss of striatal 
projection neurons (Glass et al., 2000; Hedreen et al., 1991; Sotrel et al., 1991). Chorea tends 
to diminish and be replaced with akinesia and rigidity in later stages of typical adult-onset HD 
(Roos, 2010; Storey & Beal, 1993). This change in the motor symptoms correlates well with 
the degenerative changes in the striatum. The extensive loss of striatal projection neurons would 
be expected to also cause an impairment in the ‘direct’ pathway of the basal ganglia circuit 
(Figure I.3B).  A reduction in the participation of the cortico-striato-pallido-thalamic pathway 
would ensue, i.e. a reduction of inhibition on the GPi and SNr complex by striatum, thus leading 
to a decrease in motor activity and increasing rigidity. 
 
In juvenile, akinetic-rigid and Westphal variant HD, akinesia and rigidity are the predominating 
motor symptoms and most often these motor signs occur in the absence of chorea. It has been 
shown that in these cases of HD, there is a non-selective degeneration of striatal neurons (Albin 
et al., 1990). This suggests that in these HD variants, both the ‘direct’ and ‘indirect’ pathways 
might be equally affected (Figure I.3B). The net effect from an impairment of ‘direct’ and 
‘indirect’ pathways likely leads to an uninterrupted inhibition of thalamus by the GPi and SNr 
complex. This is similar to advanced stage of adult-onset HD, and hence the akinesia and 
rigidity in these HD variants.  
 
Regardless of the HD phenotype, motor symptoms in HD correlate well with the current 
understanding of the basal-ganglia thalamocortical circuity and basal ganglia degeneration in 
HD. It can therefore be summarised that chorea in HD results from a preferential loss of the D2 
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receptor-expressing striato-GPe neurons and that akinetic-rigid HD is likely consequent upon 
additional loss of D1 receptor-expressing striato-GPi neurons in the basal ganglia.  
 
 
I.3. Human eye movement 
All types of eye movements are affected in various neurodegenerative disorders, e.g. HD, PD, 
AD, and motor neuron disease (Anderson & MacAskill, 2013). The relevance of eye movement 
in HD pathology will be discussed in the sections to follow.  
 
I.3.1. The purpose of human eye movement 
Eye movements are highly versatile movements that may occur under wide variety of 
circumstances (e.g. when the head or an object of interest is stationary or in motion) (Swenson, 
2006). It enables us to better perceive the surrounding environment by allowing the eyes to 
always keep the image of the object of interest on the fovea, the part of the retina with the 
highest visual acuity. 
 
I.3.2. Types of human eye movement 
There are five main types of human eye movement: (1) saccades; (2) smooth pursuit; (3) 
vergence; (4) the vestibular-ocular reflex (VOR); and (5) the optokinetic reflex (OKR). All five 
types of eye movement have their own unique function (Swenson, 2006; Vilis, 2013).  
 
A saccade serves to bring the image of an object of interest to the fovea in a rapid manner. 
However, due to the rapid nature of movement, visual acuity is compromised during saccades. 
Smooth pursuit allows the smooth tracking of a moving object by keeping the image of that 
moving object stationary on the fovea while the object moves. Vergence eye movements – 
convergence and divergence – involve the eyes rotating in the opposite direction to one another. 
They serve to simultaneously direct the foveae of both eyes on an object whether it is near or 
far away (Purves et al., 2001). The VOR and OKR, being the first two eye movements to have 
developed in the course of evolution (Walls, 1962), are considered the most rudimentary type 
of eye movements. The VOR is a short-loop unconscious reflex that serves to maintain the 
image stationary on the retina during fast or slow head movements. It allows compensation for 
head movements by generating conjugating eye movement of equal magnitude in the opposite 
direction to the head motion. The VOR is effective for compensating sudden and brief head 
movements whilst the OKR, which is associated with the sense of self-motion, is recruited when 
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there is a prolonged head rotation and a slip of large full-field visual stimulus on the retina 
(Vilis, 2013). Under normal circumstances, it is often difficult to distinguish OKR from VOR 
because both types of eye movement work in a concerted effort to achieve visual stability.   
 
I.3.3. Classification of the saccadic system 
Saccades are rapid eye movements that can be generated in response to external or internal cues. 
Saccades can be hierarchically arranged depending on the behavioural context. The quick 
phases of vestibular nystagmus or optokinetic nystagmus (OKN) are innate saccades elicited in 
the absence of intervention by higher centres and so are regarded as relatively rudimentary 
(Leigh & Zee, 2006). Simple visually-guided (reflexive) and complex volitional saccades 
require greater involvement of the higher cortical centres (Pierrot-Deseilligny et al., 1991a, 
1991b). Simple visually-guided saccades are generated through simple sensorimotor translation 
processes upon the appearance of external cues. By contrast, the generation of complex 
volitional saccades – delayed pro-saccades, memory-guided saccades, and anti-saccades – 
involves the interaction of multiple cognitive processes that includes saccade inhibition and 
interpretation of contextual cues (Hahn-Barma et al., 1998; Pierrot-Deseilligny et al., 2004). 
Despite a difference in the initiation process, all type of saccades share a common final neural 
pathway in the brainstem and ocular muscles.  
 
I.3.4. The basic mechanics of saccades 
The control of saccades involves the close interaction of both cortical and subcortical structures 
via multiple complex neuronal networks (Gaymard et al., 1998). Figure I.4 illustrates the 
interactions between cortical and subcortical structures in the control of saccades. The frontal 
eye field (FEF), parietal eye field (PEF), and supplementary eye field (SEF) are the key areas 
in the cerebral cortex involved in triggering saccade generation. The dorsal lateral prefrontal 
cortex (dlPFC) and the anterior cigulate gyrus are involved in governing the decisional 
processes of ocular motor behaviour (Gaymard et al., 1998; Pierrot-Deseilligny et al., 2005).  
 
An external visual cue, when processed by the visual cortex of the cerebrum, is the key event 
for the activation of saccadic system. The visual cortex subsequently activates the PEF, a 
visuospatial integration centre and also a principal region for initiating reflexive saccades. The 
dlPFC receives afferent tracts from the posterior parietal cortex and anterior cingulate gyrus, 
and sends efferent tracts to the FEF, SEF, and superior colliculus (SC). This area of the 
prefrontal cortex has been demonstrated to play an important role in: (1) the inhibition of 
reflexive saccades generated by the PEF through its direct projection to SC; and (2) integrating 
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spatial and temporal working memory for intended saccades via its direct tract to the FEF and 
SEF (Pierrot-Deseilligny et al., 2005). Depending on the types of saccade that are required, 
specific cortical output signals are then relayed to the basal ganglia via corticostriatal 























Figure I.4 The human saccadic pathways. A simplified schematic illustration of the brain structures involved in the 
initiation of saccades. VC, visual cortex; PEF, parietal eye field; FEF, frontal eye field; SEF, supplementary eye field; dlPFC, 
dorsolateral prefrontal cortex; CN, caudate nucleus; SNr, substantia nigra pars reticulata; and SC, superior colliculus are shown. 
Red arrow indicates excitatory output and black blunted arrow, inhibitory output. Illustration adapted with permission from 
Gaymard (1998) and Hikosaka et al., (2000).  
 
I.3.5.  The relationship between basal ganglia and saccades 
The basal-ganglia thalamocortical pathways exert influence on the saccadic system via the 
inhibitory and excitatory effects of the basal ganglia (Agostino et al., 1988). There is an area in 
the CN, termed the visuo-oculomotor region, that contains a population of neurons sensitive to 
visually- and saccadic-related activities in the cerebral cortex (Hikosaka et al., 2000).  In 
addition to receiving inputs from the FEF, SEF, PEF, and dlPFC, the CN is also connected to 
the SNr and SC (Agostino et al., 1988).   
 
The SNr, at resting state, exerts a tonic inhibitory effect on the SC. The CN can, however, 
phasically increase its inhibitory effect on the SNr via the ‘direct’ pathway to negate the tonic 
inhibitory effects of the SNr on SC and thus facilitate the initiation of saccades (Figure I.2). It 
has been postulated that the disinhibition effects of the CN on the SC provides a more efficient 
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control of the saccadic system compared with a system that relies on just neural excitation, since 
the latter mechanism would more likely result in saccades being generated inappropriately 
(Agostino et al., 1988).  
 
By contrast, activation of the ‘indirect’ pathway increases the inhibition on GPe which results 
in an enhancement of SC inhibition by the SNr (Agostino et al., 1988). This inhibitory effect of 
the SNr on SC is further enhanced by the excitatory effect by STN, which is accentuated by the 
inhibition of GPe. The STN can also be directly activated by the higher centres and such 
continuous stimulation of STN results in the SNr being tonically activated which in turn exerts 
an inhibitory effect on SC (Figure I.2), facilitating maintenance of fixation and saccade 
inhibition (Hikosaka et al., 2000). 
 
The two pathways outlined above are not mutually exclusive as they may occur concurrently 
or in sequence, depending on the type of saccades required. In summary, the basal ganglia via 
the two pathways contribute to the behavioural aspects of saccadic production by (1) 
suppressing saccades as appropriately; and (2) supporting the preparation of an impending 
(internally-cued) saccade by the suppression of unwanted reflexive saccades (Folstein et al., 
1975). Given the importance of basal ganglia in the effective control of saccades, it is no 
surprise that any lesions within the basal ganglia, whether it is vascular, neoplastic or 
degenerative (e.g. HD and PD), can have adverse effects on the neurophysiology of this intricate 
system.  
 
I.3.6. Eye movement in HD 
Eye movement abnormalities have long been recognised to be a feature of manifest HD (Andre-
Thomas et al., 1945; Derceux, 1945) but such deficits only came to be objectively quantified 
using electrooculography in the late 1960s (Starr, 1967). 
  
Saccade apraxia and slowness in saccade initiation are the two most commonly reported 
saccadic deficits in HD (Ali et al., 2006; Avanzini et al., 1979; Becker et al., 2009; Couette et 
al., 2008; Fielding et al., 2006; Lasker et al., 1987; Starr, 1967). The co-occurrence of saccade 
apraxia and head thrusting movements in HD have led to the suggestion that the latter are 
compensatory manoeuvres used by HD patients to facilitate saccade initiation and gaze shifting 
(Becker et al., 2009). Saccadic slowing is another characteristic feature, particularly in younger-
onset patients, but it is often absent in late onset cases (Avanzini et al., 1979; Becker et al., 
2009; Hotson et al., 1984; Peltsch et al., 2008; Starr, 1967). There is conflicting evidence on 
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whether horizontal or vertical saccades are more affected in HD. Some studies reported that 
saccadic performance is worse in the vertical direction than in the horizontal direction (Bollen 
et al., 1986; Hotson et al., 1984; Lasker et al., 1987, 1988; Leigh et al., 1985; Rupp et al., 2012). 
However, this suggestion is disputed by others, claiming that the opposite is true (i.e. horizontal 
saccades are more affected than vertical saccades) based on clinical observation (Anderson & 
MacAskill, 2013) and electrooculography (Beenen et al., 1986). 
  
It has also been demonstrated that HD patients have a higher tendency than controls to make 
timing and directional related errors in saccadic tasks involving selective inhibition and 
initiation of saccades, i.e. memory-guided (Blekher et al., 2006; Blekher et al., 2004; Lasker et 
al., 1987; Peltsch et al., 2008) and anti-saccade (Becker et al., 2009; Blekher et al., 2006; Patel 
et al., 2012; Peltsch et al., 2008; Rupp et al., 2011; Turner et al., 2011) tasks.  Some saccadic 
parameters such as saccadic velocity (Golding et al., 2006), latency (Peltsch et al., 2008; 
Winograd-Gurvich et al., 2003), and error rates (Patel et al., 2012; Tabrizi et al., 2010) were 
found to reflect disease severity in HD.  
 
Leigh et al. (1983) and Oepen et al. (1981) demonstrated that there was an increased disruption 
of smooth pursuit by saccades in HD, with performance being further impaired when irrelevant 
visual distractors were introduced during the task. These findings suggest that in HD, in addition 
to saccade apraxia, there is an increased difficulty in suppressing competing motor responses 
(Henderson et al., 2011). OKN, vestibular nystagmus, and vergence were also found to be 
affected in HD (Leigh et al., 1983; Oepen et al., 1981). Although earlier evidence suggest that 
VOR, a reflex eye movement that stabilises gaze during head movement, is relatively preserved 
even in advanced HD (Leigh et al., 1983), a later study revealed that in manifest HD, there is a 
deficit in VOR recalibration with changing visual conditions (Fielding et al., 2004).  
 
Eye movement abnormalities are not exclusive to manifest HD, as there are evidences to 
suggest that saccadic deficits precede the onset of overt motor symptoms, the ultimate criterion 
for clinical diagnosis of HD. Prolonged latency, increased variability in saccadic performance 
(Blekher et al., 2006; Blekher et al., 2004; Tabrizi et al., 2009) and higher rates of error in 
voluntary-guided saccadic tasks have been reported in premanifest HD (Kloppel et al., 2008; 
Rupp et al., 2011; Rupp et al., 2012; Turner et al., 2011). Saccadic performance declines 
progressively with disease progression in manifest HD but longitudinal studies in pre-clinical 
at-risk individuals have not been revealing (Beenen et al., 1986; Rubin et al., 1993; Tabrizi et 
al., 2010).   
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I.4. Human arm movement   
I.4.1 The basic organisation of the human motor system 
The human motor system is organised in a manner such that motor signals are sent from higher 
cortical centres via neuronal tracts to the spinal cord before diverging into individual neural 
pathways (via nerve roots and nerves) and ultimately, motor neurons that innervate the muscle 








Figure I.5 A simplified schematic illustration of human motor system showing the main descending pathways 
and the structures involved. Schematic illustration is adapted from the neuroanatomy course book of the University of 
Wisconsin-Madison (2006). Image subset, which is adapted from Wikimedia Commons (2008) under the GNU Free 
Documentation License, illustrates motor areas of the cerebral cortex.  
 
Most of the motor commands originate from the primary motor area (Broadmann’s area 4) 
located anterior to the central sulcus.  The dorsal and ventral premotor cortices, which are 
anterior to the primary motor area and occupy part of Broadmann’s area 6, modulate voluntary 
movement relative to the surrounding environment and participate in the generation of 
movements that are triggered by arbitrary cues (Dum & Strick, 2002). An area rostral to the 
primary motor area, termed the supplementary motor area (SMA) (Dum & Strick, 2002), 
contributes to the programming of internally-generated movement and movement sequences 
(Rothwell, 2012). The axons of motor projection neurons from these areas give rise to the 
corticospinal and reticulospinal tracts. The corticospinal tract provides a direct route from the 
cortical centres to the spinal cord and carries motor signals intended predominantly for the distal 
muscles of the limbs (Rothwell, 2012). The recticulospinal tract which mainly supplies the 
proximal and axial muscles, is interposed by the pons and reticular formation of the brain 
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Three subcortical structures – the vestibular system, cerebellum, and basal ganglia – have 
distinct roles in the control of motor movement (Rothwell, 2012). The vestibular system, which 
constitutes of semicircular canals and otolith organs of the inner ear, is the only subcortical 
structure to have direct projections to the spinal cord and it is responsible for balance during 
posture. Both the cerebellum and basal ganglia interact with motor areas in the cortex. The 
cerebellum is a considered a feedback centre as it compares the motor outputs from cortical 
areas to sensory inputs that relay the outcome of the motor signals. The basal ganglia functions 
as an information processing centre for the motor system (Rothwell, 2012).  
 
Neurons in the spinal cord are arranged according to the proximity of the muscle fibres to the 
spinal cord. Motor neurons innervating the distal muscles travel in the dorsolateral pathway of 
the spinal cord whereas the proximal and axial muscles are innervated by motor neurons in the 
ventro-medial pathway (Figure I.5). The final common pathway of the motor system (Figure 
I.5) involves the termination of a descending tract at the anterior horn of spinal cord and motor 
impulses are then projected to a interneuron before getting sent to the destined motor neurons 
which ultimately activates the muscle fibres to generate movements (Lemon, 2008).  
 
 
I.4.2. The basis of human arm movement control 
The control of human movement can be described as an interaction of processes involving 
ideation, planning, selecting, executing, and learning (Campos & Calado, 2009). An idea, 
defined as the goal of the movement, must first be conceptualised by an individual to initiate 
the processes involved in movement control. Action plans required to achieve the goal are then 
developed and subsequently, motor signals related to these action plans are generated to 
ultimately stimulate the different muscle groups to execute the desired movement.   
 
Decades of human arm movement control research have highlighted the dynamic nature of 
processes like planning, executing, and learning in the control of arm movement (Flash & 
Sejnowski, 2001). As commented by Campos et al. (2009), the complexity of motor control is 
mainly due to the great redundancy in the human motor system. For instance, in a simple 
reaching movement, there are multiple paths and velocity profiles that an individual may choose 
to perform that movement, and these variables will all contribute to redundancy in the system 
(Campos & Calado, 2009). Humans, however have surprisingly been consistent in movement 
control and several motor control theories have attributed this to the ability of the motor system 
to modify these processes (e.g. planning, executing, and learning) and movement specifications 
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(e.g. movement paths and velocity profiles) involved in movement control (Campos & Calado, 
2009). Despite the different views on how specifications in movement control may be modified 











Figure I.6 The hierarchical structure for movement specification in arm movement control.  Illustration adapted 
with permission from Campos et al., (2009).  
 
 
One aspect of limb control system that has garnered significant interest in recent years is 
response inhibition, which refers to the ability to suppress unwanted somatic actions that are 
deemed inappropriate in a given behavioural context. Several areas in the ventral and medial 
prefrontal cortex, specifically the inferior frontal gyrus, SMA, and pre-SMA, are implicated in 
motor suppression, as it was found that damage in these area results in a significant delay in 
response cancelling (Chambers et al., 2009). In addition, the basal ganglia and their associated 
neural circuits are essential to response inhibition. Evidence of this is that the extent of deficit 
in movement inhibition found in a circumscribed lesion of the basal ganglia is comparable to 
damage in the prefrontal cortex (Rieger et al., 2003). Response inhibition is, however, not 
limited to just inhibition of motor response. Several behavioural related processes such as 
response selection, working memory and attention were found to contribute to the underlying 
control mechanism. Consistent with this, performance in motor response inhibition declines 
with an increased working memory load of the task. Further, a review by Chambers et al. (2009) 
provided evidence of activation in various cortical areas associated with maintenance of 
working memory and attention, such as dlPFC, anterior cingulate cortex, and right parietal 
cortex, during response inhibition. In summary, inhibitory control of somatic actions is likely 
composed of multiple components, with a motor component that inhibits a pre-potent motor 
response, and a series of cognitive processes that exert cognitive influences on the inhibitory 
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I.4.3. The role of vision in the control of somatic actions  
In the course of evolution, many foveate animals of different evolutionary backgrounds have 
developed a similar pattern of eye movement, often described as the ‘saccade and fixate’ 
strategy (Land et al., 1999). This strategy enables the rapid redirection of gaze to a new object 
in the environment, and keeping the eyes still during fixation to allow visual information to be 
taken in. The concerted interactions between these two types of eye movement form the basis 
for visual perception for foveate animals, which is essential for comprehension of self-
orientation in relation to the external world.  
 
One of the earliest studies to identify the relationship between this eye movement strategy and 
somatic actions was that of Buswell et al., (1920) who demonstrated that the duration of 
fixations during reading varied according to setting, with fixations being longer when a person 
was reading aloud than when reading silently. It was however, not until the development of 
head-mounted eye movement recording devices that the significance of eye movement during 
naturalistic and unnaturalistic tasks could be appreciated.  
 
In a study of eye movement when performing normal daily tasks, approximately 250 fixations 
were made over a short period of two minutes and most of these fixations were in relation to 
the tasks being performed (Hayhoe, 2000). The relationship between eye movement and 
somatic actions was further explored by Land et al. (1999), who showed that one third of all 
fixations were related to subsequent somatic actions whereas the other two thirds were linked 
to the somatic action that was being performed currently. One might assume that fixation would 
be obsolete in automated actions (i.e. those that can be performed with minimal consciousness) 
but the same study demonstrated that to the contrary, fixations were still performed in this 
setting, albeit to a lesser extent than in non-automated actions (Land et al., 1999). Thus, vision 
has a vital role in the human motor control system, especially locating, directing, guiding, and 
checking during somatic movement (Hayhoe, 2000; Land et al., 1999).   
 
I.4.3.1 The coordination of eye, head, and body movements in the gaze 
system 
The relocation of gaze (location where one is looking), depending on the size of rotation (gaze 
rotation), can be done by eye movement alone or in combination of head and trunk movements. 
When necessary, eye movement can achieve up to ± 50° of gaze rotation in the horizontal plane. 
However, eye movement is often accompanied by head movement when gaze rotation is greater 
than 10°. Given that neck rotation allows a maximum of  ± 90° of head movement, desired gaze 
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rotation greater than 140° would require additional involvement of trunk rotation (Land, 2006). 
In any given gaze rotation, eye movement generally precedes head movement, with trunk 
movement recruited when combined eye and head movements cannot achieve the gaze rotation 
required (Figure I.7).  
 
Figure I.7 Relationship between eye and head movements.  In facilitating gaze rotation of less than 50˚, gaze 
movement (green line) is initially facilitated by the eye (purple line) and via VOR, the head (blue line) would subsequently 
catch up to return the eyes to neutral position. Illustration modified with permission from Land (2006). 
 
 
I.4.3.2. The gaze-action system 
Land (2009) postulated that there are four distinct but linked systems in performing visually-
mediated actions and these systems are collectively known as the gaze-action system. Firstly, 
the gaze system initiates eye movement to direct the eyes to the visual stimulus. The visual 
system will then process this visual information for the motor system to enable the motor system 
to generate appropriate motor actions. These systems are controlled by a ‘master controller' 
termed the schema system, which is capable of reprogramming activities and interactions of the 
different systems based on the internal representation of a desired task, to produce a sequence 








Figure I.8 Components of the gaze-action system.  The interactions of the four sub-systems (schema, gaze, visual, 
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Upon the activation of a movement by the motor system, the visual system, with the necessary 
adjustments made by the gaze system, monitors the execution of that motor action. The schema 
system is informed when the action is completed and depending on the task involved, this 
information would either act as a feedback mechanism for the existing schema to modify the 
action involved or lead to the creation of a new schema for a new motor action. The significance 
of the schema system acting as the master control of the three systems was highlighted in an 
eye-hand movement study in which it was found that prior to the start of an eye-hand task, the 
‘intrinsic salience’ of objects was found to have an effect on eye movement (i.e. where to look) 
but such an effect dissipated on the commencement of an eye-hand task, suggesting that there 
is a ‘top-down’ control (i.e. schema system) on the behaviour of the eye when performing a 
visually-mediated motor action (Land & Hayhoe, 2001).   
 
An action is closely supervised by the visual system but gaze often abandons the current motor 
action prior to the completion of the task, in order to provide new visual formation necessary 
for generating an impending (i.e. successive) action. However, the pattern of gaze movement 
in relation to somatic movement changes according to the familiarity of the task (Land, 2006). 
Fixation has repeatedly been shown to precede learned somatic action by up to one second 
(Butsch, 1932; Patla & Vickers, 2003; Weaver, 1943) whereas during the process of acquiring 
new motor skills, fixations tend to be more closely coupled, in terms of timing, to the somatic 
actions involved (Sailer et al., 2005). 
 
In humans, the ability to express and adapt learned motor movement is dependent upon varying 
combinations of feedback control and feed-forward control. Generalisation of motor learning 
enables humans to apply a motor skill learned in one context to another context. However, 
generalisation can either be beneficial or detrimental depending on the contexts of an intended 
movement. A beneficial example of generalisation might be that playing tennis may confer 
advantage when learning other types of racquet sport. In these circumstances, knowledge is 
compatible with intended action. An example of a conflict between knowledge and action is the 
‘broken escalator’ phenomenon. This effect, which is usually accompanied by a brief sensation 
of imbalance, causes a person to step inappropriately fast on a moving platform that is no longer 
moving even when this is obvious to the person. The main mechanism for this is that via feed-
forward adaption, there is a build-up and internalisation of a specific visuospatial context 
leading to the adaptation of gait which persisted even when the action, termed aftereffect, is no 
longer appropriate (Bronstein et al., 2009). Aftereffects can, however, be enhanced or inhibited 
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via high-level interactions between procedural and declarative memory, which are subserved 
by various cortical and subcortical structures (Bronstein et al., 2009).  
 
I.4.4. Upper limb movement in HD 
Motor impairment, in addition to being a characteristic sign of HD, is the key criterion for 
determining the onset of phenoconversion in at-risk individuals. A study by Hefter et al. (1987) 
was one of the earliest studies to objectively measure the kinematics of somatic movement in 
manifest HD.  The authors reported that in manifest HD, there was marked prolongation in 
contraction time to reach peak force in various muscle groups of the hand during ballistic 
forefinger movement. Further, relative to controls, there was increased variability in muscle 
contraction time in over 90% of manifest HD patients and 38% of premanifest HD individuals. 
Bradykinesia in HD is not limited to ballistic forefinger movement, as slowing is also observed 
in both simple and complex movement tasks in other muscle groups (Carella et al., 2003; Curra 
et al., 2000; Lemay et al., 2008). 
 
Subsequent studies on the kinematics of upper limb movement in HD have consistently 
demonstrated the presence of akinesia, i.e. prolonged reaction time in manifest HD (Berardelli 
et al., 1999; Boulet et al., 2005; Gordon et al., 2000; Lemay et al., 2008; Quinn et al., 1997; 
Say et al., 2011; Schwarz et al., 2001). Manifest HD is also associated with less efficient control 
of upper limb movement. Unlike controls, who were found to generally move in a straight path, 
manifest HD patients had a greater tendency to produce a more curvilinear path during reaching 
(Carella et al., 2003; Quinn et al., 1997; Quinn et al., 2001). Movement accuracy is also 
impaired in manifest HD, with higher rates of movement error (Phillips et al., 1996; Say et al., 
2011) and greater difficulty in correcting erroneous movements (Boulet et al., 2005; Smith et 
al., 2000) than controls.  
 
Somatic movements of HD patients are associated with a greater number of sub-movements 
and greater cycles of acceleration and deceleration (Phillips et al., 1996; Quinn et al., 1997) 
than controls. Motor performance in manifest HD is also influenced by the motor-task involved 
(Carella et al., 2003; Georgiou et al., 1997). In a quantitative study of chorea, Mann et al. (2012) 
noted that there was a greater fluctuation in arm velocity in manifest HD in a task involving 
subjects maintaining their hands in a constant position. Despite an increase in velocity variance 
at resting state, velocity of purposeful upper limb movement in HD, at least at movement 
initiation, is comparable to controls (Carella et al., 2003; Quinn et al., 1997). There is however, 
considerable delay in movement transition in sequential movement tasks in manifest HD 
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indicating an impairment in movement planning and selection in HD (Agostino et al., 1992; 
Gordon et al., 2000; Serrien et al., 2002; Thompson et al., 1988). There is also a greater reliance 
on visual guidance when performing a motor task as evidenced by observations that the 
availability of advance visual information (Georgiou et al., 1995) and visual feedback 
information (Boulet et al., 2005; Carella et al., 2003) have stronger influence on motor 
performance in HD patients than in controls.  
 
Quantitative changes in motor function have also been reported in premanifest HD with 
movements being slower (Hefter et al., 1987), more variable (Rao et al., 2011; Smith et al., 
2000), less efficient (Smith et al., 2000), and less accurate than controls. Further, Rao et al. 
(2011) demonstrated that the coordination of movement sequences is impaired in premanifest 
individuals. Based on these observations, it is natural to suggest that the objective measurement 
of motor function in HD may potentially be a useful marker of disease progression for HD (Rao 
et al., 2011; Smith et al., 2000). There are however, conflicting findings when attempting to 
correlate these measurable motor changes with disease severity (Gordon et al., 2000; Ruiz et 
al., 2000), suggesting that kinematic changes of motor movement in HD do not perfectly reflect 
disease status.  
 
I.5 Biomarkers and HD 
The term biomarker was previously applied only to a biological samples that could determine 
patient’s disease state or response to a drug (Baker, 2005). It has evolved over time, however, 
to include any biological measurements, such as physiological or proteomic analysis, that may 
reflect the underlying pathological changes in a disease. In 2001, the National Institutes of 
Health defined the term biomarker as ‘a characteristic that is objectively measured and 
evaluated as an indicator of normal biological processes, pathogenic processes, or 
pharmacological responses to a therapeutic intervention or other health care intervention’ 
(Biomarkers Definitions Working Group, 2001). 
 
Biomarkers are useful across the entire disease spectrum of a disease (Figure I.9), i.e. before, 
during, and after diagnosis (Kumar & Sarin, 2009). Before diagnosis, the role of biomarkers is 
to identify at-risk individuals who may benefit from early intervention, or to predict disease 
onset. During diagnosis, biomarkers are used as tools for objective and reliable identification 
of patients with a disease. After diagnosis, biomarkers may assess severity of a disease, provide 




Figure I.9 The role of biomarkers across the course of HD. The pathological process will begin at some point in a 
gene positive individual, initially resulting in non-specific symptoms and later, overt clinical signs that enable the clinical 
diagnosis of HD. *A global marker can be used for monitoring the underlying neuropathological changes that may or may not 
be accompanied with disease phenotype progression. An ideal progression marker tracks clinical changes in premanifest HD 
and continues to monitors clinical progression and disease state over the course of manifest HD. A process marker, which may 
not relate to disease state, may provide insights into the biological compounds involved in the disease process. ^The diagnosis 
of manifest HD can be expedited if there is a diagnostic marker that can positively identify those premanifest HD individuals 
with non-specific symptoms. Early diagnosis of manifest HD may potentially allow the use of disease-modifying therapies at 
the earliest possible. ῀A pharmacodynamics marker is likely to be helpful in determining pharmacological efficacy of these 
therapies. Illustration adapted with permission from Michell et al., (2004). 
 
 
According to Hersch and Rosas (2011), an ideal biomarker in HD should: (1) clearly reflect 
disease conversion from premanifest to manifest HD and disease progression from early to 
advanced HD; (2) be objective and reproducible; (3) be specific to changes in disease status; 
(4) be safe and non-invasive; (5) be inexpensive and user-friendly; (6) be easily repeated on the 
same patient so as to provide a profile of disease progression. Based on the roles of biomarkers 
in HD, they can be divided into four main categories: (1) global biomarkers; (2) process 
biomarkers; (3) pharmacodynamics biomarkers; and (4) progression biomarkers (Figure I.9). 
Global biomarkers are measurements (e.g. brain size and basal ganglia volume) that might 
possibly capture the global direction of HD. Process biomarkers (e.g. proteomics and 
metabolomics approaches) are laboratory measures of biological compounds that contribute to 
the disease process. Pharmacodynamics markers are measures of drug-body interactions that 
provide indications to whether a treatment modulates a desired target and sequentially assess 
the pharmacological efficacy of such treatment. Any measures that closely correspond to the 
clinical progression of HD (e.g. disease phenotypes, disease state, and etc.) are termed 
progression markers. An ideal progression marker should be able to track clinical changes in 
both premanifest and manifest HD. Such markers may potentially serve as surrogate endpoints 
^Diagnostic    
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for monitoring treatment efficacy and may also reflect the underlying biological progression of 
a disease. Although a definitive biomarker is yet to be identified in HD, several promising ones 
are emerging. 
 
A well-established genetic diagnostic marker for HD is the direct genetic identification of the 
defective HD gene and the quantification of CAG repeat size, which essentially determine if 
individuals will develop HD in their lifetime. It is widely acknowledged that despite there is a 
strong inverse relationship between CAG repeat size and the onset age for manifest HD, repeat 
size is a poor predictor of disease onset (Andrew et al., 1993; Myers, 2004; Stine et al., 1993). 
Nevertheless, CAG repeat size has an effect on the rate of progression in HD (Rosenblatt et al., 
2006), making it a useful tool for predicting disease prognosis. The expanded repeat in HD, can 
exhibit tissue-specific variability. That is, there are slight differences in CAG repeat size 
between different tissue types (Telenius et al., 1994), but these remain relatively consistent in 
the same tissue type across time (Cannella et al., 2009; Wheeler et al., 2007). The stable nature 
of CAG repeat size limits its value for longitudinal tracking of disease changes in HD.  
 
The motor component, functional capacity scale, and cognitive component of the UHDRS are 
thus far the dominant tools for monitoring longitudinal progression in HD. These scales 
respectively assess the motor features and functional capabilities of HD patients. The motor 
component is useful for tracking longitudinal motor changes in premanifest (Tabrizi et al., 
2012) and manifest HD (Huntington Study Group, 1996; Siesling et al., 1998; Tumas et al., 
2004). By contrast, there is a gradual decline in score in the functional capacity scale over time 
in manifest but not premanifest HD (Tabrizi et al., 2012). Despite the sensitive nature of these 
measures, there are limitations to their use in monitoring longitudinal progression of HD. Both 
components may provide adequate assessment of decline in patients with early and moderate 
stages of HD but floor effects can hamper evaluation in advanced HD (Marder et al., 2000; 
Youssov et al., 2013). In addition, functional capability in HD is found to be heavily influenced 
by disease duration and neuropsychological performance of HD patients (Marder et al., 2000), 
limiting its utility in monitoring disease progression in HD. Finally, these measures, due to 
issues related to test designs, are often argued to be lacking objectivity. These issues would be 
discussed in section I.6. Cognitive impairment in HD is evident even in premanifest HD and 
continues to decline in manifest HD (Duff et al., 2010; Paulsen, 2011), suggesting that cognitive 
measures, such as SDMT and Stroop tests (both are neuropsychological tests in the UHDRS 




Structural and functional imaging techniques, which include structural magnetic resonance 
imaging (MRI), functional MRI (fMRI), and positron emission tomography (PET), are being 
actively investigated as possible global markers of HD. Structural MRI techniques can detect 
neuropathological changes in premanifest HD years before clinical onset of HD and are 
sensitive to longitudinal deterioration in both premanifest and manifest HD. In premanifest HD, 
there is increased in cerebrospinal fluid (CSF) volume, atrophy of both grey and white matter 
in the years leading up to phenoconversion of HD (Squitieri et al., 2009). Further, relative to 
controls, there is a faster rate of atrophy in the basal ganglia and white matter, and also a greater 
reduction in global brain volume over time in premanifest HD (Aylward et al., 2011; 
Dominguez et al., 2013; Tabrizi et al., 2012). Longitudinal reduction in basal ganglia volume 
is one of key neuroimaging finding in manifest HD (Aylward et al., 1997; Tabrizi et al., 2012). 
Lobe-specific atrophic changes in the cortex have been observed in just a two year period 
(Tabrizi et al., 2012), particularly in the frontal lobe (Aylward et al., 2011). Measurable white 
matter degeneration continues in manifest HD (Weaver et al., 2009). Of all these cerebral 
components, the caudate nucleus and white matter demonstrate the largest effect sizes for 
atrophy rates in patients with early HD in comparison to healthy controls (Tabrizi et al., 2012). 
Most of these neuropathological changes correlate with individual patient disease status 
(Georgiou-Karistianis et al., 2013), suggesting that structural MRI is a potentially valuable tool 
for monitoring disease progression and assessing the efficacy of neuroprotective agents in HD.  
 
Functional MRI studies (fMRI) have consistently demonstrated a reduction in brain activation 
in premanifest and manifest HD when compared to controls during both motor and cognitive 
tasks (Kim et al., 2004; Reading et al., 2004; Wolf et al., 2007) whilst PET scanning in manifest 
HD has demonstrated a progressive loss of striatal D2 receptor binding (Pavese et al., 2003). 
Striatal metabolism remains abnormally low throughout the premanifest phase, but there is a 
switch from an increased to sub-normal thalamic glucose metabolism at onset of manifest HD 
(Feigin et al., 2007). The clear association of findings with underlying pathology and its mostly 
non-invasive nature makes neuroimaging technology an appealing candidate for use as a 
biomarker in HD. However, neuroimaging technology is mostly expensive and its application 
may be restricted to research centres or tertiary hospitals.   
 
‘Omics’ approaches, namely proteomics and metabolomics, have been utilised in the search for 
potential biochemical markers in blood or cerebrospinal fluid samples in both premanifest and 
manifest HD. Proteomic (the study of protein structures and functions) investigations have 
reported increased release of pro-inflammatory cytokines in premanifest HD (Bjorkqvist et al., 
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2008). The metabolomics (a study of small molecule metabolite profiles in a living system) 
strategy has led to indications of a pro-catabolic profile of metabolism (Underwood et al., 2006) 
in premanifest HD in the years leading up to phenoconversion of HD. The close association 
between a change in cellular activity and phenoconversion suggests that these ‘omics’ 
approaches might be useful for early diagnosis of premanifest HD individuals. However, it 
could be argued that these changes are constitutional abnormalities of HD and may not actually 
reflect disease status of individual patients and thereby limiting their use as diagnostic or 
progression markers. Nevertheless, these approaches have definitely provided insights to HD 
effect on biological processes and though their utility as diagnostic or progression markers is 
still a matter of debate, they may have the potential to be considered as process biomarkers of 
HD.  
 
As reviewed by O’Keeffe et al. (2009), rapid alternating movement and saccadic movement 
assessments are two promising motor measures for use as progression biomarkers in HD. For 
rapid alternating movement, changes in arm and hand performance could be detected as early 
as two decades before clinical diagnosis in premanifest HD (Paulsen et al., 2008) whereas 
manifest HD showed deterioration in performance level over a 2-year period (Antoniades et al., 
2010). Using saccadometry, gene negative individuals, premanifest and manifest HD patients 
were readily differentiated from one another on the basis of their saccadic latency distributions  
(Antoniades et al., 2007). A key feature of these objective motor measures is that, unlike 
UHDRS for example, these measures allow objective quantification of disease status in HD as 
well as change over time. Additionally, in contrast to some other potential progression markers, 
the ability of these measures to detect impaired performance even in premanifest HD, renders 
them applicable across the entire course of HD. Relative to other biomarkers (e.g. neuroimaging 
techniques and ‘omics’ approaches), these measures are cheap and easily repeatable without 
compromising patients’ safety. Table I.2 summarises the potential HD biomarkers and their 
associated longitudinal changes.  
 
In conclusion, there are certain limitations (e.g. cost, not accurate as progression marker, not 
sensitive to all phases of the disease) in the application of a number of potential biomarkers in 
HD research and in clinic. Genetic testing in HD is clearly indispensable to clinicians in 
diagnosis and to some extent prognosis, but lacks any utility in detecting phenoconversion or 
tracking disease changes in patients. Components (motor and cognitive) of the UHDRS, though 
sensitive to disease changes, are hampered by ceiling or floor effects, and confounding factors. 
The high cost and accessibility of neuroimaging techniques limit their routine use as HD 
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biomarkers in clinical setting. The objective measurement of cognitive and motor functions, 
however, appears to be very promising; they are practical, relatively cheap, easy to perform and 
capable of providing quantifiable measurement of clinical performance that can be monitored 
across disease course. Therefore, this study aimed to capitalise on the strengths of cognitive and 
motor measures to possibly identify cognitive- or motor-related progression markers that can 
effectively monitor longitudinal disease changes in HD and also be easily translated for use in 
a clinical setting. Subsequent sections detail the unresolved issues in the current literature 
related to the use of saccadic and somatic measures for detecting and tracking disease changes 
in HD and discuss how the present study seeks to answer these unresolved issues.  
 
Table I.2  Potential HD biomarkers and their associated longitudinal changes  
Measures Longitudinal changes in HD 
 
 
UHDRS   
Motor component Progressive increase in score 
Functional capacity scale Gradual decline in score 
Cognitive component  
SDMT Deterioration in score 
Stroop Deterioration in score 
Motor measures   
Rapid alternating arm and hand movements Decline in performance 
Horizontal reflexive saccade Increase in latency and reduction in velocity 
Neuroimaging  
MRI Gradual reduction in cortical and subcortical volume 
fMRI Changes in brain activation when performing motor or cognitive tasks 
PET Progressive loss of striatal D2 receptor binding  
‘Omics’ approaches  
Proteomics Increased release of pro-inflammatory cytokines 
Metabolomics A switch to pro-catabolic profile of metabolism prior to phenoconversion 
 
 
I.6. Unresolved issues in the literature and research questions  
Medical research has contributed much to understanding the pathogenesis of HD but thus far, 
no effective treatments for this disease have been discovered, let alone treatments for modifying 
or curing it. The UHDRS is the favoured tool for monitoring disease progression in HD. It has 
high inter-rater agreement and the motor component is sensitive to short- and medium-term 
longitudinal changes (Huntington Study Group, 1996; Siesling et al., 1998; Tumas et al., 2004). 
However, inter-rater reliability is low in non-clinicians and high only in clinicians with 
considerable clinical experience in HD (Hogarth et al., 2005).  
 
Klempir et al. (2006) however, highlighted that longitudinal changes in total motor score did 
not mirror the proportional change in individual items in the motor component of UHDRS. In 
addition, the same authors noted that cognitive status may influence items in the motor 
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component such as the ‘Luria’ test in which the successful execution of the task is dependent 
on executive functioning. There are also doubts about the utility of this disease rating scale for 
patients at the extremes of HD disease spectrum (i.e. premanifest HD, very early stage HD, and 
advanced stage HD). This argument is supported by the finding of poor inter-rater agreement 
among clinicians assessing patients with very early signs of manifest HD (Boo et al., 1998). 
Further, a floor effect may alter the validity of the UHDRS score in those patients in advance 
stage HD (Youssov et al., 2013). Thus, the UHDRS is not without its limitations in clinical 
application and a more objective and sensitive measure of disease status and progression is 
definitely warranted. 
 
Deficits in oculomotor function are common features in movement disorders in which there 
may be distinct oculomotor signs (Clark & Eggenberger, 2012). For instance, whilst there is 
selective degeneration of neurons in the basal ganglia in both PD and HD, the ocular features 
of each are distinct from one another on clinical examination and laboratory recordings 
(Anderson & MacAskill, 2013). Upon clinical examination, the authors noted that there is mild 
hypometria of up-going voluntary saccades and mild impairment in smooth pursuit in PD 
whereas in manifest HD patients, apraxia of saccades and slowing of saccadic velocity are key 
features (Anderson & MacAskill, 2013). Further, they noted that in laboratory assessment of 
eye movement in PD, there is an increase in latency of reflexive and voluntary saccades only 
in those with cognitive impairment whereas prolongation of latency and error rates in voluntary 
saccades are closely associated with disease severity in manifest HD (Anderson & MacAskill, 
2013). As discussed above, oculomotor signs have long been hallmarks of HD, with for 
example, prolongation in saccade initiation and reduced velocity being consistently reported. A 
study by Beenen et al. (1986) was one of the earliest to demonstrate longitudinal changes in 
saccadic function in manifest HD but this was based on the observation of only four patients 
over a variable time frame of 1 to 4 years. Those shortcomings have been redressed in 
subsequent studies utilising better experimental designs. Rubin et al. (1993) observed a 
prolongation of latency and slowing of velocity in saccades over a two year period in manifest 
HD patients.   
 
In a large longitudinal study employing multiple modalities to investigate progression in 
premanifest and early manifest HD patients, anti-saccade error rate seemed to be sensitive to 
disease changes at one year follow-up (Tabrizi et al., 2010). However, the authors reported in 
a subsequent publication (Tabrizi et al., 2012) that anti-saccade changes were relatively small 
and present only in the early manifest HD group at two years follow-up. Thus, there is 
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conflicting evidence on the utility of oculomotor recordings in reflecting disease progression in 
longitudinal studies. It is perhaps pertinent that most cross-sectional studies (Blekher et al., 
2006; Lasker et al., 1987; Peltsch et al., 2008; Winograd-Gurvich et al., 2003) employed a 
variety of saccadic paradigms to show various saccadic abnormalities in HD whilst longitudinal 
studies (Rubin et al., 1993; Tabrizi et al., 2012) focussed only on a specific aspect of oculomotor 
function in premanifest or early manifest HD and not in more established manifest HD.    
 
The adoption of bipedalism in human evolution has enabled humans to acquire great flexibility 
in terms of movement and acquiring skills in the upper limbs (Darwin, 1871; Sigmon, 1971; 
Washburn, 1960). Precise control of movement of our upper limbs is crucial for even simple 
daily activities such as eating, drinking, and reaching movements. With the basal ganglia being 
a key ‘modulator’ for movement control and also the seat of HD pathology, it is unsurprising 
that there is a generalised motor impairment affecting speech, swallowing, gait, and upper limbs 
in HD. Upper limb movements in both manifest and premanifest HD, as discussed in section 
I.4.4, are different from and frequently less efficient than those in controls. There is however, 
conflicting evidence on the closeness of the relationship between motor impairment and disease 
state in HD. Some studies have found that the degree of motor dysfunction was closely 
associated with clinical severity of HD patients (Ruiz et al., 2000; van Vugt et al., 1996) 
whereas others have shown the opposite due to the large variance in motor performance across 
patients (Gordon et al., 2000). Sample sizes in some of these studies have been small thus 
limiting the impact of their conclusions.  
 
Ruiz et al. (2002), were the first to describe quantitative longitudinal changes in upper limb 
function in HD. Their findings were supported by a large longitudinal study, which showed that 
there were measurable changes in various force related motor tasks in early HD at 12 month 
and 24 month follow-ups (Tabrizi et al., 2012; Tabrizi et al., 2010). In the Ruiz et al. (2002) 
study, HD patients at different disease stages were analysed collectively, meaning that there 
could be either exaggeration or underestimation of longitudinal changes in motor function of 
HD patients depending on disease stage. The reason for this is that in HD, there are differences 
in longitudinal changes across disease stages and one stage might demonstrate greater change 
than the other over time (Dominguez et al., 2013; Poudel et al., 2015; Solomon et al., 2008), 
thus the collective analysis of patients across the disease spectrum may provide misleading 
impression on the actual longitudinal disease changes in HD. The longitudinal study of Tabrizi 
and colleagues (2012; 2010) utilised only force-related motor tasks and were limited to 
premanifest and early stage HD. Thus, these initial longitudinal studies, while promising in 
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providing motor-related biomarkers of HD disease progression, have some limitations. 
Kinematic analysis of motor function is a relatively new area of research in HD and further 
studies on its applicability to the documentation of disease progression is warranted.  
 
The control of somatic movement calls upon the concerted interactions between a schema and 
gaze, visual, and motor systems. Manifest HD patients, as discussed above, exhibit strong 
reliance on visual guidance in the control of upper arm movement. It has been suggested that 
in HD, there are great similarities between eye and arm movement abnormalities (Berardelli et 
al., 1999) but eye movement deficits in HD are evident in premanifest at-risk individuals 
implying that such abnormalities may precede the development of overt motor signs, i.e. 
phenoconversion (Blekher et al., 2006; Rupp et al., 2011; Rupp et al., 2012). In light of this, the 
question is whether oculomotor deficits might contribute to impairment in somatic movement 
in HD. Thus far, no study has examined the relationship between eye movement and somatic 
movement in HD and filling this gap is one of the aims of the work contained in this thesis. 
 
There are three main aspects to the symptomatology of HD, motor impairment, cognitive 
impairment, and behavioural disturbances. In the knowledge that disordered behaviour in HD 
does not exhibit progressive deterioration over time (Huntington Study Group, 1996; Youssov 
et al., 2013) and also correlates poorly with clinical severity (Klempir et al., 2006), monitoring 
disease progression in HD is likely to be more useful using measures of cognitive and motor 
impairment. Deficits in somatic and eye movements together are present in many 
neurodegenerative movement disorders and especially those involving the basal ganglia e.g. 
HD and PD. It follows then that a detailed longitudinal study of both these motor features might 
improve the understanding of HD, and in particular be useful in reflecting disease progression. 
 
 
I.7. Study aims and hypotheses  
I.7.1 Study aims  
One of the key aims of this study is to redress some of the above unresolved issues in the 
literature, and primarily to examine the short-term (12 month) longitudinal changes in saccadic 
deficits in more established manifest HD by employing a variety of saccadic paradigms. The 
work contained in this thesis also seeks to determine the relationship between the eye and hand 
in coordinated eye-hand movements, which is an aspect that has received scant attention in the 
literature. Thirdly, the intent of the thesis work is also to examine the utility of a selection of 
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widely-used disease measures, for example brief cognitive tests, a comprehensive 
neuropsychological battery, total motor scores of the UHDRS motor component, and 
neuropsychiatric (i.e. depression, anxiety, and etc.) measures for monitoring short-term disease 
changes in manifest HD and to determine the relationship between these standard disease 
measures and saccadic and eye-hand performance. The overarching aim of the thesis work is to 
identify potentially objective biomarkers for measuring HD status and progression that could 
be employed in clinical research, therapeutic trials, and clinics. Each specific aim is discussed 
in the introductory section of each chapter to follow. The hypotheses, based on the above review 
of the prevalent literature, are outlined in the concluding section below.  
 
I.7.2 Study hypotheses  
Based on the review of the literature, I therefore hypothesized that cognitive, saccadic, and 
motor deficits are highly likely to correlate to the disease state, motor and cognitive impairment 
in particular, of manifest HD patients. Because of this close relationship, a change (decline) in 
performance in these functions is presumably quantifiable over a relatively short follow-up 
period of 12 months, hence revealing a potentially useful progression marker for HD that can 
be easily adapted for use in a clinical setting and also future therapeutic trials. I further 
hypothesised that a detailed assessment of saccadic function and eye-hand coordination with 
simple task and complex tasks in manifest HD may assist in gaining greater insight into effect 
of HD on the behavioural aspect of movement control that includes movement prediction, 















II.1. Study design 
The study was divided into two main phases, a baseline phase and a 12 month follow-up. The 
baseline phase was conducted over a period of eight months, from July, 2011 to March, 2012. 
All participants were invited for follow-up assessment which began in July, 2012 and was 
completed in March, 2013, twelve months after their baseline assessments. The baseline phase 
of the study was approved by the New Zealand Ministry of Health Upper South B Ethics 
Committee in March, 2011 [Ethics reference: URB/11/02/006] and the 12 month follow-up, in 
March, 2012 [Ethics reference: URB/12/EXP/011] (please refer Appendix). All participants 
were consented prior to study participation.   
 
II.2. Demographics 
Study participants were a convenience sample of 22 manifest HD patients (10 males and 12 
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females) with mild to moderate disease severity and 22 age, gender, and education-matched 
control volunteers recruited through the New Zealand Brain Research Institute database (Table 
II.1). Patients were genetically verified, with CAG repeats ranging from 39 to 55 (refer Table 
A of the Appendix for patient-specific CAG repeat number and mode of inheritance) and had 
been diagnosed clinically by Professor Tim Anderson, a movement disorders specialist. All 
participants self-identified as native speakers of English.  
 
Table II.1 Demographics at baseline 
 Control group HD group 
 Mean (SD) 
Age 49.8 (15.3) 49.7 (15.1) 
Education 12.8 (2.1) 12.8 (2.1) 















































II.3 Disease rating scale 
The UHDRS is the standard assessment scale used in determining disease severity of HD. The 
scale assesses four main domains of HD: motor function, cognitive function, behavioural 
function, and functional capacity (Huntington Study Group, 1996). The motor component of 
the UHDRS consists of items that assess oculomotor function and other motor signs commonly 
observed in HD (Huntington Study Group, 1996). The UHDRS cognitive component includes 
three tests of executive function (letter fluency test, Symbol Digit Modalities test, and Stroop 
test) that have been corrected to attenuate the impact of demographic variables (O'Bryant & 
O'Jile, 2004; Sheridan et al., 2006). The UHDRS behavioural component contains a 
standardised questionnaire that focuses on mood-related, behavioural, and psychotic symptoms 
(Huntington Study Group, 1996). There are three main subsections in the UHDRS functional 
capacity assessment scale: (1) a 25-question functional assessment survey; (2) an independence 
scale; and (3) a five-domain functional capacity assessment (Huntington Study Group, 1996). 
The functional rating scale (FRS), which is adapted from the Shoulson-Fahn Disease Rating 
Scale (Shoulson et al., 1989) and a common tool used for disease staging in HD (Nance et al., 
2012), uses the aggregated score of  the UHDRS functional capacity assessment. This scale 
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divides manifest HD into five disease stages and the clinical description for each stage is 
detailed in Table II.2. Permission to use the UHDRS in this study was granted by the 
Huntington Study Group on the 26th January 2011 (please see Appendix).  
 







Ability to manage 
finance 
Ability to manage 
domestic 
responsibilities 
Ability to perform 
activities of daily 
living 
Care level 
1 11 - 13 Normal Fully capable Fully capable Fully capable Home 
2 7 – 10 Lower level 
Slight assistance 
needed 
Capable Capable Home 
3 3 – 6 Marginal 
Major assistance 
needed 
Impaired Mildly impaired Home 





5 0 Unable Unable Unable Severely impaired 
Total care facility 
only 
Source: A Physician’s Guide to the Management of Huntington’s Disease (Nance et al., 2012) and Shoulson-Fahn Functional Capacity Rating 
Scale (Shoulson & Fahn, 1979) 
 
 
II.4.  Cognitive measures 
II.4.1. Neuropsychological assessment  
The Mini Mental State Examination (MMSE) (Folstein et al., 1975), Montreal Cognitive 
Assessment (MoCA) (Nasreddine et al., 2005),  and a comprehensive neuropsychological test 
battery were administered to all participants at baseline and 12 month follow-up. The 
comprehensive assessment used 19 neuropsychological tests to assess six domains of cognitive 
function: executive function; working memory and attention; processing speed; learning and 
memory; language; and visuospatial function (Table II.3). The number of tests administered 
was evenly distributed over two separate sessions, one week apart and each session was 1 – 1.5 
hours in duration. Neuropsychological tests were presented in the same order for all 
participants, with verbal tests alternating with non-verbal tests. The test order in session one 
was: MMSE; California Verbal Learning Test–II (CVLT–II) Recall and Short Delay trials; 
Judgment of Line Orientation Test; CVLT–II Long Delay Free Recall, Cued Recall, and 
Yes/No Recognition trials; Brief Boston Naming Test; Trail Making Tests (Part A and Part B); 
and Rey Complex Figure Copy Test. In session two, the order of tests was: MoCA; Stroop – 
colour naming, word reading, and interference tests; Brief Visuospatial Memory Test–Revised 
(BVMT–R) Immediate Recall trial; Symbol Digit Modalities Test (SDMT); Letter fluency test; 
Action fluency test; Digit forward, backward and sequencing tests; BVMT–R Delayed Recall, 
Recognition, and Copy trials; Ruff 2 and 7 Cancellation Test; Category fluency test; Category 
switching test; and Indiana University Token Test.   
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II.4.2. Cognitive screening tests 
The MMSE comprises eleven questions spanning five aspects of cognitive function: executive 
function, language, memory function, visuospatial ability, and orientation (Folstein et al., 
1975). It has good inter-rater, test and re-test reliability in differentiating cognitive status in 
dementia syndromes (Tombaugh & McIntyre, 1992) and other disorders featuring cognitive 
impairment (Godefroy et al., 2011b). Nevertheless, it is influenced by demographic factors 
such as age, education, and cultural background (Scazufca et al., 2009; Tombaugh & McIntyre, 
1992; Wind et al., 1997). For the MMSE, both alternatives (‘World’ spelled backwards and 
serial sevens) were assessed. 
 
The MoCA places greater emphasis than MMSE on naming, attention, abstraction, and delayed 
recall, functions that are most likely to be compromised in the earlier stages of cognitive 
impairment and, unlike MMSE, it compensates for education level (Nasreddine et al., 2005). 
Both the MMSE and MoCA have been used as measures of cognitive performance in manifest 
HD (Bezdicek et al., 2013; Gluhm et al., 2013; Mickes et al., 2010; Videnovic et al., 2010). 
However, the MoCA was found to have higher sensitivity than MMSE without losing 
specificity in identifying HD patients with cognitive impairment (Mickes et al., 2010). 
Furthermore, Bezdicek et al. (2013) demonstrated statistical significant correlations (p < 0.05) 
between almost all MoCA subtests and the cognitive tests in a neuropsychological battery in 
manifest HD.  
 
II.4.3. Executive function 
Executive function is defined as the ability to control and coordinate different higher-order 
cognitive processes involving working memory tasks, task switching, planning, and goal-
directed activities (Elliott, 2003; Miller & Wallis, 2009). The ability to monitor verbal output 
was assessed with Letter fluency and Action fluency tests (Delis et al., 2001; Piatt et al., 2004). 
The Category switching test (Delis et al., 2001) incorporates semantic switching during verbal 
fluency (Corbett et al., 2009). As HD is expected to cause an impairment in executive function 
(Lange et al., 1995; Lemiere et al., 2004; Paulsen, 2011), this study also included the 
standardised Trails Making Test (Part B) (Arbuthnott & Frank, 2000) and Stroop – interference 
test (Delis et al., 2001; Gyurak et al., 2009; Kramer et al., 2010).  
 
II.4.4.  Working memory and attention 
The ability to store, maintain and retrieve items in the short-term is also linked with elements 
of attention (Just & Carpenter, 1992; Miyake & Shah, 1999). The digits forward, backward and 
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sequencing tests (Wechsler, 2008) and Symbol Digit Modalities Test (SDMT) (Smith, 2007) 
were used to assess working memory and attention. The SDMT is also one of the prescribed 
test in the UHDRS cognitive component (Huntington Study Group, 1996). Given that motor 
deficits in manifest HD may give a disadvantage to HD patients in the written version of 
SDMT, the oral version was used instead. The Ruff 2 & 7 Cancellation Test (Ruff & Allen, 
1996) is a reliable measure of cognitive attention (Knight et al., 2010) thus accuracy scores 
from this test also contribute to the aggregated score for the working memory and attention 
domain.  
 
II.4.5. Processing speed 
Processing speed refers to the rate at which a person executes basic elementary processing 
operations (Goth-Owens et al., 2010; MacLeod, 1991; Tombaugh, 2004). Scores from Stroop 
– colour naming, Stroop – word reading (Delis et al., 2001), and Trail Making Test (Part A) 
(Reitan, 1958) were used to assess processing speed. The Ruff 2 & 7 Cancellation Test (Ruff 
& Allen, 1996) is a test that assesses both processing speed and visual attention (Cicerone & 
Azulay, 2002; Ruff et al., 1992). Speed scores from this test and scores from other processing 
speed oriented tests contributed to the aggregated score for the processing speed domain.   
 
II.4.6. Learning and memory 
Learning and memory are key processes involved for the acquisition of knowledge about skills 
and experiences. Episodic learning and memory was assessed using a verbal test and also a 
non-verbal test. The California Verbal Learning Test–II (CVLT–II), a verbal test, was used to 
measure word list acquisition and, short and delayed memory retention (Baldo et al., 2002; 
Delis et al., 2005). The Brief Visuospatial Memory Test–Revised (BVMT–R), which is a type 
of visual-graphic memory test (Benedict, 1997; Benedict et al., 1996), was used as the non-
verbal test. 
  
II.4.7. Language domain 
The expression of language involves both the interpretation of speech and the internal 
processing of the perceived speech (Saur et al., 2010). Two tests were used to assess this 
domain: the Brief Boston Naming Test and the Indiana University Token Test. The Brief 
Boston Naming Test involves the interpretation of simple drawings and word recollection 
(Graves et al., 2004). The Indiana University Token Test (Token Test) requires the internal 
processing of speech command given by the examiner and its translation into gross motor 
actions by touching the tokens presented (Unverzagt et al., 1999). 
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II.4.8. Visuospatial function 
Visuospatial skills enable a person to perceive spatial relationships between objects and their 
environment (Mervis et al., 1999). Two tests were included in this domain: (1) Judgement of 
Line Orientation Test (Form H), a perception and spatial thinking test (Benton et al., 1994); 
and (2) Rey Complex Figure Copy Test (Osterrieth, 1944; Rey, 1942), a test that evaluates 
visuospatial planning and construction (Lezak et al., 2004). 
 
Table II.3  Cognitive domains and the 19 domain-specific neuropsychological tests 
Cognitive domains tested Neuropsychological tests 
Executive function 
Letter fluency test  
Action fluency test 
Category fluency test 
Category switching test 
Trails Making Test (Part B) 
Stroop – interference test 
 
Working memory and attention 
Digit forward, backward and sequencing tests 
SDMT1 
Ruff 2 & 7 Cancellation Test - accuracy score 
Processing speed 
Stroop – colour naming test 
Stroop – word reading test 
Trails Making Test (Part A) 
Ruff 2 & 7 Cancellation Test - speed score 




Brief Boston Naming Test 
Indiana University Token Test (Token Test) 
Visuospatial function 
Judgement of Line Orientation Test (Form H) 
Rey Complex Figure Copy Test 




II.5. Behavioural measures 
Psychiatric and behavioural symptoms such as depression, anxiety, and apathy are prevalent in 
manifest HD (Paulsen, 1999; Vassos et al., 2008). This study, in addition to the UHDRS 
behavioural component, also included Beck’s Depression Inventory–II (BDI–II), Beck’s 
Anxiety Inventory (BAI), and Apathy Evaluation Scale. The BDI–II is a reliable and effective 
screening tool for depression (Beck et al., 1988). The BAI (Beck & Steer, 1993), which has 
been validated to be a useful tool for screening anxiety related symptoms in outpatient settings 
(Steer et al., 1993), was used in this study for assessing anxiety. The AES is a scale for 
measuring motivation and goal directed behaviour (Marin et al., 1991). Behavioural measures 
were assessed at the end of each assessment session, the BDI–II and BAI in the first session, 
and AES in the second.  
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II.6. Saccadic function assessment 
Saccadic function assessment consisted of six eye movement tasks: (1) reflexive; (2) self-paced; 
(3) temporally-cued (predictive); (4) delayed; (5) memory-guided; and (6) anti-saccade tasks. 
They were administered to all participants in the same order as listed above in a one-hour 
session in an eye movement laboratory at the NZBRI. 
 
II.6.1. iViewXTM Hi-Speed eye tracker 
A non-invasive high-speed video-based eye tracking system, the iViewXTM Hi-Speed (SMI, 
Teltow, Germany) was used for recording eye movement in the head-fixed tasks above. The 
device features high resolution [typically < 0.01°] and high accuracy [typically 0.25°- 0.50°] 
tracking of eye position at a sampling rate of 1250 Hz (SMI, 2010b). The hardware component 
of the device comprises an eye tracking column with adjustable ergonomic chin rest, a see-
through glass piece and a built-in infra-red camera. A DLP projector with a resolution of 1280 
x 720 pixels and a refresh rate of 100 Hz, was used to project targets (12 x 12 pixel squares) 
onto a screen measuring 1574 mm in width and 877 mm in height, placed 1649 mm from the 
eye tracker column (Figure II.1). Study subjects were seated with their chins placed on the chin 
rest and their foreheads against the forehead rest of the eye tracker column (Figure II.1). The 
eye tracking system was controlled by one PC while stimulus targets for saccadic tasks were 
presented by another PC using PsychoPy (Peirce, 2008), an open-source software package for 





Figure II.1  Laboratory setup for saccadic function assessment. The eye tracker column for the iViewXTM Hi-Speed 








II.6.2. Calibration protocols for the eye tracking system 
Trial blocks were preceded by a semi-automatic calibration procedure in which the eye tracking 
system would match eye position data from each participant relative to known fixation positions 
on the screen. Participants were asked to fixate at randomly appearing targets, one at a time, at 
13 pre-selected locations on the screen. The calibration targets were distributed to give good 
coverage over an area slightly larger than the ±15° deg (horizontal) by ±10° (vertical) field in 
which stimuli were presented. These targets were spread well within the maximum viewing 
angle of the iViewXTM Hi-Speed System which is ±30° in the horizontal direction and +30° 
(upwards), -45° (downwards) in the vertical direction (SMI, 2010b). The calibration process 
was repeated until satisfactory gaze positions relative to the actual targets were obtained and 
calibration checks were constantly reviewed between trial blocks.  
 
II.7. Eye-hand coordination assessment  
Participants attempted four eye-hand coordination tasks: reflexive, self-paced, temporally-cued 
(predictive), and delayed tasks in a 45 min session in the MoVElab at the NZBRI. Memory-
guided and anti-saccade eye-hand tasks were not assessed because of time-constraints.    
 
II.7.1. iViewXTM HED 
For the eye-hand coordination tasks, a mobile eye tracker was required to allow the participants 
to respond to the tasks naturally. The iViewXTM HED system (SMI, Teltow, Germany) is a 
mobile head-mounted video eye tracker with a manufacturer’s stated sampling rate of  200 Hz, 
a typical tracking resolution of < 0.01° and a typical accuracy of 0.5°– 1.0° (SMI, 2010a).  The 
system comprised of a set of lightweight eye and scene video cameras mounted on a modified 
baseball cap (total weight of < 80 g) connected by a USB cable to a laptop device for eye data 
compilation. This was used for recording eye movement in eye-hand coordination tasks (Figure 
II.2).  
 
II.7.2. Modified modular virtual environment platform 
The modular virtual environment platform was originally designed and developed at the New 
Zealand Brain Research Institute for use in movement and rehabilitation research in a virtual 
environment. The platform is capable of providing accurate calibration, high graphics update 
rate, and low latency feedback (Myall et al., 2008). The platform’s ability to perform in a wide 
spectrum of motion characteristics made it a suitable device for kinematic analysis in HD, in 
which movement impairment is prevalent (Phillips et al., 1996; Phillips et al., 1995). 
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The platform consisted of a 240 Hz LibertyTM electromagnetic tracker (Polhemus GMP 
Contract Manufacturer, Vermont, USA) that has an accuracy of 0.08 mm RMS in the X, Y, Z 
axes and an accuracy of 0.15° RMS for orientation (Polhemus, 2008). It was remotely operated 
using a software system written from open source and custom modules. The platform was 
modified for the eye-hand coordination tasks in order to fulfil the purpose of analysing 
kinematic characteristics of HD in a pseudo real-life environment. One motion sensor, attached 
to the tip of the index finger on the dominant hand (the hand performing the tasks), was used 
for motion tracking in eye-hand coordination tasks (Figure II.2).   
 
II.7.3. Overall MoVElab setup 
Targets (20 mm x 20 mm) were displayed on a 22-inch LCD screen with a resolution of 1680 
x 1050 pixels and a frequency of 120 Hz. The inferior border of the screen was placed 200 mm 
away from the edge of a modified desk and the screen-table angle was set at 30° (Figure II.2). 




Figure II.2  Laboratory setup for eye-hand coordination assessment. The iViewXTM HED mobile eye tracker (A) 
and motion sensor are shown on the left and the stimuli display screen on the right.  
 
II.7.4. Calibration protocols in eye-hand coordination assessment  
There were two parts to the calibration protocols in eye-hand coordination assessment: (1) a 
calibration process for the eye tracking system; and (2) a calibration process for the eye tracking 
system together with the motion tracking system. For the calibration process for the eye tracking 
system, participants were asked to fixate at five different locations on the LCD screen (the four 
corners and the mid-point of the screen) in a seated position and with their head resting on a 












tracking system), the chin rest was removed and participants were asked to fixate and touch the 
targets on the LCD screen using their index finger (the one attached to a motion sensor). 
Calibration targets were presented at 17 pre-selected locations on the screen and the process 
was repeated until satisfactory gaze positions were achieved. 
 
II.8. Experiment paradigms  
II.8.1. Visually-guided reflexive tasks 
II.8.1.1. Saccade-only reflexive tasks 
There were two blocks of trials in the reflexive paradigm, a one dimensional (1D) block 
(horizontal saccades only) and a two dimensional (2D) block (horizontal and vertical saccades).  
 
In the 1D trial block, red targets would appear, one at a time, at one of seven fixed locations (-
15°, -10°, -5°, 0°, 5°, 10°, and 15° in the horizontal axis relative to the eye column tracker) for 
108 trials. Three types of reflexive stimulus onsets (‘gap’, ‘step’, and ‘overlap’) were used in 
this task (Figure II.3) and they were randomly distributed across the trial block.  Stimulus types 
could be differentiated by the time interval between preceding and successive targets. The onset 
of a new target occurred 200 ms after the offset of the previous target in ‘gap’ stimulus. In the 
‘step’ condition, the new target appeared simultaneously to the offset of the previous target. 










Figure II.3  Screen transitions and timings between preceding and successive targets for the three stimulus types 
(‘gap’, ‘step’, and ‘overlap’) in the reflexive 1D paradigm. 
 
The 2D trial block featured individual targets appearing in a random manner in both horizontal 
and vertical positions for 120 trials. There were 35 possible locations, all confined within an 
Screen 
transitions 
200 ms 200 ms 
Gap stimulus Step stimulus Overlap stimulus 
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area of -15° to +15° in the horizontal axis and -10° to +10° in the vertical axis from the centre 
point of the screen (Figure II.4). The rationale for using a 2D task rather than an all vertical 
saccade task in this study was because of the restricted field of vision for vertical eye 
movements (Walker et al., 1990) which consequentially would limit the range of target 
locations used for assessing vertical saccades. The use of a 2D task greatly increased the number 
of possible target locations in a trial block as compared to a one dimensional task. That is, in an 
all vertical saccade task, there are only 5 possible target locations while an all horizontal saccade 
task is limited to 7 possible target positions. To control for mixed movement saccade, i.e. 
oblique movement, all target angular displacements were relative to the previous target and 
were limited to either purely horizontal or vertical movement. Only ‘Step’ stimuli were used in 
this task. 
 
In both reflexive protocols, subjects were instructed to fixate at the appearing target as fast and 
accurately as possible. 
 
Figure II.4  Possible target positions in the reflexive 2D paradigm. Target positions are measured in degrees from 
the eye tracker column.  
 
 
II.8.1.2. Visually-guided reflexive eye-hand task 
There were 60 trials of a red target alternating between a central home target and peripheral 
target locations in the visually-guided eye-hand task. For each trial, the home target, which was 
placed at a fixed position, would illuminate for a variable period between 1000 and 2000 ms 
whereas the peripheral target, which could appear at one of the 30 preset locations, would 
always be illuminated for 1500 ms. Peripheral targets were presented on three 80° arcs placed 
10 cm, 15 cm, and 20 cm from the fixation target (Figure II.5). Participants were asked to look 




Figure II.5  Fixation and peripheral targets positions in the visually-guided reflexive eye-hand task. All possible 
locations of peripheral targets are shown and home target is located at coordinate (0, 0) on the screen. Distance between home 
target and peripheral targets are shown. 
 
II.8.2. Rhythmical tasks 
II.8.2.1. Saccade-only self-paced tasks 
Self-paced tasks examined the ability to voluntarily initiate saccades and disengage from 
constantly illuminated targets (Winograd-Gurvich et al., 2003). Participants were given two 
blocks of trials, first a horizontal block and then a vertical block. Both blocks began with targets 
appearing at random locations 14 times as a calibration check and then two targets would 
simultaneously and continuously be illuminated for 30 seconds (s) at 10° left and right of the 
centre of the screen in the horizontal block and 10° above and below the centre point in the 
vertical block (Figure II.6).  In these tasks, participants were asked to fixate the two targets 





Figure II.6 Self-paced tasks. Screen display for (A) the horizontal and (B) the vertical trial blocks are shown. The red 
dotted arrows indicate the directions of saccadic and/or hand responses.  
 
II.8.2.2. Combined eye-hand self-paced tasks 
In the combined eye-hand self-paced tasks, participants were presented with two 30 s trial 
blocks, a horizontal trial block and followed by a vertical trial block. In contrast to the saccade-
only tasks, the two fixation targets in the eye-hand tasks were placed at 10 cm to the left and 
right of the screen’s midpoint in the horizontal block and 10 cm above and below the midpoint 
80° 
5 cm   
5 cm   
10 cm   
A B 
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in the vertical block. The visual angle between consecutive targets were typically 9.5˚ – 10.2˚ 
from the recorded eye depending on the distance between subject’s head and the LCD screen 
(typically 56 cm – 60 cm). Participants were instructed to look and touch the two concurrent 
illuminated targets alternately at their fastest speed for 30 s. 
 
 
II.8.2.3. Saccade-only temporally-cued (predictive) tasks 
Predictive saccades (generated in anticipation of a regularly alternating target), are known to 
occur in healthy controls after consecutive trials of target alternating at a constant rate (inter-
stimulus interval) between two peripheral locations (Crawford et al., 1989; Smit & Van 
Gisbergen, 1989). Such predictive behaviour has been shown to peak at an inter-stimulus (ISI) 
of 625 ms and diminish in trials with longer ISIs (Isotalo et al., 2005; Lasker et al., 2006; Ventre 
et al., 1992). As a compromise between the peak ISI for predictive saccades and known longer 
saccadic latency in HD (Tian et al., 1991), an ISI of 750 ms (0.67 Hz) was chosen as the shortest 
ISI in this study. Three other ISIs selected were: 1000 ms (0.5 Hz), 1400 ms (0.36 Hz), and 
2050 ms (0.24 Hz). 
 
Four trial blocks were presented in a pre-determined randomised order (ISI: 1000 ms, 2050 ms, 
750 ms, 1400 ms), generated from a square matrix, to protect against subjects predicting the ISI 
sequence. Each trial block began with a random phase and immediately followed by a 
predictable phase. In the random phase, targets (one at a time) would appear at random locations 
and intervals on the screen for 17 times. There were then 40 trials in the predictable phase, in 
which targets would appear alternately at two fixed target locations (±10° target positions) on 
the screen (Figure II.7). In all trial blocks, participants were asked to keep their eyes to the 
fixation target as accurately as possible. 
 
Figure II.7 Trial and timing sequences in the temporally-cued tasks. ISI indicates the time interval (750 ms, 1000 












II.8.2.4. Temporally-cued (predictive) eye-hand tasks 
Participants were presented with four cued trial blocks similar to the saccade-only temporally-
cued tasks.  The four cued trial blocks were presented in a pre-determined randomized order 
(ISI: 1000 ms, 2050 ms, 750 ms, 1400 ms). All four cued tasks began with a random phase, 
consisting of 17 reflexive trials, followed by a predictable phase that contained 40 temporally-
cued trials. The temporally-cued trials comprised of a target alternating at a constant ISI 
between two fixed positions, ±10 cm from the centre. These targets were typically 9.5˚ – 10.2˚ 
from the recorded eye depending on the distance between participant’s head and the LCD 
screen (typically 56 cm – 60 cm).  Participants were given the instruction to look and touch the 
targets on the screen as precisely as they could.   
 
II.8.3. Complex movement tasks  
In this study, three tasks – delayed, memory-guided, and anti-saccade – were applied to 
evaluate the control of complex movements. Participants were presented with all three tasks in 
saccade-only assessment. Only the delayed task was presented for eye-hand coordination 
assessment because of time constraints. 
 
II.8.3.1. Saccade-only delayed task 
A delayed saccade task evaluates the ability to initiate a saccade to a peripheral target only after 
a certain period of delay, when a cue is given (Curtis & D'Esposito, 2006; Everling & Fischer, 
1998; Lueck et al., 1992). There was one block of 38 individual trials in the saccade-only 
delayed task. The trial block began with the illumination of a fixation target at 0° position. A 
fixation target was illuminated for a period ranging from 3100 to 3500 ms. A peripheral target 
would then appear at either ±5°, ±10° or ±15° horizontally from the fixation target, 600 ms 
before fixation target offset. Participants were asked to withhold a saccade to the peripheral 
target until after the fixation target was extinguished, which was accompanied by a sound cue 
(Figure II.8). The position of the peripheral target in the previous trial became the fixation target 
position for the next trial.  
 
II.8.3.2 Combined eye-hand movements delayed task 
This task was an adaptation of the saccade-only delayed task. Similarly, each participant 
performed a block of 38 individual trials. The task followed the same trial and timing sequences 
as the saccade-only delayed task except that the initial fixation target was always located at the 
centre of the LCD screen and peripheral targets would appear at 5 cm, 10 cm or 15 cm to the 
left or right of that central fixation target.  Participants were asked to withhold both eye and 
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hand responses to the peripheral target until the fixation target was extinguished and a sound 











Figure II.8  The delayed task.  Screen transitions and timing sequences in a delayed task trial block are shown. The 
red dotted arrow indicates the direction in which a correct saccadic response (saccade-only delayed task) or eye-hand response 
(combined eye-hand delayed task) should be made. 
 
 
II.8.3.3. Memory-guided task 
The ability to integrate sensorimotor function and working memory and attention function, 
which is a key process in the generation of memory-guided saccade, is compromised in diseases 
associated with basal ganglia and frontal lobe pathology (Keedy et al., 2006; McDowell et al., 
2001). A memory-guided task involves the suppression of a saccade to a briefly-flashed 
peripheral target and then directing a saccade to that remembered location only after a period 
of delay.  
 
Two trial blocks were presented to each participant. Each block consisted of 18 individual 
memory-guided saccade trials. A trial block would begin with a fixation target at 0° position 
and a peripheral target would flash briefly (400 ms) at 5°, 10° or 15° horizontally from that 
fixation target. The offset of the fixation target, accompanied by a sound cue, occurred after a 
delay of 1500 ms to 2500 ms. Participants were told to withhold a saccade to the briefly-flashed 
peripheral target and only to direct a saccade to that remembered position (position of the 
briefly-flashed target) when the fixation target was extinguished. The briefly-flashed peripheral 
target then reappeared on the screen 3150 ms after the offset of the fixation target and became 
the fixation target for the next trial (Figure II.9).   
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Figure II.9 Screen transitions and timing sequences in the memory-guided saccade task. The red dotted arrow 
indicates the direction of a correct saccadic response.  
 
 
II.8.3.4. Anti-saccade task 
The anti-saccade task, introduced by Hallett (1978), involves the decoupling of stimulus 
encoding and saccadic response selection (Everling & Fischer, 1998; Everling & Munoz, 2000) 
and is a widely-used behavioural task in saccade assessment (Munoz & Everling, 2004). 
Participants performed two blocks of trials, each consisting of 36 trials of anti-saccade. Each 
trial began with a fixation target at 0° position that was illuminated for a period ranging from 
1500 ms to 2500 ms. A green peripheral target would then appear at ±5°, ±10° or ±15° 
horizontally from the central fixation target for 1500 ms. Participants were instructed to look at 








Figure II.10 Screen transitions and timing sequences in the anti-saccade task. A correct response (red dotted arrow) 
is illustrated in ‘A’ and an incorrect response (green dotted arrow) in ‘B’.  
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II.9. Analysis 
II.9.1. Cognitive status classification 
The cognitive status – normal, mild cognitive impairment (MCI) or dementia – of HD 
participants was determined from the neuropsychological test battery and relevant items in the 
UHDRS (functional assessment scale, independence scale, and functional capacity). Criteria 
for mild cognitive impairment (MCI) followed that described for Parkinson’s disease by 
Dalrymple-Alford et al. (2011) and Litvan et al. (2012), with a requirement of two measures at 
below or equivalent -1.5SD of norms within a single domain. Dementia criteria followed that 
of Peavy et al. (2010), who defined HD dementia as having deficits in at least two areas of 
cognition (not limited to memory deficits) in the context of impaired everyday function, as 
determined using the UHDRS Functional Independence Scale. 
 
II.9.2. Scoring system for cognitive measures 
The raw scores of each test in the neuropsychological test battery were converted to a 
standardised z-score using test-specific norms. Domain-specific scores were the mean 
aggregated scores of component tests within each cognitive domain and the mean aggregated 
scores of all six cognitive domain determined the global cognitive z-score. MoCA scores were 
adjusted to participants’ education level (Nasreddine et al., 2005). The three cognitive tests in 
the UHDRS cognitive component were also part of the neuropsychological test battery so the 
mean aggregated score of these tests was used as the UHDRS cognitive score for both the HD 
and control groups. 
 
II.9.3. Saccade detection and measuring techniques 
All eye movements were measured individually via a semi-automatic process using the 
Saccade Analysis, Measurement, and Research Application (SAMARA) software, developed 
in-house at the NZBRI for measuring eye movement responses. The automatic saccade 
detection algorithm searched forward in time for any movement with a minimum velocity of 
150 deg/s in the horizontal-only (1D) task and 100 deg/s in the 2D task. It then searched 
backwards for the first zero-crossing prior to that, which was deemed as the onset of a saccade. 
The system would continue to search forward and when the horizontal velocity dropped below 
a 5 deg/s threshold, this marked the end of a primary saccade. All saccades detected through 
the automated system were verified by the operator prior to being accepted for further analysis. 
Eye movements made towards to the left and to the right were represented as negative and 
positive respectively on the y-axis while upward and downward movements were positive and 
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negative on the y-axis of the eye movement trace. For all saccadic tasks, except the anti-saccade 
task, saccades that were opposite to the direction of a stimulus were excluded from the data 
pool.  
 
The SAMARA software allowed the use of three cursors to mark three different time points of 
an eye movement response. In any given eye movement response, the onset of a response was 
denoted with Cursor 1 (green) and the end of the primary eye movement response was 
represented with Cursor 2 (blue) while Cursor 3 (maroon) demarcated the final fixation position 
of the eye (Figure II.11). 
 
 
Figure II.11 Measuring saccades in the SAMARA software. The red line indicates stimuli positions and the dark 
blue trace, position of the eye. Saccadic events are marked by: (A) Cursor 1 (green), onset of saccade; (B) Cursor 2 (light 
blue), end of primary saccade; and (C) Cursor 3 (maroon), final eye position.   
 
 
II.9.4. Visually-guided reflexive tasks 
A reflexive saccade is defined as a ‘reactive’ eye movement made in response to randomly 
appearing visual targets. The time required for a visual stimulus to be perceived and processed 
by the visual afferent system and the onset of a saccade is estimated to be around 80 ms (Fischer 
et al., 1995).  Therefore, any eye movement responses with latency less than 80 ms or greater 
than 1000 ms were excluded from the analysis as they were regarded as either an anticipatory 
saccade or a non target-directed eye movement. There are considerable variations in terms of 
maximal saccadic velocity for healthy controls, which typically range from 500 deg/s to 1000 
deg/s (Baloh et al., 1975a; Baloh et al., 1975b; Boghen et al., 1974; Wright & Ward, 2008). 
Given that saccadic amplitude in any given tasks in this study was less than 30˚, any eye 
movement responses with maximal velocity greater than 810 deg/sec were removed from the 
data pool. Saccades were not measured if a blink occurred: (1) immediately before target onset; 
(2) in the period from target onset to saccade initiation; or (3) during a saccade.  
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The principal saccadic parameters measured in this task were: (1) saccadic latency; (2) maximal 
velocity; (3) primary gain; and (4) saccade count. Saccadic latency, expressed in milliseconds 
(ms), was defined as the delay between target onset and saccade initiation in all three types of 
reflexive stimuli (‘gap’, ‘step’, and ‘overlap’) (Figure II.12). The maximal speed attained in a 
saccadic response (peak saccadic velocity) was measured in degree per second (deg/s).  
Primary saccade amplitude was the distance covered (measured in degrees) by the primary 
saccade and was measured relative to the position of the fixation target (Figure II.12). Primary 
gain was the ratio of primary saccade amplitude over amplitude of the target displacement. 
Saccade count, defined as the number of saccades occurring between the first and last cursors, 
was a measure of how many saccades (primary plus corrective) made to reach the target. Upon 
the detection of a primary saccade, the automated system used a lower threshold (1D task: 30 
deg/s; 2D task: 50 deg/s) to detect corrective saccades, which usually have a peak velocity of 
less than 150 deg/s. The rationale for the higher threshold for primary saccade detection was 
to prevent the automated saccade detection algorithm for falsely detecting small fixation 
saccades (i.e. non target-directed saccades) during fixation periods.  
 
 
Figure II.12 An eye trace from the reflexive 1D task. Three types of reflexive stimuli (‘step’, ‘overlap’, and ‘gap’) 
are shown. The red line indicates target positions and the dark blue trace, position of the eye. The green cursor indicates the 
onset of primary saccade. Primary saccade amplitude, marked by a light blue cursor, is the distance made in the primary 
saccade and final amplitude, marked by a maroon cursor, is the distance attained in the final saccade. As illustrated, saccadic 
latency in the ‘gap’ stimulus is visibly the shortest and followed by a ‘step’ stimulus and an ‘overlap’ stimulus.  
 
II.9.4.1. Express saccades 
In ‘gap’ stimuli of the reflexive task, there is a time delay between fixation target offset and 
peripheral target onset. The distribution of saccadic reaction time is often described as bi-modal 
or tri-modal, with peaks occurring first at 100 ms after target onset, secondly at around 150 ms, 
and some have reported another peak at much longer latencies (Fischer et al., 1993a; Fischer 
& Boch, 1983; Fischer & Ramsperger, 1984; Fischer et al., 1993b; Hamm et al., 2010). The 
term ‘express saccades’ (saccades with very short latencies) has been used to describe the sub-






study defined express saccades as those with a latency of 90 ms to 110 ms (Wenban-Smith & 
Findlay, 1991) but a majority of studies use criteria of saccadic latency in the range of 90 ms 
to 150 ms (Clementz, 1996; Currie et al., 1993; Fischer et al., 1993b; Hamm et al., 2010).  
 
Given that 100% of saccades with directional errors in a pro-saccadic ‘gap’ task have been 
found to have a latency less than 100 ms (Fischer & Boch, 1983; Fischer et al., 1993b) and 
saccades with a latency shorter than 75 ms were associated with greater than 20% error in 
amplitude (Fischer & Ramsperger, 1984), saccades with a latency less than 90 ms have been 
suggested to be anticipatory in nature and not under the influence of visual target.  Fischer et 
al. (1997)  reported that fast regular saccades in a pro-saccade task occurred in the range of 135 
ms to 179 ms. Taking these factors into consideration, a criterion of 90 ms to 135 ms was used 
in this study to ensure the inclusion of express saccades and exclusion of anticipatory saccades. 
 
II.9.4.2. Saccadic main sequence 
A main sequence analysis was performed only for peak velocity achieved in response to ‘step’ 
stimuli in the horizontal reflexive saccade task, as peak velocity varies with cognitive 
involvement in a task (Chen et al., 2013; Van Gelder et al., 1997). As the maximal saccadic 
velocities calculated for patient S5 were unrealistically fast in comparison to other HD patients 
with similar clinical severity (refer Figure IV.4 and Figure IV.5), it was deemed that patient S5 
was an outlier and thus data from this patient was removed in this analysis. A negative 
exponential curve function [Saccadic velocity (Amp) = Vmax (1- e
-(Amp/C))] (Baloh et al., 1975b) 
was fitted to the data of all participants. ‘Vmax’ was the maximal saccadic velocity of which 
the main sequence function saturates, ‘Amp’ was the saccadic amplitude in degrees, and ‘C’ 
was a constant. Subject-specific maximal saccadic velocities (Vmax) were then fitted to a linear 
mixed-effect model to establish group differences and relative change after 12 months.   
 
II.9.5. Rhythmical tasks 
II.9.5.1 Self-paced tasks 
Manual counting was used to determine the number of self-initiated saccades in the self-paced 
tasks. A saccade made from the vicinity of one target towards the opposite target was 
considered as one self-paced movement. Self-paced saccades were only considered to be 
complete if the primary amplitude of a saccade was greater than 50 percent of the total distance 
between the two targets. That is, a saccade must have at least crossed the centre line (x) on the 
eye trace (Figure II.13). Saccades that failed to meet the criterion would not contribute to the 
final tally.  
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Figure II.13 An eye trace from the self-paced task. The red lines indicate stimuli positions (-10° and +10° concurrent 
targets) and the dark blue trace, eye position. A saccade must have at least crossed target position 0°, labelled as ‘x’, to be 
considered a self-paced movement.  
 
 
II.9.5.2. Temporally-cued (predictive) tasks 
Healthy controls are capable of generating predictive saccades when the target alternates 
between two fixed positions at a temporally predictable manner (Crawford et al., 1989; Isotalo 
et al., 2005; Zorn et al., 2007). That is, these saccades may coincide with or even occur prior 
to the onset of the next target (McDowell et al., 1996). Each trial block, which consisted of a 
random phase and a predictable phase, was further divided into three sub-phases (Phase I, Phase 
II, and Phase III). The random phase (i.e. the first 17 trials of a trial block with stimuli appearing 
at random locations and time intervals) was labelled as Phase I. Phase II consisted of the first 
30 trials of the predictable phase (i.e. the stimulus alternating between two fixed positions at a 
constant ISI) and Phase III, the last 10 predictable trials (Figure II.14).  
 
Any saccades in Phase I with a latency less than 80 ms were excluded from the data. Saccades 
with latencies greater than 1000 ms in this phase were considered outliers and were also 
removed from further analysis. Accepted saccades provided the mean saccadic latency in the 
random phase. Due to the predictable nature of stimuli in Phase II and III, saccades with a 
latency less than 80 ms were considered as valid responses and were included in the data. In 
Phase II and Phase III, a saccade was only accepted as a valid response if, relative to the target 
amplitude, the primary gain was greater than 0.2 and not followed by a corrective saccade in 
the direction opposite of the impending target (Figure II.14).  
 
Saccadic latencies were defined as ‘positive’ if they occurred after target onset and ‘negative’ 
if they preceded target onset. All participants completed all four ISI trials blocks except for one 
stage 4 HD patient (S08) who was unable to perform some of the trial blocks. Data from this 





Figure II.14 An eye trace from the temporally-cued (predictive) task. Three phases (Phase I, Phase II, and Phase 
III) of a trial block are shown. The red line indicates stimuli positions and the dark blue trace, eye position. In Phase I, a 
saccade had to have a latency of greater than 80 ms to be accepted. In Phase II and Phase III, early saccades were considered 
valid responses, but the primary saccade had to exceed 20% of the target distance and corrective saccades (if any) must be 
made only to the direction of the next target.  
 
Saccadic latencies in the predictable phase decline rapidly over the first few trials until saccades 
are initiated on the basis of internal prediction of target onset (Ross & Ross, 1987). An 
exponential decay function [Saccadic latency (n) = C + A*е 
(B*n)] was fitted to the group-specific 
mean latencies of each trial in the predictable phase (Phase II and Phase III) to determine the 
group-specific learning curves in all four ISIs for the control and HD groups. ‘A’ represents 
the mean latency at the start of the predictable phase. ‘B’ denotes the decay rate, i.e. the rate of 
change in the shortening of saccadic latency. ‘C’ is the plateau (final saccadic latency in a trial 
block) and ‘n’, the trial number in each trial block. Ideally, analysis of the predictable phase is 
best assessed by examining the exponential decay function of saccade latencies in the 
predictable phase in each subject. However, an exponential decay function could not be fitted 
to the data of 18 HD patients. Therefore, saccades in the last 10 predictable trials (Phase III) 
were used instead for the analysis of the predictable phase as it was assumed that all participants 
had established a stable predictive pattern at this stage. The mean latency and proportion of 
predictive saccades (expressed in percentages) in the last 10 predictable trials of all four ISIs 
were calculated. 
 
II.9.6. Complex movement tasks 
II.9.6.1. Delayed task 
Saccadic responses in the delayed task were labelled as ‘correct’ or ‘disinhibited’ based on the 
latency of responses (Figure II.15). As there was a 600 ms time delay between peripheral target 
onset and fixation target offset, only responses made more than 90 ms after fixation target offset 
were classified as ‘correct’. Disinhibited responses were defined as responses made between 
90 ms and 690 ms after peripheral target onset. The rate of disinhibited responses was 
Phase I Phase II Phase III 
Random phase First 30 predictable trials Last 10 predictable trials 
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calculated as a percentage of the total number of responses made (correct and disinhibited). 
Saccadic latency of correct responses was measured from fixation target offset and of 
disinhibited responses, from peripheral target onset. 
 
Figure II.15 An eye trace from the delayed task. The red line indicates the positions of stimuli and the dark blue 
trace, the eye position. In the eye trace above, there are two correct responses (A) and a disinhibited response (B) that was later 
corrected (C). Cursor 1 (green) marks the onset of a primary saccade. Cursor 2 (light blue) denotes the end of a primary saccade 
and Cursor 3 (maroon), final position of the eye. 
 
II.9.6.2. Memory-guided task 
Responses in this task were also categorised as ‘correct’ or ‘disinhibited’. They were 
considered ‘correct’ if they were initiated at least 80 ms after fixation target offset but prior to 
the reappearance of the briefly-flashed target (i.e. the fixation target for the next trial) (Figure 
II.16). Disinhibited responses were those made: (1) immediately towards the briefly-flashed 
peripheral target; (2) during the time delay, i.e. after the offset of briefly-flashed peripheral 
target but prior to fixation target offset; and (3) less than 80 ms after fixation target offset 
(Figure II.16). The proportion of disinhibited responses was calculated as a percentage of the 
total number of responses made (correct and disinhibited). Saccadic latency of correct 
responses was measured from fixation target offset. 
  
Figure II.16  An eye trace from the memory-guided task. The red lines indicate the positions of the stimuli and the 
dark blue trace, position of the eye. The first response is a disinhibited response (A) that was later ‘corrected’ (B) and the 
second, a correct response (C). Cursor 1 (green) marks the onset of the primary saccade and Cursor 2 (light blue), the end of 
the primary saccade. The onset of the corrective saccade is marked by Cursor 3 (maroon) and Cursor 4 (pink), final position 







II.9.6.3. Anti-saccade task 
Responses made in the opposite direction to the green peripheral targets were classified as 
‘correct’ and those towards the target, ‘disinhibited’. Disinhibited responses were further 
classified as ‘corrected’, if a corrective saccade, i.e. a saccade in the opposite direction to the 
green peripheral target, was made immediately after a disinhibited response, and ‘uncorrected’, 
if otherwise (Figure II.17). The proportion of disinhibited responses was calculated as a 
percentage of the total number of responses (correct and disinhibited) made. The proportion of 
corrected pro-saccade errors was calculated as a percentage of the total number of disinhibited 
responses (corrected and uncorrected) made. Latencies for correct and disinhibited responses 
were calculated as the time from green peripheral target onset to saccade initiation. Latency for 
correcting a disinhibited response (pro-saccade correction) was the time between the end of a 
disinhibited saccade and the onset of the first corrective saccade to that disinhibited saccade. 
 
Figure II.17 An eye trace from the anti-saccade task. The red lines indicates positions of fixation targets and the 
green, positions of green peripheral targets. The black trace denotes position of the eye. In the eye trace above, a disinhibited 
response (A) that was corrected (B) and two correct responses (C) are shown. The onset and the end of the primary saccade 
are marked by Cursor 1 (green) and Cursor 2 (light blue) respectively. The latency for correcting a disinhibited response is 
defined as the time between Cursor 2 (light blue) and Cursor 3 (maroon). Cursor 4 (pink) marks final position of the eye for 
that trial.  
 
II.9.7. Hand movement detection and measuring techniques  
Hand movement data were measured offline using a fully-automated movement detection 
system which was capable of firstly, matching the movement data to the stimuli data and 
secondly searching forward and backward in time for hand movements corresponding to the 
stimulus targets. A signal processing filter, a low-pass Butterworth filter, with a filter order of 
8 and a cut-off frequency of 10 Hz was applied in both directions (forward and backward) to 
the movement data to reduce high-frequency noise in the recorded data. Hand velocity was 
defined as the absolute rate of change in hand distance travelled in the three dimensions (x, y, 
and z) combined over time. The time point when a velocity exceeded two percent of its peak 
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stimulus target onset to the initiation of the matched hand movement. Several other criteria 
were used to minimize false detections (Figure II.18): (1) Hand movements identified had to 
have a latency that fell within the range of latencies specified for the given eye-hand task (Table 
II.4); (2) The direction of the detected movement was required to match the stimulus target 
direction; and (3) The movement gain, a ratio of movement amplitude over stimulus target 
amplitude, had to be greater than 0.2, i.e. movement amplitude had to be greater than 20% of 
the stimulus amplitude. Hand movements that satisfied all three criteria were accepted as valid 
hand responses. If there were multiple hand movements within the allowed latencies that met 





















Figure II.18 The automated hand movement response selection process 
 
Table II.4 Latency ranges used for selecting valid hand responses in the movement data 
 Latency (ms)  
Eye-hand task Minimum Maximum 
Visually-guided   
Reaching 120 1000 
Return - 1000 1000 
   
Temporally-cued   
Random phase 120 800 
Predictable phase - 1200 1200 
   
Delayed - 600 1200 
Valid hand response(s) 
Discard 
Movement data 
Movement onset = velocity > 2% of the peak velocity 
Is the latency within the specified latency range? 
Does movement direction match the target direction? 









Match movement data to stimuli data 
If there were more than one valid hand response to a 
matched stimulus, the valid response with the largest 
amplitude was chosen.  
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II.9.8. Hand movement in the visually-guided reflexive task 
As reported by Schmidt et al. (2005), simple motor movements usually have a reaction time 
that ranges from 130 ms to more than 200 ms but a minimum reaction time of 100 ms is 
typically used as the conservative criterion for a reactive motor movement. There were two 
distinct hand responses in the visually-guided reflexive task, reaching (to randomly appearing 
peripheral targets) and return (to the home target) movements. After taking both the 
conservative criterion and the typical range of reaction time for simple motor movements, a 
latency of 120 ms was used as the minimum cut-off for a reactive hand response in the reflexive 
task and any movements with a latency of shorter than 120 ms were considered as anticipatory 
in nature. Anticipatory movement was accepted as a valid response only in the return 
movement because of the predictable nature of target location and onset for the home target. 
All anticipatory-type reaching movements were removed from the final data pool. The eye-
hand latency interval was calculated by subtracting the mean eye latency (across trials) from 
the mean hand latency (across trials) of the corresponding movement for each subject. A 
positive latency difference indicates that the eye was leading the hand while for a negative 
difference, the hand led the eye.  
 
II.9.9. Hand movement in the self-paced tasks 
The number of self-initiated hand movements made in the self-paced tasks was manually 
counted offline. A movement made from one target to the opposite target was considered as 
one self-paced movement. A self-paced movement was only considered complete if its 
amplitude was greater than 50 percent (by visual inspection of offline data) of the movement 
amplitude of the preceding hand movement. The total number of self-paced hand movements 
for each subject was tallied for further analysis.   
 
II.9.10. Hand responses in the temporally-cued tasks  
Each trial block in the temporally-cued tasks was divided into two phases, the random phase 
that consisted of 17 trials of stimuli appearing at random locations and time intervals, and a 
predictable phase that contained 40 trials of stimuli alternating between two fixed positions and 
at a constant ISI. All anticipatory hand movements in the random phase (i.e. movements with 
latencies shorter than 120 ms) were excluded. However, due to the predictive nature of stimulus 
targets in the predictable phase, all reactive and anticipatory movements were deemed as valid 
responses. Mean hand latency was calculated for the random phase and also the last 20 trials 
of the predictable phase. The last 20 predictable trials, instead of the last 10 (as in the saccade-
only task), were used because based on the group-level data, participants were found to already 
Chapter II Methods 
63
have expressed a predictive pattern at this stage. For each subject, eye-hand latency interval 
was computed by subtracting mean hand latency (across trials) from mean eye latency (across 
trials) of the corresponding phases in the four ISI trial blocks.  
  
II.9.11. Disinhibited hand responses in the delayed task 
Hand responses in the delayed task were categorized as ‘correct’ or disinhibited’ depending on 
their latencies. Hand latency was calculated from fixation target offset. A disinhibited response 
was defined as a hand response with a latency of shorter than 120 ms while a correct response 
must have a latency of longer than 120 ms and must also not be preceded by a disinhibited 
response. The proportion of disinhibited hand responses was calculated as a percentage of the 
total of hand responses made (correct and disinhibited).  
 
II.9.12.  Statistical analysis 
Data analysis was performed in the R software environment for statistical computing and 
graphics (R Development Core Team, 2012). Statistical data were plotted with the ggplot2 
plotting system (Wickham, 2009).  
 
The package lme4 (Bates et al., 2014a) was used for fitting generalized linear models (Bolker 
et al., 2009) for binomially distributed data and the package nlme (Pinheiro et al., 2014), for 
fitting linear mixed-effects models (Gelman & Hill, 2007) for continuous and discrete 
variables. These models take into account the correlated measurements within a participant 
when assessing the differences between groups and changes over time. Heteroscedasticity (i.e. 
when the variance of the dependent variables is not constant across the range of a predictor 
variable) between groups and tasks was allowed for in the models as required.  
 
The overall effect of multi-levelled factors such as disease stage (three levels) and or task 
factors was assessed using linear mixed-effects models with ordered factors. Likelihood ratio 
tests were used to determine group and disease stage effects on binomially distributed data, for 
example the proportions of disinhibited saccade in complex volitional saccade tasks and the 
proportions of corrected pro-saccade error in the anti-saccade task. The likelihood ratio test, 
which compares the fit of two models, the null and the alternative models, uses likelihood ratios 
to calculate a critical value, and hence a p value, to decide whether to reject the null model and 
to accept the alternative model. Results yielding a p value of less than 0.05 is considered as 




Correlation coefficients were used to determine the strength of the linear associations between 
two variables. Bootstrapping procedures (Efron, 1979), a statistical method involving random 
sampling with replacement from a dataset to measure the variability of estimates, were used to 
determine the statistical significance of the differences between two r2 values (coefficients of 
determination for correlation coefficients). During the process of bootstrapping, the random 
sampling of data with replacement was repeated 1000 times and the resulting distribution of 
differences between two r2 coefficients gave an indication of the mean difference and a 95% 
confidence interval (95% CI). In this analysis, a difference was considered statistically 
significant if the estimated 95% CI of the R2 difference did not contain ‘0.0’. 
 
Cohen’s d was used to report effect sizes for between-group differences. Effect sizes for relative 
change at 12 month follow-up in the HD group in the three summary tables of Chapter VII 
(Table VII.1 – 3) were calculated using a modified Cohen’s d formula, d = t.c*[2*(1-r)/n]
0.5 
(Dunlap et al., 1996), that takes into account the correlation between baseline and 12 month 
follow-up measurements. ‘t.c’ represents the t value of the relative change at 12 month follow-
up in the HD group. ‘r’ is the correlation coefficient for the relationship between baseline and 
12 month follow-up measurements. ‘n’ denotes sample size. A transformation of effect sizes is 
essential when combining the results across independent-groups and of repeated measures 
designs (Morris & DeShon, 2002). For repeated measures, effect sizes must take into 
consideration the change over time in a measure relative to the combined sample distribution 
(Dunlap et al., 1996) of the control and HD groups, and hence the application of the 
aforementioned modified Cohen’s d formula.  
 
Due to the exploratory nature of this research, there were numerous statistical tests performed. 
The focus was on estimating effect sizes (both absolute and standardised) and hence, family-
wise error corrections were not performed. However, if focusing on single significant results 
rather than the overall picture, then the results should be confirmed in future research to gain 
confidence that they are not just due to sampling variability.   
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HD is characterized by involuntary hyperkinetic movements, cognitive impairment, and 
behavioural disorders. Cognitive impairment, which may be evident even in gene-positive 
individuals yet to be clinically diagnosed (Blackmore et al., 1995; Duff et al., 2010; Kirkwood 
et al., 1999; Peavy et al., 2010), is progressive in nature and a contributing factor in the loss of 
everyday function (Bates et al., 2002). Subtle cognitive impairment can be overlooked by 
clinicians during routine follow-up (Chodosh et al., 2004), indicating the need for easily 
administered and yet robust tools to detect cognitive changes in HD. Comprehensive 
neuropsychological testing is necessary to establish cognitive status definitively. However, 
neuropsychological batteries are time-consuming and brief cognitive screening tools such as 
the Mini Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) 
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are commonly used in clinical settings and in a broad range of conditions. The Unified 
Huntington’s Disease Rating Scale (UHDRS), a standard assessment tool for HD, also includes 
a brief cognitive component.  
 
The MMSE (Folstein et al., 1975) comprises eleven questions spanning five aspects of 
cognitive function: executive function, language, memory function, visuospatial ability, and 
orientation. It has good inter-rater, test and re-test reliability in differentiating cognitive status 
in dementia syndromes (Tombaugh & McIntyre, 1992) and other disorders featuring cognitive 
impairment (Godefroy et al., 2011a). Nevertheless, it is influenced by demographic factors such 
as age, education, and cultural background (Scazufca et al., 2009; Tombaugh & McIntyre, 1992; 
Wind et al., 1997). The MoCA places greater emphasis than the MMSE on naming, attention, 
abstraction, and delayed recall, functions that are most likely to be compromised in the earlier 
stages of cognitive impairment. Unlike the MMSE, it compensates for education level 
(Nasreddine et al., 2005). Both the MMSE and MoCA have been employed as measures of 
cognitive performance in manifest HD patients (Bezdicek et al., 2013; Gluhm et al., 2013; 
Mickes et al., 2010; Videnovic et al., 2010). The MoCA was found to have higher sensitivity, 
without losing specificity, compared to the MMSE in identifying those with cognitive 
impairment in HD (Mickes et al., 2010). Furthermore, Bezdicek et al. (2013) demonstrated a 
strong correlation between MoCA scores and comprehensive neuropsychological assessment 
scores in manifest HD patients. The UHDRS cognitive component (Huntington Study Group, 
1996) includes three tests of executive function – letter fluency test, Symbol Digit Modalities 
test, and Stroop test; which can be used with corrected norms to attenuate the impact of various 
demographic variables (O'Bryant & O'Jile, 2004; Sheridan et al., 2006).   
 
The progressive nature of HD means that any cognitive assessments should be useful 
longitudinally. HD patients are routinely followed up at clinics at 6 month and 12 month 
intervals thus it is preferable that brief cognitive assessment tools are sensitive to changes even 
over relatively short time intervals. Effective yet brief cognitive tools would enable easier 
detection of cognitive changes in HD patients in clinic settings, compared to time-consuming 
comprehensive cognitive assessment. They would also assist health care providers in designing 
treatment and care plans aimed at improving patient’s quality of life. MMSE and MoCA  have 
been extensively evaluated in previous cross-sectional HD studies (Gluhm et al., 2013; Mickes 
et al., 2010; Videnovic et al., 2010) but there is a lack of longitudinal data on the utility of these 
brief cognitive tests, compared to the UHDRS cognitive assessment, in monitoring cognitive 
changes in HD patients. Therefore the objective of this study was to examine and compare the 
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utility of two widely used brief cognitive tests (MMSE and MoCA) and the UHDRS cognitive 
component, relative to a comprehensive neuropsychological test battery for monitoring 
cognitive changes in HD patients over an interval of 12 months. Such a direct comparison has 
not been previously reported.  
 
In addition, this study also examine the longitudinal changes in behavioural aspect of HD by 
using commonly-used neuropsychiatric measures such as Beck Depression Inventory (BDI), 
BAI (Beck Anxiety Inventory), AES (Apathy Evaluation Scale), and the UHDRS behavioural 
component.  
 
III.2.  Methods 
Please refer to Chapter II: Methods for a detailed description of study methods. 
 
III.3.  Results 
III.3.1.   Demographics at 12 month  
Invitations were sent out to all study subjects 10 months after their initial visit, asking them to 
return for a follow-up assessment after 12 months. The HD group had a 100% retention rate 
while the controls recorded a 9% dropout rate (n=2). The two control subjects declined due to 
non-health related reasons. Table III.1 summarizes the demographics at 12 month follow-up. 
 
Table III.1 Demographic changes of control and HD groups 
 Control group HD group 
 Mean (SD) 
Age (years) 50 (16) 51 (15) 






















Retention rate (%) 91% (n= 20) 100% (n = 22) 
 
The disease stages of the Huntington’s disease patients ranged from stage 1 to stage 4 as 
determined through the scores from the FRS of the UHDRS. At baseline, there were eight 
patients in stage 1, eight in stage 2, five in stage 3, and one having stage 4 disease. Nine patients 
deteriorated in disease status at 12 month follow-up: three patients progressed from stage 1 to 
stage 2, four from stage 2 to stage 3, one from stage 3 to stage 4, and one from stage 2 to stage 
4. However, one patient showed an improvement from stage 3 to stage 2. 
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III.3.2. Cognitive function 




Figure III.1 Change in cognitive scores over 12 months.  Baseline and 12 month scores for the control and HD groups 
in: (A) the five cognitive measures; and (B) the six cognitive domains within the global assessment. LMEM-estimated group 
means, and scores for individual subjects, are shown.     
 
At baseline, six HD patients were classified as having normal cognition, 10 met criteria for 
MCI, and six had dementia (Peavy et al., 2010). All 22 controls had normal cognition. The HD 
group showed significantly lower scores in global cognition from the test battery and brief 
cognitive tests compared to controls both at baseline and at 12 month follow-up. The effect size 
at baseline in global cognition was d = 2.4 whereas in the brief cognitive tests, it ranged from d 
= 1.1 in the MMSE with ‘World’ spelled backwards to d = 2.4 in the UHDRS cognitive 
component (Figure III.1A; Table III.2). In terms of domain-specific scores, the HD group had 
significantly lower scores compared to controls across all cognitive domains and the effect sizes 
at baseline ranged from the smallest (d = 1.4) in the language domain to the largest (d = 2.7) in 
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baseline and 12 month follow-up and the brief cognitive tests are detailed in Figure S1 and 
Table S1 of the Appendix respectively.  
 
There was an overall pattern of improvement in the control group across all cognitive tests after 
12 months. In contrast, the HD group showed minimal change in global cognitive z-score and 
a general decline across all brief cognitive tests scores after 12 months, which was significant 
for the UHDRS cognitive score and MMSE (with ‘World’ spelled backwards) (Figure III.1A; 
Table III.2). The control group showed an improvement at 12 month in most cognitive domains, 
excepting the executive function and visuospatial domains. In contrast, the HD group 
demonstrated a decline in the executive function domain but an increase in language domain z-
score 12 months later. There were no significant changes in the other cognitive domains in the 
HD group (Figure III.1B; Figure S1). However, relative to the change in controls, there was a 
significant decline in global cognition, executive function domain score, learning and memory 
domain score, and MMSE with ‘World’ spelled backwards in the HD group after 12 months 
(Table III.2).  
 
III.3.3. Behavioural and motor functions 
            
Figure III.2 Change in neuropsychiatric measures and UHDRS motor scores over 12 months.  Baseline and 12 
month follow-up scores for control and HD groups in: (A) the BAI, BDI, and AES; and for the HD group only in (B) the 
UHDRS motor and behavioural components. LMEM-estimated group means, and scores for individual subjects, are shown.     
 
Similarly, linear mixed-effect models were fitted to the neuropsychiatric measures to determine 
group differences at baseline and relative change after 12 months. At baseline, the HD group 





(Figure III.2; Table III.2). The range of scores for the UHDRS motor component at baseline 
was 11 to 82 points. Although there was an increase in the UHDRS motor component score 
over time in the HD group, there was no evidence of a change in any of the behavioural indices 
(Figure III.2; Table III.2). In contrast to the controls, who showed no significant changes, HD 
group showed a significant drop in their AES scores after 12 months indicating that there was 
worsening of apathy in HD patients at a group level (Figure III.2; Table III.2). 
Table III.2 Scores# at baseline, within-group changes and group over time interactions of control and HD 
groups 
 z-scores 





Change after           
12 months 




Change after          
12 months 
Mean [95%CI]  
Baseline difference  
Mean [95%CI] 
Relative change at 
12 month 
Mean [95%CI] 
Global cognitive level 0.4 [0.2 – 0.7] 
0.2 [0.1 – 0.3], 
p < 0.001 
 -1.2 [-1.4 – -0.9] 
0.01 [-0.1 – 0.1], 
p = 0.8 
 
-1.6 [-2.0 – -1.1], 
p < 0.001 
-0.2 [-0.4 – -0.1], 
p = 0.006 
Executive function 0.8 [0.4 – 1.2] 
0.1[-0.04 – 0.1], 
p = 0.1 
 -1.4 [-1.7 – -1.0] 
-0.2 [-0.4 - -0.02], 
p = 0.03 
 
-2.2 [-2.7 – -1.7], 
p < 0.001 
-0.3 [-0.6 – -0.1], 
p = 0.01 
Working memory & 
attention 
0.2 [-0.1 – 0.5] 
0.2 [0.05 – 0.3], 
p = 0.01 
 -1.0 [-1.2 – -0.7] 
0.08 [-0.1 – 0.2], 
p = 0.3 
 
-1.1 [-1.5 – -0.7], 
p < 0.001 
-0.1 [-0.3 – 0.1], 
p = 0.3 
Processing speed 0.7 [0.3 – 1.1] 
0.1 [0.01 – 0.03], 
p = 0.04 
 -1.4 [-1.8 – -1.0] 
-0.01 [-0.1 – 0.1],     
p = 0.8 
 
-1.7 [-2.1 – -1.3], 
p < 0.001 
-0.2 [-0.3 – 0.02], 
p = 0.09 
Learning & memory 0.5 [0.1 – 0.9] 
0.6 [0.3 – 0.9], 
p < 0.001 
 -1.0 [-1.4 – -0.6] 
-0.04 [-0.3 – 0.2], 
p = 0.8 
 
-1.4 [-2.0 – -0.9], 
p < 0.001 
-0.6 [-1.0 – -0.3], 
p < 0.001 
Language 0.1 [-0.2 – 0.4] 
0.3 [0.1 – 0.6], 
p = 0.008 
 -0.9 [-1.2 – -0.6] 
0.3 [0.1 – 0.6], 
p = 0.01 
 
-1.0 [-1.4 – -0.6], 
p < 0.001 
-0.02 [-0.4 – 0.3], 
p = 0.9 
Visuospatial 0.3 [0.0 – 0.6] 
-0.02 [-0.2 – 0.2], 
p = 0.8 
 -1.4 [-1.7 – -1.1] 
-0.07 [-0.2 – 0.3], 
p = 0.5 
 
-2.1 [-2.7 – 1.6], 
p < 0.001 
-0.04 [-0.3 – 0.2], 
p = 0.8 
UHDRS cognitive 
score 
0.6 [0.2 – 1.0] 
0.06 [-0.1 – 0.2], 
p = 0.5 
 -1.5 [-1.9 – -1.1] 
-0.2 [-0.3 – -0.001], 
p = 0.048 
 
-2.1 [-2.6 – -1.5], 
p < 0.001 
-0.2 [-0.4 – 0.01], 
p = 0.06 
  
 Points 





Change after 12 
months 




Change after 12 
months 
Mean [95%CI]  
Baseline difference  
Mean [95%CI] 
Relative change at 
12 month 
Mean [95%CI] 
MMSE         
with WORLD item 29 [28 – 30] 
0.4 [-0.3 – 1.1], 
p = 0.3 
 26 [25 – 28] 
-0.8 [-1.5 – 0.08], 
p = 0.03 
 
-2.6 [-4.0 – -1.1], 
p < 0.001 
-1.2 [-2.2 – -0.2], 
p = 0.02 
with Sevens item 29 [28 – 30] 
0.5 [-0.4 – 1.4], 
p = 0.3 
 25 [24 – 26] 
-0.5 [-1.3 – 0.4], 
p = 0.3 
 
-4.0 [-5.8 – -2.3], 
p < 0.001 
-1.0 [-2.2 – 0.3], 
p = 0.1 
MoCA 28 [26 – 30] 
0.4 [-0.6 – 1.4], 
p = 0.5 
 21 [20 – 23] 
-0.5 [-1.5 – 0.5], 
p = 0.3 
 
-6.4 [-8.8 – -4.0], 
p < 0.001 
-0.9 [-2.3 – 0.5], 
p = 0.2 
UHDRS motor score* - -  42 [33 – 51] 
7.4 [3.4 – 11.3], 
p < 0.001 
 - - 
UHDRS behavioural 
score* 
- -  23 [17 – 30] 
0.7 [-6.4 – 7.8], 
p = 0.8 
 - - 
BAI 3 [1 – 5] 
-0.5 [-3.0 – 2.0],        
p = 0.7 
7 [5 – 9] 
-0.5 [-2.9 – 2.0],         
p = 0.7 
 3.9 [0.8 – 7.0],         
p = 0.01 
0.02 [-3.5 – 3.6],         
p = 1.0 
BDI 5 [2 – 9] 
-2.5 [-6.3 – 1.3],        
p = 0.2 
12 [9 – 15] 
1.3 [-2.4 – 4.9],         
p = 0.5 
6.6 [2.1 – 11.1],         
p < 0.005 
3.7 [-1.5 – 9.0],         
p = 0.2 
AES 59 [56 – 61] 
-0.7 [-2.5 – 1.0],        
p = 0.4 
47 [44 – 50] 
-5.2 [-6.8 – -3.5],         
p < 0.001 
-11.6 [-15.7 – -7.5],         
p < 0.001 
-4.4 [-6.8 – 2.1],         
p < 0.001 
* UHDRS motor and behavioural components were assessed in the HD group only. 
# Baseline and 12 month follow-up SD and ranges for all variables are detailed in the Appendix: Table S1 and score changes after 12 months 
in individual component tests are shown in the Appendix: Figure S1. 
 
III.3.4. Usefulness of brief cognitive tests for measuring change over time 
There are several considerations to take into account when determining which brief cognitive 
Chapter III Cognitive, motor, and behavioural functions 
71
test has greatest utility for measuring cognition over time. This includes how well the score 
reflects global cognition, whether there is any ceiling effect, and how noisy (variability of score 
residuals) the score is after taking systematic changes into consideration. 
 
Simple correlations confirmed that the scores of all three brief cognitive screening tests, as 
judged by their r coefficients, were significantly correlated with the scores of the full 
neuropsychological test battery at baseline (Figure III.3) and 12 month follow-up (not shown). 
Bootstrapping procedures confirmed that there were no significant differences between the 
three brief cognitive screening tests in extent of correlation with global cognition (Table III.3). 
Thus all brief cognitive tests provided a reasonable cross-sectional measure of global cognition.  
 
Figure III.3 Correlations between brief cognitive screening tests scores and global cognitive z-scores at baseline.  
The control group is shown in the top row and the HD group in the bottom row. r [95% CI] and p values are shown.  
 
Table III.3 Differences in r2 coefficients (coefficients of determination for correlations between full cognitive 
battery and brief cognitive tests) between the brief cognitive tests 
 
A reliable test would have a low level of score variability over time. To determine the variability 
of score residuals over time, simple linear models were fitted to the baseline and 12 month 
 
Differences in r2 values [95% CI] 
MMSE – WORLD MMSE - Sevens MoCA 
UHDRS cognitive 
component 
0.1 [-0.0 – 0.4] 0.1 [-0.1 – 0.3] 0.0 [-0.2 – 0.2] 
MMSE - WORLD - -0.1 [-0.3 – 0.1] -0.1 [-0.4 – 0.0] 
MMSE - Sevens - - -0.0 [-0.2 – 0.1] 
r = 0.47 [0.07 -0.75],  
p = 0.02 
r = 0.45 [0.03 – 0.73],  
p = 0.04 
r = 0.67 [0.35 – 0.85],  
p = 0.001 
r = 0.26 [-0.18 – 0.61],  
p = 0.2 
r = 0.80 [0.57 – 0.91],  
p < 0.001 
r = 0.86 [0.68 – 0.94],  
p < 0.001 
r = 0.88 [0.73 – 0.95],  
p < 0.001 
r = 0.88 [0.74 – 0.95], 
 p < 0.001 
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follow-up scores of the global cognition and of brief cognitive tests. The correlations of baseline 
and 12 month follow-up scores of the different cognitive measures were evaluated by 
examining the r coefficients of the model fits (Figure III.4).  
    
Figure III.4 Correlations between baseline and 12 month scores of the five cognitive measures.  The control group 
is shown in the top row and the HD group in the bottom row. r [95% CI] and p values are shown.   
 
Table III.4 Differences in r2 coefficients (coefficients of determination for correlations between baseline and 12 
month scores) between the different cognitive measures 
 
Differences in r2 coefficients  [95% CI] 
UHDRS cognitive 
component MMSE - WORLD MMSE - Sevens MoCA 
Global cognitive z-score -0.0 [-0.1 – 0.1] 0.2 [0.0 – 0.4]* 0.2 [0.0 – 0.5]*  0.1 [-0.0 – 0.3] 
UHDRS cognitive 
component 
- 0.2 [0.0 – 0.5]* 0.2 [0.0 – 0.4]* -0.1 [-0.0 – 0.4] 
MMSE - WORLD - - 0.0 [-0.2 – 0.1] -0.1 [-0.3 – 0.1] 
MMSE - Sevens - - - -0.1 [-0.3 – 0.2] 
* The estimated 95% CI of r2 differences contains ‘0.0’, suggesting that the difference in r2 values between the two cognitive measures tested 
could be considered significant. 
 
In the control group, the range of scores in MMSE and MoCA was narrow due to ceiling effects, 
presumably contributing to low r values (r ≤ 0.60). In contrast, the global z-score and UHDRS 
cognitive score showed greater utility in the control group, with a wider range of values together 
with small deviations from the linear fit, resulting in high r values. In the HD group the baseline 
scores were well correlated (r ≥ 0.82) with 12 month follow-up scores for global cognition and 
all three brief cognitive tests (Figure III.4). The comprehensive neuropsychological test battery 
and UHDRS cognitive component, as confirmed by bootstrapping procedures, had smaller 
deviations from linear fits (i.e. lower level of score variability after 12 months) than the two 
versions of the MMSE but not the MoCA (Table III.4). This finding indicates that the two 
r = 0.87 [0.70 – 0.95],  
p < 0.001 
r = 0.92 [0.80 – 0.97],  
p < 0.001 
r = 0.50 [0.07 – 0.77],  
p = 0.02 
r = 0.39 [-0.06 – 0.71], 
 p = 0.09 
r = 0.60 [0.22 – 0.83],  
p = 0.005 
r = 0.94 [0.87 – 0.98],  
p < 0.001 
r = 0.94 [0.88 – 0.97],  
p < 0.001 
r = 0.82 [0.62 – 0.92],  
p < 0.001 
r = 0.82 [0.60 – 0.92],  
p < 0.001 
r = 0.87 [0.71 – 0.95],  
p < 0.001 
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versions of MMSE had higher measurement noise (i.e. greater score variability over time), 
compared to global cognition and the UHDRS cognitive component after 12 months.  
 
 
III.4.  Discussion  
Cognitive decline in HD, has been shown to assume a relatively slow course, especially in early 
stages of HD (Bachoud-Levi et al., 2001; Snowden et al., 2001). Although MMSE and MoCA 
have been extensively evaluated in previous cross-sectional HD studies (Gluhm et al., 2013; 
Mickes et al., 2010; Videnovic et al., 2010), there has been no longitudinal data on the utility 
of these brief cognitive tests compared to the UHDRS cognitive component. This study 
attempted to evaluate the usefulness of these two widely-used brief cognitive assessment tools 
and the UHDRS cognitive component over a 12 month interval by comparing them to a 
comprehensive neuropsychological test battery. The key findings were: (1) there was no 
significant change in global cognition, despite the presence of significant decline in the 
executive function domain in the HD group; (2) relative to the control group, which showed an 
increase over time in global cognitive z-score and learning and memory domain scores, the HD 
group demonstrated significantly less change on these scores; and (3) the UHDRS cognitive 
component performed the best (compared to MMSE and MoCA) as a brief cognitive assessment 
tool in monitoring cognitive progression in HD over 12 months. 
 
III.4.1. Domain-specific cognitive performance 
Overall, the findings of the present study were consistent with other longitudinal studies on pre-
manifest and early manifest HD patients wherein, relative to a control group, cognitive changes 
were evident after 12 months in the HD group (Tabrizi et al., 2010). Similar conclusions were 
found at 24 months follow-up (Tabrizi et al., 2012). The change in apparent global cognition in 
the control group is consistent with practice effects, which have been reported previously in 
healthy controls in longitudinal studies (McCaffrey & Westervelt, 1995; Salthouse & Tucker-
Drob, 2008). Practice effects are characteristic of many neuropsychological tests during serial 
assessments (Goldberg et al., 2015). It is hypothesized that score improvement caused by 
practice effects do not actually reflect a true enhancement in a person’s ability that is being 
measured by the neuropsychological test (Calamia et al., 2012; Reeve & Lam, 2007). Practice 
effects are most apparent in the early phases of repetitive testing, with performance scores 
tending to plateau on subsequent testing (Collie et al., 2003; Falleti et al., 2006), or after 
changing to low frequency testing (Bartels et al., 2010).  
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Several factors are thought to contribute to practice effects, such as reduced anxiety on retesting 
(Messick & Jungeblut, 1980), increasing familiarity with testing environment (Hausknecht et 
al., 2007), memory of specific test items (Kulik et al., 1984; McCaffrey et al., 2000), and 
enhancement of test taking strategies (Sackett et al., 1989). Practice effects, when not taken into 
consideration, can compromise the validity of a cognitive test or research finding. The main 
implication of practice effects in clinical trials and clinical practice is that it can lead to incorrect 
conclusions about cognitive changes over time (Calamia et al., 2012). In clinical trials, it may 
provide a false impression that a medical intervention is beneficial when the score improvement 
was in fact attributable to practice effects. In clinical practice, practice effects may mask slow 
deterioration in cognition during serial assessments, hence giving a false illusion of stability 
and no change in cognition over time. This may inadvertently lead to incorrect classification of 
performance and subsequently, the delay in the implementation of useful medical interventions 
for a patient. Therefore, taking practice effects into account, the statistically significant group-
over-time interaction in the global cognitive z-score between HD and control groups likely 
indicates that the control group had benefited from practice effects, rather than the HD scores 
declining on the comprehensive neuropsychological battery.  
 
Although practice effects are usually regarded as confounding factors, it is posited that a failure 
to demonstrate practice effects might be a useful prognostic marker of a patient’s cognition in 
the future (Duff et al., 2007a). For example, it was found that patients with mild cognitive 
impairment who had minimal practice effects at one week retesting had higher risk of 
developing cognitive decline after one year than those with larger practice effects (Duff et al., 
2011). Further, practice effects are capable of differentiating longitudinal cognitive changes 
related to healthy ageing from changes in Alzheimer’s disease (Ivnik et al., 2000). Based on the 
findings from those studies, it can be inferred that the smaller practice effect-related score 
improvement in global cognition at 12 month follow-up in the HD group compared to controls 
may suggest of a concurrent or predictive indicator of cognitive deterioration.  
 
Despite the lack of changes in the HD group in the majority of cognitive domains after 12 
months, there was a significant improvement in the language domain. Perhaps, patients with 
early stages of HD benefited from practice effects at least in this domain, as genuine 
improvement is unlikely. As reported by Bachoud-Lévi et al. (Bachoud-Levi et al., 2001) in a 
medium- to long-term longitudinal study on disease progression in early HD, there was a 
significant retest effect in many neuropsychological tests in HD patients. The significant decline 
in executive function domain in HD is consistent with previous work that this domain is most 
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vulnerable to HD (Lawrence et al., 1996), with progressive impairment evident in both pre-
manifest (Lemiere et al., 2004) and early stages of HD (Bachoud-Levi et al., 2001; Ho et al., 
2003). Atrophy of the caudate nucleus is found in the normal aging process but when compared 
to healthy controls, it was demonstrated on serial radio-imaging that atrophy occurs at an 
expedited rate in HD patients (Roth et al., 2005; Tabrizi et al., 2012). This suggests that although 
patients do deteriorate over time, such changes may not be easily measurable with cognitive 
tests over short intervals.  
 
The present study reaffirmed the general slow progression of cognitive deterioration in HD 
patients over short time interval. This inevitably, creates great difficulty in monitoring cognitive 
changes in HD patients on routine follow-up in clinic settings. Longitudinal monitoring of 
disease progression is generally conducted to evaluate potential interventions for delaying 
phenoconversion in HD. Therefore, it is often argued that it is more meaningful for serial 
evaluation of disease progression in pre-manifest HD. However, understanding short-term 
changes and the utility of various cognitive tools in manifest HD patients are also important for 
multi-disciplinary health teams in planning and modifying disease plans, which consists of 
pharmacological and non-pharmacological interventions aimed at improving patient’s quality 
of life. Findings from the current study have implications for clinical practice and research. 
Cognitive decline in HD appeared to be most marked in executive function, and learning and 
memory domains after 12 months. Therefore in the clinic, cognitive deterioration in HD should 
not be determined by changes in global cognitive score of comprehensive neuropsychological 
test battery but ideally by detailed analysis of individual cognitive domain-specific 
performance. Due to practice effects, it is important in short- to medium-term longitudinal 
clinical research to include a control group when assessing the cognition of patients. 
 
III.4.2. Usefulness of brief cognitive tests for longitudinal assessment 
As expected, the MMSE, MoCA, and the UHDRS cognitive component scores correlated well 
with global z-scores of the comprehensive neuropsychological test battery in the HD group. 
These findings support the utility of the three brief cognitive assessment tools in cross-sectional 
detection of cognitive deficits in manifest HD patients. Furthermore, there were no significant 
differences between the three brief cognitive tests in reflecting global cognition in HD patients, 
providing no evidence that one test is better than the other in this respect. 
 
However, the baseline scores of the comprehensive neuropsychological test battery (global 
cognition) and UHDRS cognitive component were highly correlated with themselves at 12 
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month follow-up, with minimal deviations from the linear fit, indicating that both had low score 
variability over time.  The reliability of the MMSE in the HD group, though reasonable, was 
significantly lower than that for the full neuropsychological test battery and the UHDRS 
cognitive component. Deficiencies in the reliability of the MMSE were highlighted in a study 
by Bowie et al. (1999), who inferred that the test was inadequate in detecting small cognitive 
changes longitudinally. Moreover, large score variance on annual assessment was another 
weakness of the MMSE as shown in a study on patients with Alzheimer’s disease (Clark et al., 
1999), which further limits its value in assessing disease progression. Similarly in the HD 
sample of the current study, the two versions of MMSE were found to have greater score 
variance than the comprehensive neuropsychological test battery and the UHDRS cognitive 
component. The large score variance in the MMSE is likely to be caused by practice effects in 
some HD patients. Previous studies have concluded that the MMSE is highly susceptible to 
practice effects, especially in the healthy older adult population (Helkala et al., 2002; Hensel et 
al., 2007; McCaffrey & Westervelt, 1995; Stein et al., 2012; Tombaugh, 2005). However, such 
effects are usually minimal or absent in those with dementia (Helkala et al., 2002). Even though 
the present study demonstrated that there were significant within-group changes after a 12 
month period in the MMSE (with ‘World’ spelled backwards) in HD patients, its use in routine 
follow-up in clinical practice should be interpreted with caution because of its tendency to vary 
unsystematically from one assessment to the next.  
 
On the contrary, the MoCA and UHDRS cognitive component, as judged by the differences of 
linear fit models, had comparable performance to the comprehensive neuropsychological 
battery. A likely explanation for this is the nature of short-term cognitive progression in HD, 
which is most marked in executive function and also the overall design of these two brief 
cognitive tests, which has greater emphasis on testing executive function. The MoCA, which 
has been claimed to have superior sensitivity for detecting MCI compared to the MMSE (Larner 
et al., 2013), contains more demanding tasks for assessing executive and memory functions  
while the UHDRS cognitive component essentially assesses the executive function domain 
only. However, MoCA is a multiple cognitive domain assessment tool, hence, similar to global 
cognitive score, short-term cognitive decline in HD patients may have been counteracted by 
practice effects in other domains within the test. The MoCA, like other neuropsychological 
tests, is also susceptible to practice effects on repeated assessment (Cooley et al., 2015). It was 
found in Cooley et al.’s study that there was a lack of age-expected decline in MoCA scores 
over a three year period in healthy older adults. In addition, there was a significant increase 
scores from baseline to first 12 month follow-up assessment, mainly in those who scored lower 
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scores at baseline assessment (Cooley et al., 2015). It is recommended that alternate form of 
the MoCA should be considered to minimise the effects of practice on serial assessment (Costa 
et al., 2012). 
 
On the basis of the findings in the present study, it is recommended that the UHDRS cognitive 
component is a good brief substitute for comprehensive neuropsychological testing and a 
sensitive cognitive measure to assess short-term cognitive changes in manifest HD, compared 
to MMSE and MoCA. The MoCA and MMSE, in that order, might be considered as reasonable 
alternatives to the ‘gold standard’ for use in clinic setting in circumstances where the UHDRS 
cognitive component is unavailable. However, due a higher level of score variability over time 
in MMSE and issues concerning practice effects in MMSE and MoCA, short-term longitudinal 




III.4.3. Behavioural measures and the UHDRS motor score 
There was no significant worsening in the UHDRS behavioural score in the HD group at follow-
up, similar to prior observations (Huntington Study Group, 1996). Behavioural abnormalities 
in HD are heterogeneous in nature and without clear temporal progression (Jauhar & Ritchie, 
2010). Furthermore, psychiatric interventions are often effective in managing behavioural 
disturbances of HD patients (Phillips et al., 2008) so such features are less likely to exhibit 
progressive deterioration over time. Thus, the UHDRS behavioural index is not particularly 
useful as a measure of short- to medium-term disease progression in HD.  
 
In contrast to the absence of measurable change in the behavioural measure, there was a 
significant increase (an average of seven points increase) in the UHDRS motor score over 12 
months. This is consistent with the Huntington Study Group’s (1996) report of an average three 
point increase in motor score over six months in manifest HD patients. The ability to 
demonstrate increase in the UHDRS motor score is not exclusive to manifest HD patients, with 
another study on pre-manifest patients showing that while the change was minimal after one 
year, there was a significant increase in motor scores over five years (Rao et al., 2011). These 
observations combined suggest that motor changes are possibly more aggressive in the short-




III.5. Chapter summary 
While the HD group exhibited no clear change in global cognitive z-score after a 12 month 
period, a decline was observed in the executive function domain.  The significant improvement 
in the control group’s cognitive scores, along with the language domain score in the HD group, 
suggested some practice effects. Such practice effects may have implications for clinic follow-
up and clinical research and the inclusion of a control group is vital in serial or longitudinal 
research studies involving HD patients.  
 
Finally, cognitive findings in this study provided a new perspective on the utility of two widely 
used brief cognitive assessment tools (MMSE and MoCA) in comparison to UHDRS cognitive 
component and other measures on longitudinal monitoring of cognitive changes in manifest HD 
patients over a 12 month period. Despite the MMSE and MoCA being effective at describing 
global cognition in HD patients in cross-sectional analysis, they are less useful for monitoring 
longitudinal cognitive changes, hence their serial test scores should be interpreted prudently. 
The UHDRS cognitive component, which is a relatively brief cognitive assessment tool, is 
sensitive to short-term cognitive changes in HD and also a more reliable brief cognitive 









Chapter IV   
 




Abnormal saccadic function is a relatively well-established deficit in cross-sectional studies in 
HD (Becker et al., 2009; Lasker et al., 1987; Peltsch et al., 2008; Tsai et al., 1995; Winograd-
Gurvich et al., 2003). Several studies have examined longitudinal changes in reflexive and 
complex saccades but many of these studies are limited by the small number of saccadic 
variables investigated (Tabrizi et al., 2012; Tabrizi et al., 2010) or the long follow-up period 
between baseline and follow-up assessments (Beenen et al., 1986; Rubin et al., 1993). It was 
suggested by Hotson et al. (1984) that HD has greater impact on vertical saccades than 
horizontal saccades. Although the performance of vertical and horizontal saccades of HD 
patients has been compared in a cross-sectional study (Patel et al., 2012), there is no longitudinal 
study that compares changes in both horizontal and vertical saccades over time.  
 
Somatomotor movement and eye-head movement coordination in HD have been well 
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documented (Becker et al., 2009; Berardelli et al., 1996; Georgiou-Karistianis et al., 2014; 
Phillips et al., 1996; Thompson et al., 1988; Thompson et al., 1986). Becker et al. (2009) 
concluded that eye-head coordination of HD patients was identical to that of controls and that 
the use of head movement to facilitate eye movement was thought to be an adaptive behaviour 
employed by advanced stage HD patients. However, the relationship between eye and 
somatomotor or more specifically eye and hand movements in HD has yet to be explored. 
 
The present study is an attempt to examine in a novel way the longitudinal changes of horizontal 
and vertical saccades and also of changes in eye-hand coordination in visually-guided reflexive 
tasks in manifest HD over a short interval of 12 months. These movement parameters were also 
then compared to measures of disease status, namely the UHDRS motor score and global 








IV.3A. Reflexive saccades 
IV.3A.1. Saccadic latency by stimulus type in reflexive 1D paradigm 
Mean latency in the ‘gap’ stimulus condition (task) in the control group was 145 ms. In the 
control group, mean latencies in the ‘step’ and ‘overlap’ tasks were longer than the ‘gap’ task 
by 44 ms [95% CI: 33 – 54; p < 0.0001] and 74 ms [95% CI: 64 – 85; p < 0.0001] respectively 
(Figure IV.1). There was likely only a small increase in latency in the HD group in the ‘gap’ 
task relative to controls, with an estimated non-significant increase of 24 ms [95% CI: -3 – 52; 
p = 0.07]. The ‘step’ task in HD didn't appear to be overtly affected, with an estimated 9 ms 
increase in latency over the increases observed in the control group ‘step’ task and HD group 
‘gap’ task [95% CI: -6 – 24; p = 0.3]. In contrast, there was a strong additional effect of the 
‘overlap’ task in HD, with an additional 46 ms [95% CI: 31 – 61; p < 0.0001] increase in latency 
relative to the ‘overlap’ task effect in controls and the effect of HD in ‘gap’ task (Figure IV.1). 
There was an effect of time, with latency increasing in the follow-up session by 24 ms across 
tasks and groups [95% CI: 17 – 31; p < 0.0001] (Figure IV.1). 




Figure IV.1 Saccadic latency by stimulus type (‘Gap’, ‘Step’, and ‘Overlap’). Baseline and 12 month data for 
controls and HD patients are shown. LMEM-estimated group means are shown in filled circles and means for individual 




IV.3A.2. Express saccades in HD 
 
Figure IV.2 Latency distributions in ‘Gap’, ‘Step’, and ‘Overlap’ tasks. Baseline data only is shown for controls 
and HD patients. Two red dotted line mark the latency range for express saccades (70 – 135 ms). The binwidth for the 





Express saccades are those with very short latencies (70 – 135 ms) and are commonly found in 
saccadic responses of healthy controls in the ‘gap’ task (Fischer & Weber, 1993; Munoz et al., 
1998). The saccadic latency distributions of the three tasks, i.e. ‘gap’, ‘step’, and ‘overlap’, are 
shown in Figure IV.2. Although both groups had noisy unimodal distributions in all three 
stimulus types, the bulk of latency values in the ‘gap’ task appeared to be different to the ‘step’ 
and ‘overlap’ tasks. That is, in ‘gap’ task, a larger number of observations was found on the left 
margin of the distribution plot.  
 
A binomial family type generalized linear mixed-effect model was fitted to the binary 
classification of each trial (express saccade vs. regular saccade) to determine whether there was 
any effect of HD on express saccades. The model showed that in both groups, the occurrence 
of express saccade was higher in the ‘Gap’ task than the other two tasks (Control group: χ2 = 
162.7, p < 0.001; HD group: χ2 = 175.2, p < 0.001). There were minimal differences in express 
saccades rate between controls and the HD group in the ‘Gap’ task (Table IV.1). Both groups 
in general made fewer express saccades (p ≤ 0.01) in the ‘Gap’ task in the follow-up session 
(Table IV.1). 
 
Table IV.1 Express saccade percentages in ‘Gap’, ‘Step’, and ‘Overlap’ tasks  
 Control group  HD group  HD vs. Controls 
Stimulus type Baseline 
Mean (SD) 
Change after  
12 months 
Mean (SD)  
Baseline 
Mean (SD) 
Change after  
12 months 
Mean (SD)  
Baseline 
difference 
z, p value 
Relative change 
at 12 month 
z, p value 
Gap 43 (22) 
-11 (20), 
p = 0.01 
 33 (23) 
-11 (17), 
p < 0.001 
 -1.5, p = 0.1 -0.6, p = 0.6 
Step 9 (10) 
-8 (11), 
p < 0.001 
 4 (9) 
-3 (8), 
p = 0.07 
 -2.1, p = 0.03 2.0, p = 0.04 
Overlap 8 (8) 
-6 (7), 
p < 0.001 
 6 (10) 
-4 (7), 
p = 0.005 
 -1.6, p = 0.1 1.2, p = 0.2 
 
 
IV.3A.3. Saccadic performance in the reflexive 2D paradigm  
In the 2D task, only ‘Step’ stimuli were used. Mean latency in the control group was 191 ms 
for horizontal saccades and 201 ms for vertical saccades. Mean latency for vertical saccades in 
the HD group was longer than controls by 32 ms (p = 0.03). Both groups had longer latencies 
in vertical saccades than horizontal saccades (p ≤ 0.04). There was possibly a small effect of 
time upon latency in controls, with an estimated increase of 9 ms (p = 0.05) in horizontal 
saccades and 11 ms (p = 0.03) in vertical saccades at follow-up (Figure IV.3A). By contrast, 
there was a strong additional effect of time in HD, with an additional increase of 21 ms (p = 
0.002) and 24 ms (p = 0.003) over the increases observed in the control group in horizontal and 
vertical saccades (Figure IV.3A). 
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Figure IV.3  Horizontal and vertical saccades in the reflexive 2D paradigm. Saccadic parameters assessed are: (A) 
latency (ms); (B) maximal velocity (deg/s); (C) primary gain (ratio); and (D) saccade count (n). Baseline and 12 month follow-
up data for controls (red) and the HD patients (blue) are shown. Filled circles are LMEM-estimated group means and unfilled 
circles, means for individual subjects.  
 
Saccadic main sequences (representations of the relationship between saccadic velocity and 
amplitude) for horizontal (Figure IV.4) and vertical (Figure IV.5) saccades in HD patients 
showed a high degree of variability across subjects and amplitudes. A main sequence could not 
be fitted to horizontal saccades (baseline and 12 month follow-up) for HD patient S05 or 
vertical saccades (12 month follow-up) for HD patient S06 because the data did not obey the 
typical logarithmic function. For example, patient S06 had velocities that were too low to 
saturate and remained linear across the entire range of amplitudes. They were therefore, 






maximal velocity achieved at baseline for horizontal and vertical saccades were 484 deg/s and 
483 deg/s respectively. There was likely a slightly lower maximal velocity in the HD group, 
with an estimated decrease of 50 deg/s (p = 0.2) in horizontal saccades and 55 deg/s (p = 0.2) 
in vertical saccades (Figure IV.3B). However, it should be noted that the HD group had a larger 
variance in maximal velocity than controls. In both groups, there were minimal differences in 
maximal velocity between the two directions of saccade (Controls: -1 deg/s [95% CI: -48 deg/s 
– 47 deg/s]; p = 1.0; HD: -6 deg/s [95% CI: 53 deg/s – 42 deg/s]; p = 0.8). There was an effect 
of time upon maximal velocity in the HD group only, with an estimated decrease in maximal 
velocity by 50 deg/s (p ≤ 0.01) in both directions in the follow-up session (Figure IV.3B).  
 
There were minimal differences of 0.02 (p = 0.4) and 0.06 (p = 0.05) in primary gain (ratio) 
between the two groups, in the horizontal and vertical direction respectively (Figure IV.3C). In 
the HD group only, primary gain in vertical saccades was lower than in horizontal saccades by 
0.06 (p = 0.03). There were minimal 12 month changes of 0.01 (p ≥ 0.7) in primary gain in 
controls (Figure IV.3C). By contrast, there was a decline of 0.07 (p = 0.005) in horizontal 
saccades and 0.09 (p = 0.001) in vertical saccades in HD in the follow-up session, resulting in 
a group × time interactions (p ≤ 0.03).  
 
The HD group had higher saccadic count (p ≤ 0.007) than controls in both directions (Figure 
IV.3D). Both groups had minimal changes in the range of -0.08 to 0.05 (p ≥ 0.1) in saccadic 
count in either directions in the follow-up session.  
 
A summary of LMEM-estimated means and 12 month changes for controls and the HD groups 
in the four saccadic parameters measured (latency, maximal velocity, primary gain, and 
saccadic count) is shown in Table IV.2 (see overpage). 
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Table IV.2 LMEM-estimated group means [95% CIs] and 12 month changes in saccadic parameters measured 
in the reflexive 2D paradigm 
 Control group  HD group  HD vs. Controls 
Saccadic parameter Baseline  
Mean [95% CI] 
Change after  
12 months  
Mean [95% CI] 
 
Baseline 
Mean [95% CI] 
Change after  
12 months  
Mean [95% CI] 
 Baseline 
difference 
Mean [95% CI] 
Relative change 
at 12 month 
Mean [95% CI] 
Latency (ms)         
Horizontal 191[174 – 208] 
9 [-0.1 – 18], 
p = 0.05 
 
208 [191 – 225] 
30 [21 – 39],  
p < 0.001 
 17 [-8 – 42],  
p < 0.2 
21 [8 – 34],  
p = 0.002 
Vertical 201 [180 – 221] 
11 [0.3 – 22],  
p = 0.04 
 
233 [213 – 253] 
35 [24 – 45],  
p < 0.001 
 32 [3 – 62],  
p = 0.03 
24 [9 – 39],  
p = 0.003 
Maximal velocity (deg/s)         
Horizontal^ 484 [428 – 541] 
16 [-24 – 57],  
p = 0.4 
 
434 [378 – 490] 
-58 [-97 – -20],  
p = 0.004 
 -50 [-130 – 29],  
p = 0.2 
-75 [-130 – -19], 
 p = 0.01 
Vertical* 483 [429 – 537] 
-23 [-61 – 16],  
p = 0.2 
 
428 [374 – 482] 
-50 [-87 – -12],  
p = 0.01 
 -55 [-132 – 21],  
p = 0.2 
-27 [-80 – 26],  
p = 0.3 
Primary gain (ratio)         
Horizontal 0.97 [0.9 – 1.0] 
0.01 [-0.04 – 
0.05],  
p = 0.8 
 
0.95 [0.9 – 1.0] 
-0.07 [-0.1 –  
-0.02],  
p = 0.005 
 -0.03 [-0.1 –  
0.04],  
p = 0.4 
-0.07 [-0.1 –  
-0.01],  
p = 0.03 
Vertical 0.95 [0.9 – 1.0] 
-0.01 [-0.06 – 
0.04], 
p = 0.7 
 
0.88 [0.8 – 0.9] 
-0.09 [-0.1 –  
-0.05], 
 p = 0.001 
 -0.06 [-0.1 –  
0.00],  
p = 0.05 
-0.09 [-0.2 –  
-0.02],  
p = 0.02 
Saccade count (n)         
Horizontal 1.6 [1.5 – 1.7] 
-0.01 [-0.1 – 0.1],  
p = 0.8 
 
1.8 [1.7 – 1.9] 
-0.01 [-0.1 – 0.1],  
p = 0.9 
 0.3 [0.1 – 0.4],  
p = 0.001 
0.0 [-0.2 – 0.2],  
p = 1.0 
Vertical 1.7 [1.6 – 1.8] 
-0.08 [-0.2 – 
0.02],  
p = 0.1 
 
1.9 [1.8 – 2.0] 
0.05 [-0.05 – 0.2],  
p = 0.3 
 
0.2 [0.1 – 0.4],  
p = 0.007 
0.1 [-0.02 – 0.3],  
p = 0.08 
^Saccadic main sequences (horizontal saccades) for HD patient S05 at baseline and 12 month follow-up failed to fit an exponential curve 
function, hence this patient was removed from group-level analysis for maximal velocity in horizontal saccades.  *Saccadic main sequence 
(vertical saccades) for HD patient S06 at 12 month follow-up failed to fit an exponential curve function, and therefore was excluded from 








Figure IV.4  Main sequences of horizontal saccades for HD patients. The red reference lines represent the mean main 










Figure IV.6  Main sequences of vertical saccades for HD patients. The red reference lines represent the mean main 






IV.3A.4. Usefulness of saccadic parameters in reflecting disease severity and 
measuring change over time 
Several issues must be considered in assessing the utility of saccadic measures for measuring 
disease progression over 12 months. These issues include: (1) whether there are any within-
group and between-group relative changes in those measures over a 12 month period; (2) how 
well these measures reflect patients’ disease status; and (3) reliability of a measure, as 
determined by the variability of the measurements on repeated testing after taking account of 
12 month systematic changes.  
 
Three saccadic parameters – latency, maximal velocity, and primary gain – were selected to 
have their utility in monitoring longitudinal changes evaluated because these parameters were 
found to show a deterioration in the HD group and also a significant group × time interaction. 
The correlations between these saccadic parameters and the UHDRS motor scores, and global 
cognitive scores of HD patients determined how well these saccadic measures reflect HD 
patients’ disease status. All three saccadic parameters were found to have moderate correlations 
to either the UHDRS motor score or global cognitive scores at baseline (Figure IV.6) and also 
at follow-up (not shown).  
 
Bootstrapping procedures (refer section II.9.12 for a detailed description) determined the 
differences in r2 coefficients (coefficients of determination for correlations between saccadic 
measures and UHDRS motor scores, and global cognitive scores) of one saccadic parameter to 
another. This analysis provided an indication of whether all saccadic parameters were identical 
in reflecting the severity of motor and cognitive impairment in HD. The bootstrapping 
procedures showed that there were no significant differences among the three saccadic 
measures in terms of their relationships to the UHDRS motor scores and global cognitive 
scores, suggesting that all three saccadic parameters are reasonably similar in reflecting the 
severity of motor impairment and cognitive impairment in manifest HD.  
 
The variability of measurement residuals in a saccadic parameter after taking account into 12 
month systematic changes was determined firstly by fitting simple linear models to the baseline 
and 12 month measurements of that parameter and then evaluating the correlation within a 
parameter by assessing the r coefficient from the fitted models. Baseline measurements were 
well correlated with 12 month measurements for all three saccadic parameters in the HD group 
(Figure IV.7A).  
 




Figure IV.6 Correlations between saccadic parameters and UHDRS motor scores, and global cognitive scores in 
the HD group. r [95% CI] and p values are shown.
r = 0.30 [0.01 – 0.55], p < 0.05 
r = -0.38 [-0.60 – -0.09], p = 0.01 
r = -0.38 [-0.61 – -0.09], p = 0.01 
r = -0.45 [-0.66 – -0.18], p = 0.002 
r = 0.51 [0.25 – 0.70], p < 0.001 
r = -0.43 [-0.65 – -0.16], p = 0.003 
r = -0.56 [-0.74 – -0.32], p < 0.001 
r  = 0.57 [0.33 – 0.74], p < 0.001 
r = 0.48 [0.21 – 0.68], p = 0.001 
r = 0.51 [0.26 – 0.70], p < 0.001 





          
 
 
Figure IV.7 Correlations between baseline and 12 month measurements of the three saccadic parameters in 
horizontal and vertical saccades (A), and of the UHDRS motor component (B).  r [95% CI] and p values are shown. 
 
The variability of measurement residuals after 12 months for the three saccadic parameters 
(Figure IV.7A) was compared to the variability of score residuals after 12 months in UHDRS 
motor score (Figure IV.7B) using bootstrapping procedures. This provides an objective 
indication of whether saccadic measures were as reliable as the UHDRS motor component in 
showing a decline in HD patients over a 12 month interval. This analysis showed that there 
were minimal differences in terms of the variability of measurements after 12 months between 
the UHDRS motor component and most saccadic parameters, except for primary gain of 
horizontal and vertical saccades (the estimated 95% CIs of r2 differences: 0.1 – 0.9). This 
indicates that latency and maximal velocity showed similar profile of variability of 
measurements over time to the UHDRS motor component. 
A 
Saccadic performance: Baseline 
B 
r = 0.51 [0.12 – 0.77], p = 0.01 r = 0.46 [0.04 – 0.74], p = 0.03 
r = 0.89 [0.75 – 0.95], p < 0.001 
r = 0.80 [0.57 – 0.91], p < 0.001 r = 0.82 [0.62 – 0.93], p < 0.001 
r = 0.89 [0.75 – 0.95], p < 0.001 
r = 0.90 [0.78 – 0.96], p < 0.001 
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The combination of a significant decline in saccadic latency and maximal velocity after 12 
months, high correlations of these measures to UHDRS motor and global cognitive scores, and 
low measurement variance across time (a consistent 12 month change among patients) indicate 
that latency and maximal velocity of reflexive saccades are reliable measures in reflecting 
disease progression in HD over a 12 month interval.  
 
IV.3B. Visually-guided reflexive eye-hand movement  
IV.3B.1. Eye-hand coordination in the visually-guided reflexive task 
The visually-guided reflexive eye-hand task comprised two types of movement, reaching 







Figure IV.8 Eye and hand latencies in the visually-guided reflexive task for controls and HD patients. Baseline 
and 12 month data for reaching (A) and return (B) movements are shown. Filled circles are LMEM-estimated group means and 







In reaching towards an unpredictable target, eye latency in controls was 163 ms [95% CI: 144 
– 181] and in HD, it was longer than controls by 43 ms [95% CI: 18 – 69; p < 0.001]. In controls, 
hand latency was longer than the eye by 57 ms [95% CI: 43 – 71; p < 0.001] in the reaching 
movement (Figure IV.8A) but 336 ms ahead of the eye in the return movement (Figure IV.8B), 
indicating that the eye led the hand when reaching for an unpredictable target whereas the hand 
preceded the eye upon returning to a known target. The HD group, despite showing a similar 
pattern of eye-hand movement behaviour to controls in the two movements (Figure IV.8A), had 
longer hand latency in the reaching movement, with the estimated latency 69 ms [95% CI: 36 
– 102; p < 0.001] longer than the hand latency of controls. It should be noted that in reaching 
movements, hand latency variance in the HD group was noticeably larger than amongst 
controls. Both groups had a minimal change in latency in the follow-up session, except for a 
statistically significant increase in eye latency in the reaching movement (Controls: 19 ms [95% 
CI: 1 ms – 36 ms]; p = 0.03; HD: 24 ms [95% CI: 13 ms – 36 ms]; p < 0.001) (Figure IV.8A).   
 
            
Figure IV.9 Eye-hand latency interval (ms) in reaching (A) and return (B) movements for controls and the three 
sub-group of HD patients. Baseline and 12 month data are shown. Filled circles are LMEM-estimated group means and 
unfilled circles, means of individual subjects. *NB: The only stage 4 patient in this study was analysed collectively with stage 3 patients.  
 
A linear mixed effect model fitted to eye-hand latency intervals (i.e. the time between the 
initiation of each eye and its corresponding hand movements) and disease stages revealed that 
there was a strong positive linear effect of disease stage (p < 0.001) on eye-hand latency 
intervals in the reaching movement (Figure IV.9A), indicating that there is progressive 
prolongation in the time interval between eye and hand movement initiation as disease 
progresses in HD. There was however, no evidence of a disease stage effect (p = 0.2) in the 
return movement (Figure IV.9B). The change if any for the follow-up is small in eye-hand 
A B 
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latency interval across disease stages in the follow-up session, with an estimated decrease of 9 
ms [95% CI: -18 ms – 35 ms; p = 0.5] in the reaching movement and an increase of 45 ms [95% 
CI: -166 ms – 75 ms; p = 0.5] in the return movement.  
 
 
IV.3B.1.2. Hand velocity 
Peak hand velocity in the reflexive eye-hand task in controls was 36 cm/s for a movement 
amplitude of 10 cm. There was a reduction in peak hand velocity in the HD group compared to 
controls, with an estimated decrease of 7 cm/s [95% CI: 1 cm/s – 13 cm/s; p < 0.001] for the 
same movement amplitude. Both groups showed that there was a non-linear effect of movement 
amplitude (p < 0.001) on the change in velocity in the reaching movement (Figure IV.10). That 
is, hand velocity rises in a non-linear manner with rising movement amplitude.  
 
In both groups, the pattern of change in velocity in the return movement (not shown) was 
identical to the reaching movement. In controls, there was an increase in hand velocity by 13 
cm/s [95% CI: 10 cm/s – 16 cm/s; p < 0.001] for movement amplitude of 20 cm but no increase 
(p = 0.8) for 15 cm. However, in HD, there was an overt increase in hand velocity in movements 
of 15 cm and 20 cm in movement amplitude, with an estimated increase of hand velocity of 4 
cm/s [95% CI: 1 cm/s – 8 cm/s; p < 0.03] and 6 cm/s [95% CI: 1 cm/s – 11 cm/s; p = 0.03] 





Figure IV.10 Hand velocity (cm/s) by movement amplitude in the reaching movement of the visually-guided 
reflexive eye-hand task. Baseline and 12 month follow-up data are shown. Filled circles are LMEM-estimated group means 




As there was an insufficient range of movement amplitudes to determine the absolute maximal 
hand velocity of individual subjects, the mean velocity at 20 cm movement amplitude (the 
largest movement amplitude in this task) was used instead. There was no overt effect of disease 
stage on maximal hand velocity (p ≥ 0.2) in either reaching (Figure IV.11) or return movements, 
indicating that maximal hand velocity in a reflexive task was relatively unchanged across 
disease stages in HD. There was however, an effect of time on maximal velocity in both controls 
and HD (Figure IV.11), with hand decreasing by about 7 cm/s [95% CI: 4 cm/s – 9 cm/s; p < 
0.001] in the follow-up session for reaching and return movements.   
 
 
Figure IV.11  Maximal hand velocity (cm/s) in the reaching movement for controls and the three sub-groups of HD 
patients. Baseline and 12 month data are shown. Filled circles are LMEM-estimated group means and unfilled circles, means 
for individual subjects. NB: ^Mean velocities in 20 cm movement amplitude were considered as maximal hand velocities. *The only stage 
4 patient in this study was analysed collectively with stage 3 patients.  
 
 
IV.3B.2. Clinical correlates of eye-hand movement parameters 
To determine the relationships between eye-hand movement and disease status in HD, the eye-
hand movement parameters in the reaching movement were each correlated with UHDRS motor 
scores and global cognitive scores using correlation tests.  
 
Both eye and hand latencies showed moderate positive correlations (r = 0.48, p = 0.03) to 
UHDRS motor scores and moderately strong negative correlations to global cognitive scores (r 
≥ -0.66, p ≤ 0.001) in HD (Figure IV.12). Mean eye-hand latency intervals showed moderate 
negative correlation (r = -0.61, p = 0.003) to global cognitive scores only. Mean velocities in 
movement amplitude of 20 cm however, had weak correlations to the UHDRS motor scores (r 
= -0.19, p = 0.4) and global cognitive scores (r = 0.34, p = 0.1). Correlations of eye-hand 
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movement parameters to CAG repeat number were analysed in addition and showed that CAG 
repeat numbers generally had poor associations (0 ≤ r ≤ 0.1, p > 0.3) to all parameters, thus 
indicating that changes in eye-hand movement performance is not related to CAG repeat size.    
 
 
Figure IV.12 Correlations between mean latency (ms) of the eye and hand and UHDRS motor scores, and global 




The key findings in the saccadic and eye-hand movement visually-guided reflexive tasks were 
that the HD group exhibited: (1) A stronger ‘overlap’ effect than controls; (2) A decline in 
saccadic performance in most saccadic parameters in the reflexive 2D task over 12 months, 
relative to controls; and (3) A prolongation in the time interval between eye movement and 
hand movement initiation compared to controls.  
 
IV.4A. Reflexive saccades 
IV.4A.1. ‘Gap’ and ‘overlap’ effects in HD 
The ‘gap’ and ‘overlap’ effect on saccadic latency in the HD group reaffirms the findings of a 
previous study (Tian et al., 1991). Although the basal ganglia, the main sites of HD pathology, 
are implicated in the generation of saccades (Hikosaka et al., 2000), Keating et al. (1983) 
suggested that reflexive saccades in healthy controls are generally triggered by the direct 
r = -0.66 [-0.8 – -0.32],  
p = 0.001 
 
r = 0.48 [0.06 – 0.76], 
p = 0.03 
 
r = 0.48 [0.07 – 0.75],  
p = 0.03 
 
r = -0.69 [-0.86 – -0.38],  




projections from the parietal cortex to the superior colliculus. Therefore, Tian et al. (1991) has 
ascribed the appropriate effects of the ‘gap’ and ‘overlap’ stimulus conditions on saccadic 
latency to the relative preservation of the parietal-superior colliculus pathways.  
 
Further, the present study provides evidence that HD patients have similar proportions of 
express saccades in the ‘gap’ condition to controls. Express saccades, which is exclusive to the 
‘gap’ condition, are defined as saccades with shorter than normal reaction times (Fischer & 
Weber, 1993). A rhesus monkey lesional study demonstrated that a defective frontal eye field 
did not have a noticeable effect on the production of express saccades whereas a unilateral 
ablation of the superior colliculus resulted in the loss of express saccades when directing 
saccades to the direction opposite to the side of the lesion, suggesting that the superior colliculus 
has a critical role in the control system of reflexive saccades (Schiller et al., 1987). Hamm et 
al. (2010) further demonstrated that in humans, express saccades are facilitated by priming the 
saccade generating circuitry in the brain stem and this process is directly associated with the 
enhancement of activity in the occipital-parietal network. Based on these studies, it can be 
deduced that the ability to generate express saccades is dependent upon an intact superior 
colliculus and occipital-parietal network. The finding of an identical proportion of express 
saccades in HD compared to controls is therefore suggestive of a relative preservation of these 
neural structures in manifest HD and that in HD, there is a disparity in the degenerative changes 
occurring within and outside the basal ganglia. 
 
Although there were ‘gap’ and ‘overlap’ effects upon saccade latency in the HD group, the 
latency of saccades in the ‘overlap’ condition for the HD group was significantly greater than 
controls. This observation could be attributed to a HD effect on three separate neural 
mechanisms: (1) failure of cortical regulatory systems on fixation release; (2) delay in 
information processing; or (3) inefficiency in basal ganglia-regulated threshold mechanisms. 
As proposed by Findlay and Walker (1999), saccade generation involves the integration and 
resolution of competing signals from fixation and saccadic activities through a slow build-up 
of saccadic activity and a decline in fixation activity. This proposition was based on the 
physiological observation of a competitive interaction between fixation and saccade-related  
neurons in the superior colliculus (Dorris et al., 1997). Findlay et al. (1999) argued that the 
occurrence of the ‘gap’ effect was related to an automatic reduction of fixation that occurs 
during the blanking period between two visual stimuli, which ultimately facilitates the 
generation of saccades.  However, the reduction in fixation activity may not be an automated 
process for all types of visual stimuli. In normal human development, maturation of the 
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subcortical system occurs earlier than the cortical regulatory systems (Johnson, 1990) leading 
to a normal ‘gap’ effect but longer latency in the ‘overlap’ condition in a normal human infant 
when compared to a healthy adult (Hood & Atkinson, 1993). These findings suggest that 
cortical involvement in the reduction of fixation activity is essential for saccade generation in 
the ‘overlap’ condition. An increased magnitude of ‘overlap’ condition effect in the HD group 
may therefore translate to an impairment in fixation disengagement. This might be a result of a 
dysfunctional cortical regulatory system caused by HD.  
 
Nevertheless, a study comparing saccades of four hominid species in the ‘gap’ and ‘overlap’ 
conditions revealed that despite cross-species similarities in saccadic latencies in the ‘gap’ 
condition, saccadic latencies of humans subjects were significantly longer compared to other 
hominids in the ‘overlap’ condition (Kano et al., 2011). The authors attributed the slower 
response in humans in the ‘overlap’ condition to humans’ visual strategy, which favours 
fixation over frequent gaze shifting to enable the facilitation of internal processing of 
information (Kano et al., 2011). Given that information processing may be a contributing factor 
to the delay in saccade initiation in the ‘overlap’ condition for controls, the greater increase in 
time delay in the ‘overlap’ task in manifest HD may be an effect of a slower information 
processing system in HD, i.e. the system requires considerable longer time to internalize the 
new information given and to conceptualise a response. Such a deficit is likely to be caused by 
HD-related neurodegenerative changes in the central nervous system. Further, Schmidt et al. 
(2005) proposed that there are three distinct processes in a human model of information 
processing: (1) stimulus identification; (2) response selection; and (3) response programming. 
The significantly prolonged latency in the ‘overlap’ condition in manifest HD might be caused 
by deficits in these processes. However, the present study lacks the specific and quantitative 
data pertaining to these processes, hence it is not possible to determine which of these processes 
might have contributed to an increased magnitude of ‘overlap’ condition effect in manifest HD.  
 
Another possible interpretation of the very strong ‘overlap’ effect in the HD group relates to 
the overall vitality of the basal ganglia, the main neuropathological site of HD. In another model 
of human saccades, it is proposed that a saccade is generated when the discharge rate in the 
saccade-related neurons of FEF and superior colliculus reaches a certain threshold level of 
activation (Brown et al., 2008; Pare & Hanes, 2003). As demonstrated via a computational 
accumulator model, this threshold mechanism can be adaptively tuned by the efficacy of the 
synapses in the cortico-basal ganglia pathway depending upon the behavioural tasks involved 
(Lo & Wang, 2006). Loss of anatomic integrity of the basal ganglia in HD, which clearly begins 
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in premanifest HD (Stoffers et al., 2010), might have altered the threshold level of saccade 
initiation and such deficit may become more pronounced in tasks with higher behavioural 
demands. In this instance, the ‘overlap’ task has the highest level of behavioural demands of 
the three stimulus conditions, hence the stronger ‘overlap’ effect translate to a deficiency in the 
basal ganglia to recalibrate this threshold mechanism to facilitate saccade initiation when 
presented with competing visual stimulus.  
 
IV.4A.2. Usefulness of saccadic measures for reflecting disease status and 
longitudinal assessment 
Longitudinal changes in various horizontal saccade parameters in the HD group are broadly 
consistent with findings in earlier studies (Abel et al., 1988; Beenen et al., 1986; Rubin et al., 
1993; Tabrizi et al., 2010). In addition to the conventional measures of saccade latency and 
velocity used in those reports, the present study provided evidence of deterioration in the 
primary gain of horizontal saccades in HD over 12 months. As suggested by Leigh et al. (1983), 
the effect of HD might be greater on vertical saccades than horizontal saccades. Thus, 
longitudinal changes in vertical saccades might be a more sensitive progression marker of HD. 
In the present study, this hypothesis was examined by assessing both horizontal and vertical 
saccades. A strong group × time effect was evident in latency, primary gain, and maximal 
velocity of both horizontal and vertical saccades, hence suggesting that saccades in either 
directions are susceptible to change over a 12 month interval. Further, the strong interaction 
effects in those saccadic parameters suggest that a decline in the HD group is highly likely an 
effect of HD, rather than normal short-term ageing effect. 
 
In line with an earlier study by Patel et al. (2012), all three saccadic parameters (mean latency, 
maximal velocity, and primary gain) correlated well with UHDRS motor scores and global 
cognitive scores. These findings suggest that saccade measurement in general was useful in 
reflecting disease state in manifest HD, thus supported its application for tracking disease 
progression. The baseline values of the UHDRS motor score, mean saccadic latency, and mean 
maximal velocity were highly correlated with the same measurements taken 12 months later 
and with minimal deviation from linear fits. These observations confirm the reliability of 
repeated testing, especially UHDRS motor score, saccadic latency, maximal velocity, and 
perhaps less so for saccadic gain. Humans are known to exhibit plasticity in the modification 
of saccadic gain (Deubel et al., 1986), which consists of two key processes, visual remapping 
and motor adjustment (Wallman & Fuchs, 1998). Albano et al. (1989) also showed that this 
adaptive process changes more rapidly in humans than in other hominid species. This adaptive 
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nature of saccadic gain modification may explain the higher variability in primary gains in the 
HD group after 12 months. Although primary gains of horizontal and vertical saccades in the 
current study showed significant deterioration in the HD group after 12 months, the larger 
variance in the same measurement over time limits its utility as a measure of disease progression 
in routine follow-up. In contrast, the reliability performance of saccade latency and also 
maximal velocity was comparable to the UHDRS motor component, a current gold-standard 
measure of disease progression, highlighting the robust nature of these saccadic parameters.  
 
Most saccadic measures were found to be sensitive in detecting longitudinal changes in 
manifest HD over 12 months and also have a level of reliability that was comparable to the 
UHDRS motor component. These findings suggest that reflexive saccade measurement may 
represent a useful strategy for detecting and tracking either clinical progression or pathological 
changes in the basal ganglia and its associated circuits involved in the control of eye movement. 
Some may have reservations about this postulation, as it was demonstrated in a study by Tabrizi 
et al. (Tabrizi et al., 2012) that disappointingly, there were no significant saccadic changes in 
premanifest and early HD over a longer follow-up interval (i.e. 24 months). It should be 
highlighted that there are two main shortcomings in that study that unlike the present study, (1) 
the saccadic task was unidirectional (horizontal only); and (2) vertical saccades were not 
assessed. The reflexive task in the present study was bi-directional, i.e. target displacement for 
any given trial could occur either in the horizontal or vertical direction. This design inevitably 
adds another level of uncertainty (compared to a unidirectional task) to the presentation of an 
impending target. There is evidence to suggest that in HD, there is a dysregulation of 
information processing in the striatum (Miller et al., 2008). A 2D reflexive task, which is likely 
to place additional burden on a compromised information processing system in HD, may be 
better in accentuating the effect of HD on saccadic function and also the longitudinal changes 
of HD.  
 
In summary, the findings of the present study suggest that saccadic latency in a reflexive 2D 
task appears to be a sensitive and reliable marker for short-term disease changes/progression in 
manifest HD, and superior to other saccadic measures. The maximal velocity of saccades also 
appears to be a useful short-term progression marker for HD, and may complement saccadic 






IV.4B. Visually-guided reflexive eye-hand movement 
IV.4B.1. Eye-hand coordination in HD 
In the combined eye-hand task, there was a delay in hand movement initiation in the HD group 
compared to controls. This observation supports previous findings of prolonged latencies in 
somatomotor movement in other muscle groups in HD (Hefter et al., 1987; Koller & Trimble, 
1985; Thompson et al., 1988).   
 
Under normal circumstances, coordination of human eye and hand movements is tightly 
coupled and operates in a fixed temporal sequence, whereby hand movements typically lag eye 
movement (Pelz et al., 2001). In contradistinction, hand movements may precede eye 
movement when there is prior knowledge (i.e. spatial information) of target location (Abrams 
et al., 1990). The present study provides evidence that temporal sequencing of eye and hand 
movements is relatively preserved in manifest HD, with the eyes leading the hand in response 
to randomly appearing peripheral targets, and lagging the hand when returning to a fixed-
positioned home target.  
 
There was however, an abnormally long interval between eye and hand movement initiation in 
the visually-guided reflexive task in the HD group. Further, the duration of the interval 
increased with an increase in disease stages, implicating an origin in the progressive 
neurodegeneration of the eye-hand control pathways in HD. The medium spiny neurons, which 
are selectively degenerated in HD (Vonsattel et al., 2011), are important for normal information 
processing in the basal ganglia (Murer et al., 2002). In a mouse model of HD, reduction in basal 
ganglia output burst firing activity (Salinas & Sejnowski, 2001) correlated with medium spiny 
neuron degeneration and dysregulation of information processing (Miller et al., 2008). Thus, 
the longer latency in hand movement initiation in HD patients in the present study may 
represent an increased processing time – to select and execute the movement appropriate for 
the task involved – within the compromised basal ganglia.  
 
The superior colliculus (SC), an integral structure for saccade generation (McDowell et al., 
2008), is also suggested to be involved in the coordination of eye and hand movements because 
neuronal activity in the SC was found to be closely associated with the pattern of 
electromyographic activity of the musculature in the proximal limb during reaching (Stuphorn 
et al., 1999). Furthermore, strong interactions were found between gaze- and arm-related 
neurons in the SC in gaze coordinated arm movements (Lunenburger et al., 2001; Stuphorn et 
al., 2000). A direct inference from this is that degeneration of the basal ganglia in HD 
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(Berardelli et al., 1999) may interfere with the activity of the superior colliculus which is under 
the direct influence of basal ganglia (Hikosaka et al., 2000), resulting in an increase in the 
silence period between the eye and hand movements. Nevertheless, an increased firing in the 
SC with simultaneous eye and hand movements may not necessarily translate to a role for SC 
in limb control as such. Limb control is likely dependent on the combined activation of SC and 
motor cortex, with SC regulating the eye aspect and motor cortex controlling the hand aspect 
of eye-hand movement. The exact role of SC in eye-hand movement control can only be 
deciphered via functional neuroimaging techniques that primarily focus on SC and motor cortex 
activation during gaze coordinated hand movements.   
 
An fMRI study revealed that a distributed network, involving various cortical and subcortical 
structures, was activated in healthy controls when performing a visually-guided task that 
involves eye-hand coordination (Lavrysen et al., 2007) with the highest activation peak being 
in the cerebellum. The cerebellum is well known to contribute to the coordination and timing 
of eye and hand movements in visually-guided arm movements (Miall et al., 2000; Miall & 
Reckess, 2002). Although the basal ganglia are the main sites of HD pathology, studies have 
consistently reported about the coexistence of cerebellar and striatal atrophy in manifest HD 
patients on routine post-mortem and neuroimaging examinations (Rub et al., 2013; Ruocco et 
al., 2006). Thus, some contribution to deficits in eye-hand coordination in HD might be from 
cerebellar neuropathology. However, as discussed above, a number of cortical brain regions are 
also involved in the control of voluntary movement. Visuomotor processing during a visually-
guided reaching task requires the interpretation of visual information in the visual cortex, and 
sensorimotor transformation in the parietal lobe and the premotor areas of the frontal lobe 
(Ellermann et al., 1998). Progressive cortical atrophy is a well-established neuroimaging feature 
in premanifest and manifest HD (Tabrizi et al., 2012; Tabrizi et al., 2010; Tabrizi et al., 2013), 
with the sensorimotor cortex being the most affected (Rosas et al., 2008). One might propose 
therefore that a prolonged interval between eye and hand movement initiation in HD, as 
observed in the present study, results from the disruption of sensorimotor transformation 
processes particularly in the parieto-frontal cortex which causes a protracted delay in hand 
movement initiation. Neurodegeneration continues to worsen with disease progression in HD 
and this may translate to a concurrent deterioration of sensorimotor transformation system in 
HD, hence the progressive prolongation of eye-hand latency interval with higher disease stages.  
 
IV.4B.2. Clinical correlates of eye-hand movement parameters 
There was a significant relationship between slowness in hand movement and UHDRS motor 
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scores, consistent with the observations of a previous study (van Vugt et al., 2004). These 
findings are consistent with an origin, at least in part, in an abnormally functioning motor circuit 
in the basal ganglia. However, the prolongation of the interval between eye and hand movement 
initiation (eye-hand latency interval) in the HD group also correlated well with global cognitive 
level (global cognitive scores) of HD patients, suggesting cognitive processes also contribute 
to the control of eye-hand coordination.  
 
The traditional model of basal ganglia physiology hypothesized the existence of multiple 
circuits in the basal ganglia, arranged in a parallel manner but functionally segregated from one 
another (Alexander et al., 1990). Later, Joel (2001) posited that these circuits are inter-
connected to each other at different levels so consequently, impairment at a specific site in the 
basal ganglia circuitry could influence neural processes in other parallel pathways. According 
to this hypothesis, the motor circuit of the basal ganglia connects with the associative circuit, 
which in turn has projections to the prefrontal cortex. A connection between the two circuits 
might explain a deficit in eye-hand coordination associating with both motor and cognitive 
impairment in HD. Alternatively, as discussed above, visuomotor processing, which involves 
close interaction of cognition and motor function, is integral in the control of eye-hand 
coordination. Therefore, the coexistence of an association between eye-hand coordination 
abnormality and cognitive decline may conceivably reflect an underlying deficit in visuomotor 
processing in HD.  
 
IV.4B.3. 12 month changes in eye and hand movement parameters 
The HD group, despite having a significant within-group deterioration in eye and hand latencies 
at 12 month follow-up, demonstrated minimal change in eye-hand latency interval in the 
visually-guided reflexive task. These findings could relate to heterogeneity in the longitudinal 
progression of cognitive and motor aspects of eye-hand coordination. In fact, several studies 
have demonstrated that the rate of change in various neural structures varies by HD clinical 
stage (Aylward et al., 2011; Tabrizi et al., 2012; Tabrizi et al., 2013). In addition, in comparison 
to the striatum, there is greater variability in cortical atrophy in early manifest HD patients 
(Kassubek et al., 2004).  
 
There was, rather surprisingly, comparable decline in eye-hand coordination performance in 
the HD and control groups. The decline in the control group was unexpected, not readily 
explained and may have masked a true comparative decline in the HD group. One possible 
postulation for this is that the paradigm used in the present study does not have as high test 
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reliability as envisioned. Alternatively, the absence of a decline relative to controls in the HD 
group might be due to a very slow rate of deterioration in HD, or a lack of uniform changes 
across different sub-groups of HD patients in this study over 12 months. Consistent with this 
postulation, Tabrizi et al. (2010) reported variation in performance changes across various tasks 
after 12 months in premanifest and early manifest HD. Compensatory processes might also 
explain a relative lack of decline in eye-hand coordination in the HD group. One piece of 
evidence to support this argument is that there is reorganisation of brain activation to retain 
motor performance in premanifest (Kloppel et al., 2009) and also manifest (Bartenstein et al., 
1997) HD. However, it is necessary to take into consideration of the considerable large variance 
in hand latency in the HD group (refer Figure IV.8). For a group with a large variance, the group 
average may have inadvertently masked the true effects of HD upon changes in eye-hand 
coordination performance over time. The lack of a significant change in eye-hand movement in 
the HD group, relative to controls, does suggest that this methodology has doubtful utility for 
monitoring short-term disease progression in HD. On the other hand, reflexive saccades, in 
comparison to reflexive visually-guided somatic movement, may be a better measure for 
detecting disease changes over one year.  
 
IV.5.  Chapter summary 
This study provides novel perspectives on 12 month changes in visually-guided reflexive 
saccades and eye-hand coordinated movements in manifest HD. It shows that two saccadic 
measures, namely latency and velocity are sensitive to 12 month longitudinal changes in HD 
and are as reliable as the current gold-standard measure of disease progression, the UHDRS 
motor component for tracking disease changes in manifest HD. However, similar 12 month 
longitudinal performance decline in eye-hand coordination in the HD and control groups was 
unexpected and possible explanations include slow and heterogeneous disease progression or a 
compensatory brain processes for maintaining behavioural performance. The HD group did 
however, show a significant 12 month decline in eye movement performance in the eye-hand 
variant of the visually-guided reflexive task, reinforcing the postulation that saccade 
measurement is a potentially useful marker of short-term disease changes and progression in 
manifest HD. The 2D reflexive paradigm (assessing both horizontal and vertical saccades in 
the same task) used in this study, which has added uncertainty in the presentation of targets, 
may accentuate HD effect on saccadic function. This paradigm, given that it better highlights 
the saccadic deficits in HD, may potentially have greater utility for tracking longitudinal 



















Planning a motor response in advance of an upcoming change in the environment provides a 
distinct evolutionary advantage (Isotalo et al., 2005) because it allows motor responses with 
shortened reaction times. This behaviour has been shown in the human ocular motor system, 
with saccades initiated at or before target onset after just a few repetitions of a target alternating 
at a constant frequency between two predictable locations (Isotalo et al., 2005; Ross & Ross, 
1987). This type of saccade is commonly known as ‘predictive’. The latency of predictive 
saccades is dependent upon the frequency at which the target alternates (Crawford et al., 1989; 
McDowell et al., 1996; Shelhamer & Joiner, 2003; Smit & Van Gisbergen, 1989). Saccades are 
generally reactive when stimuli are presented at low frequencies (< 0.3 Hz, i.e. at longer inter-
stimulus intervals [ISIs], ≥ 1600 ms). They switch to a predictive response, i.e. with fast or even 
negative latencies, at higher frequencies (> 0.5 Hz, i.e. shorter ISIs, ≤ 1000 ms) (Shelhamer & 
Joiner, 2003). Tian and colleagues (1991) demonstrated that unlike controls, HD patients did 
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not show a reduction in saccadic latency in a predictive task, suggesting that individuals with 
HD are unable to benefit from the regular timing of stimuli. 
 
Rhythmical saccadic movement, which includes self-paced saccades, has been evaluated in HD 
but the results have thus far been mixed. Winograd-Gurvich et al. (2003) reported that HD 
patients, in addition to increased performance variability, generate fewer horizontal self-paced 
saccades than controls. The authors proposed that in HD, degeneration in the cortico-striatal 
loops indirectly degrades the normal functioning of the supplementary motor area, a region 
involved in regulating voluntary and rhythmical saccades. Despite there is evidence suggesting 
vertical reflexive saccades in HD are more affected than horizontal saccades (Leigh et al., 1983) 
and that deficits in vertical saccades are closely associated with neuroimaging changes on MRI 
(Rupp et al., 2012), vertical self-paced saccades in HD are yet to be examined.   
 
The studies of Tian et al. (1991) and Winograd-Gurvich et al. (2003) were cross-sectional so 
questions on longitudinal changes in self-paced and predictive saccades, and the sensitivity of 
these saccade types to disease progression of HD, remain largely unanswered. In their study of 
predictive saccades in HD, Tian et al. (1991) examined saccadic performance of manifest HD 
patients using only stimuli at a fixed frequency of 0.5 Hz. Assessing a wider spectrum of 
saccadic behaviour, driven by a range of alternating target frequencies (i.e. ISIs) might provide 
greater insight into the effect of HD on neurophysiological processes. Therefore, one of the 
objectives of this study was to extend current findings on rhythmical saccadic movement in 
HD, determining its relationship to disease status and 12 month longitudinal changes.  
 
Studies of Parkinson’s disease, which is also a basal ganglia disorder, suggested that deficits in 
predictive and rhythmical hand movements are associated with degenerative changes in the 
basal ganglia (O'Boyle et al., 1996). In HD, repetitive hand tapping rate, in addition to being 
well correlated with the current functional status of manifest HD patients, also showed a 
progressive decline in performance rate over time (Collins et al., 2014). However, another 
longitudinal study showed that hand tapping performance of HD patients declined significantly 
less than the systematic prolongation of reflexive saccade latencies in HD patients over a period 
of three years (Antoniades et al., 2010), suggesting that saccadic deficits may potentially be 
more sensitive than somatomotor changes to underlying disease progression in HD. Eye 
movement, in normal circumstances, is essential in the coordination of somatomotor 
movement. Although it is well established that rhythmical movement is impaired in HD, 
previous works were restricted to investigating the performance of the eye and hand separately 
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(Antoniades et al., 2010; Delmaire et al., 2010; Michell et al., 2008; Winograd-Gurvich et al., 
2003). This study, in addition to assessing rhythmical saccades, also examined the combined 
behaviour of the eye and hand in rhythmical movements using self-paced tasks (horizontal and 
vertical) and temporally-cued tasks with different ISIs.  
 
 
V.2.  Methods 




V.3.  Results 
V.3A. Rhythmical saccades   
V.3A.1. Self-paced tasks 
The mean number of self-paced saccades made in 30 s by controls was 64 [95% CI: 57 – 70] in 
the horizontal task and 63 [95% CI: 56 – 70] in the vertical task. The HD group made 29 [95% 
CI: 20 – 38; p < 0.001] fewer self-paced saccades than controls in the horizontal task and 28 
[95% CI: 18 – 38; p < 0.001] fewer saccades in the vertical task. The effect size for the between-
group differences was d = 1.9 for both tasks. Both groups showed that there were minimal 
differences (d ≤ 0.1, p ≥ 0.5) between tasks (horizontal vs. vertical), in terms of the number of 
self-paced saccades made.  
 
There was a strong negative linear effect of disease stage (p < 0.001) in the horizontal and 
vertical tasks, indicating that there is a linear progressive decline in the number of self-paced 
horizontal and vertical saccades made across disease stages in HD (Figure V.1). The data also 
revealed that this decline in performance is evident even in Stage 1 HD (Figure V.1), with the 
estimated number of horizontal and vertical saccades made being 13 [95% CI: 3 – 23; p ≤ 0.01] 
fewer than controls.  
 
Controls showed no relative change in the number of self-paced saccades made in the two tasks 
at follow-up (0.001 < d ≤ 0.05, p ≥ 0.8). In general, there was no apparent effect of time in self-







Figure V.1  Number of self-paced saccades made in 30 s by controls and patients in the three stages of HD at 
baseline and at 12 month follow-up. Data from the horizontal task is shown in the left panel and vertical, in the right panel. 




V.3A.2. Temporally-cued tasks 
V.3A.2.1. Random phase 
In the random phase, the LMEM-estimated mean latency was 174 ms [95% CI: 134 ms – 214 
ms] in controls. There was likely a minimal prolongation of latency in the HD group compared 
to controls, with an estimated prolongation of 20 ms [95% CI: -3 ms – 44 ms; p = 0.1] in the 
HD group. There was an effect of time on latency, with an estimated increase of 15 ms [95% 
CI: 9 ms – 21 ms; p < 0.001] in controls. In the HD group, relative to controls, there was an 
estimated additional increase of 15 ms [95% CI: 3 ms – 26 ms; p = 0.02] in latency at follow-
up.  
 
V.3A.2.2. Predictable phase 
A generalised linear mixed-effect model showed that in controls, there was a strong negative 
linear effect of ISI (p < 0.001) on the proportion of predictive saccades in the last 10 trials of 
the predictable phase (Figure V.2). That is, the occurrence of predictive saccades was highest 
in the shortest ISI (750 ms) and gradually reduced with increasing ISI. This effect was not 
evident in the HD group (p = 0.4), with the proportion of predictive saccades being relatively 
similar across all ISIs (Figure V.2). There was no evidence of a time effect (p = 0.5) on the 
proportion of predictive saccades in the last 10 trials across ISIs in either groups.  
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Figure V.2  Proportion of predictive saccades in last 10 trials of the predictable phase for the four ISIs (750 ms, 
1000 ms, 1400 ms, and 2050 ms). *NB: There was only one stage 4 patient and this patient was analysed with the stage 3 patients. 
 
 
Saccadic latencies appeared fairly consistent across trials in the random phase but there was a 
progressive reduction in latencies after the change to predictable target motion (Figure V.3A). 
In controls, latencies in the last 10 predictable trials were less than the random phase by 226 ms 
[95% CI: 187 ms – 265 ms; p < 0.001] at the 750 ms ISI and 59 ms [95% CI: 24 ms – 93 ms; p 
< 0.001] at the 2050 ms ISI. There was likely only a small reduction in latency in the HD group, 
with an estimated reduction of 12 ms [95% CI: -27 ms – 51 ms; p = 0.6] at the 750 ms ISI and 
43 ms [95% CI: 10 ms – 77 ms; p = 0.01] at the 2050 ms ISI.  
 
In controls, there was a strong linear effect of ISI (p < 0.001) on saccadic latency in the 
predictable phase (Figure V.3B). There was a steep reduction in saccadic latency from the 
random phase to the predictable phase with the shortest ISI (750 ms) but there was less 
reduction in latency with increasing ISI. That is, saccadic latency in the predictable phase 
increases with increasing ISI. By contrast, latency was not affected by the change in ISI (p = 
0.2) in the entire HD group. That is, the reduction in saccadic latency in the predictable phase 
was relatively similar across all ISIs. There was a weak ISI effect across all disease stages of 
HD, with the effect being the weakest in the highest disease stage (Figure V.3B) 
 
There was in general, a global increase in latency at follow-up with no additional effect of ISI 






       
 
Figure V.3 Saccadic latency in the saccade-only temporally-cued tasks. (A) Mean saccadic latency by trial number 
for the four ISIs (750 ms, 1000 ms, 1400 ms, and 2050 ms) in the control group (left panel) and HD group (right panel). There 
were 17 trials in the random phase, indicated by negative trial numbers (-16 to 0), and 40 in the predictable phase (1 to 40). 
The dotted vertical line in each plot indicates the end of the random phase and the start of the predictable phase. The exponential 
decay curves model the change in mean latency by trial number at baseline (red lines) and at 12 month follow-up (blue lines). 
(B) Mean latency of the random phase and of the last 10 predictable trials for the four ISIs (750 ms, 1000 ms, 1400 ms, and 
2050 ms) in controls and the three sub-groups of HD patients. Filled points represents the LMEM-estimated group means and 
unfilled points, means for individual participants.  
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V.3A.3.  Correlations between saccadic measures and disease measures 
Saccadic parameters were correlated against UHDRS motor scores and global cognitive z-
scores at baseline in the HD group.  
 
Correlation tests showed that the number of self-paced horizontal and vertical saccades made 
was strongly positively associated with UHDRS motor score (r = 0.8, p < 0.001) and negatively 




Figure V.4  Correlations between the number of self-paced horizontal and vertical saccades made in 30 seconds 




In all trial blocks, the mean saccadic latencies of the last 10 trials of the predictable phase 
correlated positively with the UHDRS motor scores (0.44 ≤ r ≤ 0.59, 0.005 ≤ p ≤ 0.04) and 
negatively with global cognitive z-scores (-0.57 ≤ r ≤ -0.40, 0.007 ≤ p ≤ 0.07) (Figure V.5). 
This indicates that a reduction in saccade prediction in the temporally-cued tasks is associated 
with a higher UHDRS motor score and lower cognitive level.  
 
r = 0.83 [0.71– 0.91], p < 0.001 r = -0.79 [-0.55 – -0.91], p < 0.001 




Figure V.5 Correlations between mean saccadic latency (ms) of the last 10 predictable trials and UHDRS motor 




V.3B. Rhythmical eye-hand movement 
V.3B.1. Eye-hand coordination in the self-paced tasks 
Analysis of eye-hand movement data of individual participants revealed that self-paced hand 
movements could be made in the absence of a corresponding eye movement. In controls, the 
number of hand movements (Horizontal: 81 [95% CI: 73 – 88]; Vertical: 83 [95% CI: 76 – 91]) 
made was more than the eye (Vertical: 78 [95% CI: 72 – 85]) in the vertical task (Difference: 5 
[95% CI: 1 – 9; p = 0.01]) but relatively identical to the eye (Horizontal: 81 [95% CI: 73 – 88]) 
in the horizontal task (Difference: 1 [95% CI: -1 – 3]; p = 0.4).  
r = 0.59 [0.21 – 0.82], p = 0.005 
r = 0.44 [0.01 – 0.73], p = 0.04 r = -0.50 [-0.77 – -0.09], p = 0.02 
r = -0.56 [-0.80 – -0.17], p = 0.008 r = 0.52 [0.11 – 0.78], p = 0.02 
r = 0.56 [0.16 – 0.80], p = 0.01 r = -0.57 [-0.80 – -0.19], p = 0.007 
r = -0.40 [-0.71 – 0.03], p =0.07 
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The HD group however, had minimal differences in the number of self-paced movements 
between the eye (Horizontal: 50 [95% CI: 43 – 57]; Vertical: 49 [95% CI: 43 – 56]) and the 
hand (Horizontal: 50 [95% CI: 42 – 57]; Vertical: 52 [95% CI: 44 – 959]) in both tasks 
(Horizontal difference: -1 [95% CI: -3 – 2], p = 0.5;  Vertical difference: 2 [95 % CI: -2 – 6], p 
= 0.2).  
 
At baseline, the entire HD group generally made fewer self-paced eye and hand movements 
than controls in either tasks. In the horizontal task, it was estimated that the HD group made 29 
[95% CI: 19 – 39; p < 0.001] less eye movements and 31 [95% CI: 21 – 41; p < 0.001] less 
hand movements than controls. In the vertical task, the estimated reduction was by 29 [95% CI: 
19 – 39; p < 0.001] movements in the eye and in the hand, 32 [95% CI: 21 – 42; p < 0.001] 
movements. The effect sizes for the between-group differences were d ≥ 1.9.  
 
Figure V.6 Number of eye-hand movement made in 30 s by controls and patients in the three* HD stages in the 
self-paced tasks. Horizontal tasks are shown in the top panel and vertical tasks in the bottom panel. Bars in light grey indicate 
baseline performance while dark grey bars are 12 month performance. Error bars shown are means and 95% CIs. *NB: The sole 
stage 4 patient was analysed collectively with stage 3 patients in disease stage-specific analysis.  
 
There was a very strong linear effect (z ≥ - 2.2, p < 0.001) of disease stage on the number of 
self-paced eye and hand movements made in the horizontal and vertical tasks (Figure V.6). This 
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indicates that the number of self-paced eye and hand movements made in both tasks reduces in 
a linear manner with disease progression in HD. It was also revealed that even at stage 1, HD 
patients made significantly fewer number of self-paced eye (p ≤ 0.01) and hand movements (p 
≤ 0.007) than controls in both the horizontal and vertical tasks (Figure V.6). 
 
Controls in general showed minimal changes in the number of self-paced eye and hand 
movements made in the two tasks in the follow-up session (Figure V.6). There was however, 
relative to controls, a strong effect of time in the entire HD group across most movements and 
tasks at 12 month follow-up. In the horizontal task, relative to controls, the number of self-
paced movement in HD reduced by 8 [95% CI: 1 – 16; p = 0.03] in the eye and by 11 [95% CI: 
1 – 20; p = 0.03] in the hand. In the vertical task, relative to controls, there was a reduction of 
8 movements [95% CI: 2 – 14; p = 0.01] in the eye and likely a small reduction of 4 movements 
[95% CI: -3 – 12; p = 0.3] in the hand in the HD group. There was however, no significant 
disease stage × time effect (p ≥ 0.06) across movements and tasks, indicating that there was a 
similar trend of decline in number of self-paced eye and hand movements made in the two tasks 
across all disease stages in HD at follow-up (Figure V.6). 
 
V.3B.2. Correlations between self-paced eye and hand movements, and 
disease measures  
 
Figure V.7 Correlations between number of self-paced horizontal and vertical eye-hand movements made and 
UHDRS motor scores of HD patients. r [95% CIs] and p values are shown. 
 
r = -0.74 [-0.88 – -0.46], p < 0.001 
 
r = -0.76 [-0.90 – -0.50], p < 0.001 
 
r = -0.85 [-0.93 – -0.66], p < 0.001 
 
r = -0.82 [-0.92 – -0.61], p < 0.001 
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Simple correlations were used to establish the relationship between self-paced movements and 
disease status, as measured using UHDRS motor scores and global cognitive scores in the HD 
group at baseline.  
 
The number of self-paced eye and hand movements in both tasks (horizontal and vertical) 
showed strong negative correlations (r ≤ -0.7, p < 0.001) with the UHDRS motor scores (Figure 
V.7), indicating that a higher UHDRS motor score is associated with a smaller number of eye 
and hand movements made in either direction.  
 
In contrast, global cognitive scores showed strong positive correlations (r ≥ 0.7, p < 0.001) with 
the number of self-paced eye and hand movements in either direction (Figure V.8). That is, a 
lower global cognitive score is associated with a smaller number of self-paced movements 
made.  
 
Figure V.8 Correlations between number of self-paced horizontal and vertical eye-hand movements made and 
global cognitive scores of HD patients. r [95% CIs] and p values are shown. 
 
The UHDRS motor component contains two test items for rapidly alternating hand movement 
(Item 6: finger tapping and Item 7: hand pronating/supinating) for each hand (Huntington Study 
Group, 1996). The number of self-paced eye-hand movement and the aggregated scores of the 
two items (a maximum score of four in each hand for each item, leading to a maximum total 
score of 16 for both hands) of each of the HD patients were fitted by simple linear models. Both 
eye and hand movements demonstrated moderately strong but statistically significant negative 
r = 0.66 [0.33 – 0.85], p < 0.001 r = 0.67 [0.34 – 0.85], p < 0.001 
r = 0.76 [0.50 – 0.90], p < 0.001 r = 0.79 [0.56 – 0.91], p < 0.001 
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correlations to the aggregated score (Figure V.9), suggesting that a decline in the number of 
self-paced movement made corresponds to a decline in the score in those two items in the 
UHDRS motor component.  
 
Figure V.9 Correlations between number of self-paced horizontal and vertical eye-hand movements made and 
aggregated scores of HD patients for test items 6 and 7 (items containing rapidly alternating hand movement) in the 
UHDRS motor component.  r [95% CIs] and p values are shown. 
 
V.3B.3. Eye-hand coordination in temporally-cued tasks 
One of the objectives of this study was to examine eye-hand coordination in a temporally-cued 
tasks and any changes in eye-hand coordination performance after 12 months. However, due to 
unforeseen technical issues related to the software used for recording hand movement in this 
task, raw data for some subjects in certain cued trials were incomplete at baseline and corrupted 
for many subjects at 12 month assessment. This issue was only discovered after the completion 
of data collection at 12 month. Given the circumstances, it was decided that only the baseline 
data of the temporally-cued eye-hand tasks would be analysed.  
 
There were two phases in the temporally-cued tasks, the random and predictable phases. 
Subjects had to reach for the target on the screen with their fingertip while having their eye 
movement recorded. Eye and hand latencies of individual subjects in the four temporally-cued 
tasks are illustrated in Figure S3 – S10 of the Appendix. Six distinct behavioural strategies were 
identified in the 2050 ms ISI temporally-cued task in the control (Figure S6) and HD groups 
(Figure S10): (1) very ‘early’ saccades with ‘early’ hand movements, in which ‘early’ means 
r = -0.73 [-0.88 – -0.45], p = 0.001 
r = -0.70 [-0.87 – -0.39], p < 0.001 
r = -0.77 [-0.90 – -0.51], p < 0.001 
r = -0.71 [-0.87 – -0.42], p < 0.001 
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responses were made in advance of target onset; (2) ‘reactive-type’ eye and hand movement 
responses, i.e. responses were made after target onset; (3) ‘early’ saccades with alternating 
‘early’ and reactive-type hand responses, i.e. ‘reactive-type’ hand responses interspersed with 
‘early’ hand responses; (4) concurrent ‘early’ eye and hand movements, i.e. both eye and hand 
responses were made in advance of target onset; and (5) a mixture of ‘early’ and ‘reactive-type’ 
eye and hand responses.  
 
Approximately 50% of controls exhibited a strategy involving very ‘early’ saccades with ‘early’ 
(but slower than the eye) hand responses in the 2050 ms ISI block. In contrast to controls, only 
three HD patients (two ‘Stage 1’ patients and one ‘Stage 3’ patient) utilised this strategy. Fifty 
percent of HD patients (n = 11) were found to show a ‘reactive-type’ response in eye and hand 
movements, compared to three controls who used this strategy in the same trial block.  
 
V.3B.3.1. Random phase 
In the random phase, the LMEM-estimated mean eye latency was 156 ms [95% CI: 98 ms – 
215 ms] in controls and 195 ms [95% CI: 135 ms – 225 ms] in the HD group. Hand latency was 
longer than the eye by 79 ms [95% CI: 65 ms – 92 ms; p < 0.001] in controls and 109 ms [95% 
CI: 95 ms – 125 ms; p < 0.001] in the HD group, indicating that the eye leads the hand when 
reaching for a novel and unpredictable target.  
 
V.3B.3.2. Predictable phase 
Figure V.10A shows that in both groups, eye and hand latencies were fairly consistent across 
trials in the random phase but there was a progressive reduction in latencies following the 
change to predictable target motion.  
 
In controls, the LMEM-estimated reduction in eye latencies in the last 20 predictable trials, 
compared to the random phase, ranged from 308 ms at the 750 ms ISI to 683 ms at the 2050 ms 
ISI. There was a more modest reduction in eye latency in HD, with an estimated reduction of 
145 ms at the 750 ms ISI and 237 ms at the 2050 ms ISI.  Reduction in hand latencies in controls 
ranged from 124 ms at the 2050 ms ISI to 402 ms at the 750 ms ISI whereas in HD, it ranged 
from 164 ms at the 2050 ms ISI to 251 ms at the 750 ms ISI. For eye-hand latency intervals (i.e. 
the time between the initiation of each eye and its corresponding hand movements) for the 
control group, they ranged from -16 ms (i.e. the hand preceded the eye) at the 750ms ISI to 698 
ms at the 2050 ms ISI. In the HD group, eye-hand latency intervals ranged from -2 ms at the 






          
 
Figure V.10 Eye and hand latencies in the temporally-cued tasks. (A) Mean eye and hand latencies in the random 
and predictable phases of the four ISI trial blocks (750 ms, 1000 ms, 1400 ms, and 2050 ms) by trial number. There were 17 
trials in the random phase, indicated by negative trial numbers (-16 to 0), and 40, in the predictable phase (1 to 40). The dotted 
vertical line in each plot indicates the end of the random phase and the start of the predictable phase. The exponential decay 
curves model the change in mean eye latency (red lines) and hand latency (blue lines) by trial number. (B) Mean saccadic 
latency of the random phase and the last 20 predictable trials of the four ISIs (750 ms, 1000 ms, 1400 ms, and 2050 ms) in 
controls and the three sub-groups of HD patients. Filled circles are the LMEM-estimated group means and unfilled circles, 
means for individual subjects.  
A 
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In controls, ISI had a strong but diverging effect in eye (p < 0.001) and hand (p = 0.02) latencies 
in the predictable phase (Figure V.10B). In the eye, there was progressive reduction in eye 
latency with increasing ISI, with the greatest latency reduction at the 2050 ms ISI. That is, 
controls initiated an eye movement well in advance of an appearing target when the target was 
alternating at the slowest speed. This is a directly opposite to the effect of ISI on eye latency in 
the saccade-only temporally-cued task, in which the greatest reduction in latency was found at 
the shortest ISI (refer section V.3A.2, Figure V.3). By contrast, the reduction in hand latency 
was greatest at the shortest ISI and the reduction in latency progressively diminished with the 
prolongation of ISI. There was also a strong ISI effect (p < 0.001) in eye-hand latency interval. 
That is, eye-latency interval was the shortest at the shortest ISI and gradually increased with 
increasing ISI. These findings in combination indicate a disparity in eye and hand behaviour in 
different ISIs.  
 
The effect of ISI was however, not apparent in the entire HD group in either the eye (p = 0.07) 
or the hand (p = 0.2), suggesting that reduction in eye and hand latencies was not affected by 
the length of ISI. When analysed by disease stage, it appears that there was a weak ISI effect 
across all disease stages in HD (Figure V.10B). By contrast, there was an effect of ISI (p = 
0.03) on eye-hand latency interval in the entire HD group. That is, there was a slight reduction 
in eye-hand latency interval at the shortest ISI and this gradually increased (albeit smaller 
compared to controls) as ISI increased.  
 
 
V.3B.4. Correlations between temporally-cued eye and hand movements, and 
disease measures  
The relationships between performance in the temporally-cued tasks and disease status in the 
HD group was determined by separately correlating mean eye and hand latencies in the last 20 
trials of the predictable phase of all four ISIs with the UHDRS motor scores and global 
cognitive scores of HD patients.   
 
Mean eye latencies in the last 20 trials of predictable phase of all ISIs, except for 1400 ms ISI, 
showed weak to moderate positive correlations (0.31 ≤ r ≤ 0.42, p ≤ 0.04) with UHDRS motor 
scores (FigureV.11A) and moderate negative correlations (-0.45 ≤ r ≤ -0.36, p ≤ 0.02) with 
global cognitive scores (FigureV.11B). This translates to a prolongation of latency in last 20 
trials of predictable tasks is associated with an increase in UHDRS motor scores and a decrease 
in global cognitive function. In contrast, mean hand latencies in the last 20 trials of all ISIs 
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generally showed weak and insignificant correlations to either the UHDRS motor scores or 
global cognitive scores (Figure V.11).  
 
Correlation analyses of CAG repeat number and eye-hand parameters, which was performed in 
an addition, showed that CAG repeat number was poorly associated (0 ≤ r ≤ 0.2, p > 0.1) with 
any parameters measured in these tasks.  
 
 
    
Figure V.11 Correlations between eye-hand movement latencies in the last 20 predictable trials and (A) the 
UHDRS motor scores, and (B) global cognitive scores of HD patients for the four ISIs (750 ms, 1000 ms, 1400 ms, and 
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V.4.  Discussion  
V.4A. Rhythmical saccades 
Rhythmical saccades of HD participants were evaluated and the relationships of their saccadic 
performance to measures of disease severity were examined. The main findings in rhythmical 
saccades were that: (1) In the HD group, the number of self-paced saccades made decreased 
with worsening HD disease severity; (2) There was a lack of prediction in the HD group 
irrespective of inter-stimulus interval (ISI), unlike controls, in whom there was greater 
prediction at shorter ISIs; (3) Saccadic characteristics of HD patients in the self-paced and 
temporally-cued tasks correlated with UHDRS motor scores and global cognitive level; and (4) 




V.4A.1. Self-paced saccades 
The finding that HD patients made significantly fewer saccades than did healthy controls 
confirms a previous study of horizontal self-paced saccades (Winograd-Gurvich et al., 2003). 
However, in contrary to the view that vertical reflexive saccades are more affected than 
horizontal reflexive saccades in HD (Leigh et al., 1983; Rupp et al., 2012), the present study 
revealed that there was no difference between the horizontal and vertical tasks in the number 
of self-paced saccades generated.  
 
Several regions in the cerebral cortex, particularly the frontal eye-field (FEF) and 
supplementary eye field (SEF), have been implicated in the control of self-paced and internally-
generated saccades. Neurophysiological evidence suggests that neurons in the FEF are involved 
in saccade fixation and disengagement (Everling & Munoz, 2000) whereas the SEF has a 
preparatory role in self-initiated oculomotor movement (Goldberg, 1985). The observations of 
increasingly impaired self-paced saccade generation with increasing HD disease severity in the 
present study suggest that the severity of FEF and SEF dysfunction is associated with HD 
pathophysiology and degeneration (Selemon et al., 2004). In addition to cortical structures, the 
basal ganglia are also involved in voluntary saccade production (Alexander et al., 1990). 
Neurodegeneration of the basal ganglia, which is evident in premanifest HD (Tabrizi et al., 
2009) and worsens with disease progression (Aylward et al., 1997; Tabrizi et al., 2010), may 




V.4A.2. Predictive saccades 
Controls had the highest proportions of predictive saccades and lowest saccadic latencies in the 
predictable phase of trial blocks with the shortest ISIs (i.e. 750 ms and 1000 ms). This is 
consistent with previous work which showed that short ISIs (less than 1000 ms) promote the 
generation of predictive saccades (Isotalo et al., 2005; Shelhamer & Joiner, 2003). Predictive 
saccades in HD were first explored by Tian et al. (1991), who reported less saccadic prediction 
in HD patients than controls, when a target alternated between two fixed locations at a constant 
frequency of 0.5 Hz. The current study extended this work by examining a range of ISIs. In 
contrast to controls, who demonstrated a clear transition between strongest predictive behaviour 
a shorter ISIs (e.g. 750 ms) to weaker saccadic prediction at longer ISIs (e.g. 2050 ms), there 
was no strong evidence of such a transition, regardless of clinical severity, in our HD patients 
(Figure V.2), suggesting an abnormality in the predictive system in manifest HD.  
 
Everling & Munoz (2000) demonstrated (in a non-human primate study) that in volitional 
saccades, saccadic latency is negatively correlated with pre-saccadic activity in the saccade-
related neurons in the FEF (i.e. shorter latency is related to increased activity in those neurons). 
A number of frontal cortical and basal ganglia regions are important in the generation of 
predictive saccades. A functional MRI study of healthy human subjects demonstrated that 
advanced knowledge of spatial and temporal information, which is the key factor for predictive 
saccade generation (Ross & Ross, 1981), was associated with increased brain activation in the 
FEF, SEF, dorsolateral prefrontal cortex, and basal ganglia (Gagnon et al., 2002). Gagnon et al. 
(2002) also found that there was greater activation of caudate nucleus with advanced spatial 
information and greater activity in the lentiform nucleus with advanced temporal information, 
indicating that there is different activation of basal ganglia with different types of advance 
information. In HD, there is atrophy of various cortical structures, the FEF included, and also 
degeneration of the basal ganglia (Reiner et al., 2011). Degenerative changes in these structures 
may ultimately affect the handling of advanced spatial and temporal information in HD, which 
consequently hamper the ability to generate predictive saccades in HD, as observed in this 
study.   
 
Humans are capable of achieving a high degree of synchronisation to external stimuli in 
repetitive rhythmic movement tasks, leading to the proposal that such behaviour is mediated by 
an ‘internal clock’ mechanism (Rao et al., 1997; Semjen et al., 2000). Joiner & Shelhamer 
(2006) postulated that predictive saccades, which can be established even after only two 
successive equal target intervals in healthy controls, are also under the influence of an ‘internal 
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clock’. The cerebellum and basal ganglia are thought to be integral to the internal representation 
of temporal information (Buhusi & Meck, 2005; Ivry, 1996). This notion is supported by the 
observation that patients with cerebellar (Spencer et al., 2003) and basal ganglia lesions 
(O'Boyle et al., 1996) exhibit deficits and increased variability in timed movements. Concurrent 
activation in the FEF and cerebellum during predictive saccades suggests that neural circuits 
between the FEF and cerebellum are critical in their generation (O'Driscoll et al., 2000). 
Pertinently, in addition to striatal atrophy in HD, recent evidence indicates that cerebellar 
degeneration begins relatively early in HD and is independent of the neurodegenerative changes 
in the striatum (Rub et al., 2013).  
 
Reduced saccadic prediction in HD might also be a consequence of a disrupted error monitoring 
system. Timing errors from the current saccade during a temporally-cued task are thought to 
expedite the neural command for the subsequent saccade via a feed-forward programming 
system (Shelhamer, 2005). In contrast to controls, who showed a distinct pattern of event-
related brain potentials to correct and erroneous responses, there were relatively minimal 
differences in event-related brain potentials between the two type of responses in patients with 
basal ganglia and prefrontal cortex lesions (Ullsperger & von Cramon, 2006), suggesting that 
dysfunctional fronto-striatal circuits can affect performance monitoring. Based on these 
observations, one can draw a parallel between patients with basal ganglia lesions and HD 
patients, who also suffer from basal ganglia degeneration. Therefore, in HD, inefficient fronto-
striatal circuits may compromise the performance monitoring system, which in this task results 
in a reduction in saccadic prediction. The reduction in motor prediction as a consequence of an 
impaired performance monitoring system may have implications on HD patients in their 
activities of daily living.  
 
Additional mechanisms may however, also be involved in the generation of predictive saccades. 
Zorn et al. (2007) demonstrated that in addition to motor actions, sensory information such as 
visual and auditory cues can also be used to develop predictive mechanisms in human saccades. 
These observations suggest that saccade prediction impairment in HD may not be explained 
solely by the degeneration of fronto-striatal circuits but may be a result of a multi-site and multi-
system degeneration in the central nervous system.   
 
An alternative explanation for impaired saccadic prediction in HD might be a tendency of HD 
patients to favour reactive over predictive responses due to relative preservation of the parietal 
lobe-superior colliculus network (Tian et al., 1991). This is however, unlikely to be a 
 
124 
contributing factor to the present findings. Firstly, the HD group exhibited predictive saccades 
in the last 10 trials of the predictable phase at all four ISIs (Figure V.3). Besides, the time series 
of reactive saccade latency (i.e. saccade latencies by trial number) is relatively flat whereas in 
predictive mode, the latency series decayed as a function of frequency in an exponential fashion 
(Shelhamer & Joiner, 2003). Group analysis of saccade latencies in the predictable trials of the 
HD group in the present study did show evidence of an exponential decay in saccadic latency 
by trial number at all four ISIs, albeit to a much lesser degree than controls. These findings did 
not support the idea that in HD there is a preference for reactive to predictive responses, but 
rather, there is a deficit in the predictive mechanism itself. Taken together, the evidence 
discussed above suggests that impairment in predictive saccades in HD likely has a basis in 
neurodegeneration involving particularly the cerebellum, the basal ganglia – especially the 
lentiform nuclei – and the frontal oculomotor control centres, resulting in a faulty predictive 
process. 
 
V.4A.3. Clinical correlates of rhythmical saccades 
In the present study, the relationships between saccadic parameters and CAG repeat number, 
the UHDRS motor score, and global cognitive score were examined to determine if deficits in 
rhythmical saccades are associated with the genetic load, motor or cognitive status in HD.  
 
As expected, self-paced and predictive saccade impairments were poorly correlated with CAG 
repeat number. This is because CAG repeat number only provides prognostic information 
pertaining to disease onset and also speed of disease progression but not disease status at any 
one point in time (Penney et al., 1997). Saccadic performance in the HD group did however, 
correlate with current UHDRS motor scores. The UHDRS motor component contains mostly 
items of voluntary movements which are governed by the frontal-striatal circuits 
(Groenewegen, 2003). Therefore, the significant correlation between the two variables suggests 
that in HD, a decline in rhythmical saccades and motor scores may reflect the pathological 
process in the frontal-striatal circuits. Shabbott et al. (2013) however, argued that caution should 
be taken when correlating kinematic data to disease severity scales due to the fact that clinical 
severity of HD patients, as determined by various rating scales, on their last assessment prior 
to their death, showed poor correlations with the degree of striatal degeneration at autopsy 
(Pillai et al., 2012).  
 
Cognitive function has been suggested to have an influential role in the control of saccadic 
movement (Anderson & MacAskill, 2013; Hutton, 2008; Isotalo et al., 2005). There were 
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significant correlations between nearly all saccadic parameters (in the self-paced and 
temporally-cued tasks) and global cognition in HD patients. Thus, these findings support the 
conclusion that both motor and cognitive decline is associated with deterioration in rhythmical 
saccade performance in HD patients.  
 
V.4A.4. Short-term longitudinal changes in rhythmical saccades 
There was in general, no obvious effect of time in self-paced saccades in either direction in the 
HD group over a period of 12 months. Based on this, it might be argued that performance in 
self-paced saccades is independent of the neuropathological changes in HD. However, the close 
association of self-paced saccade performance with UHDRS motor scores and global cognitive 
score in our HD patients suggested otherwise. Therefore, the parsimonious interpretation of this 
lack of change is that regions involved in the control of self-paced saccades, at least over short-
term (i.e. 12 months), are relatively spared from the effect of HD. It would also seem that self-
paced saccade measurement is useful for reflecting current disease status but not a sensitive 
progression marker for tracking 12 month disease changes in HD.  
 
It was found that there was an increase in saccadic latency in both the HD and control groups 
in the random phase, suggesting that an age effect might have contributed to this change after 
12 months. However, this study also revealed that at follow-up, there was a greater increase in 
latency in the HD group compared to controls. This indicates that the increase in latency in the 
HD group is not solely contributed by ageing effect but also caused by the effect of HD. The 
presence of an additional HD effect on normal ageing effect in latency in the random phase of 
temporally-cued tasks reaffirms the postulation that measurement of saccadic latency may 
potentially be a useful short-term progression marker for HD.  
 
There was however, no additional HD effect on the increase in saccadic latency in the 
predictable phase of all ISI trial blocks over time. It is unlikely that changes in predictive 
behaviour of saccades are not linked to the underlying pathology in HD as it was found in this 
study that in the patient group, the mean saccadic latencies of the last 10 predictable trials (a 
measure of saccade predictive behaviour) showed moderate to strong correlations with UHDRS 
motor scores and global cognitive level. Therefore, it is hypothesized that in HD, there was a 
global deterioration in saccadic latency over time with a relative preservation of saccade 
predictive behaviour over a short follow-up period. Such a hypothesis is supported by our 
finding of a relatively stable proportion of predictive saccades in the HD group after 12 months 
(refer to Figure V.2). Based on these findings, it appears that the measurement of predictive 
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saccades in a temporally-cued task is useful for reflecting patients’ current disease status but 
has limited utility as a HD progression marker for detecting or tracking short-term longitudinal 
disease changes.  
 
 
V.4B. Rhythmical eye-hand movement 
The current study extended previous studies, which examined either the rhythmical movement 
of the eye or the hand in manifest HD, by investigating coordinated eye-hand movement in 
manifest HD in a self-paced task and a temporally-cued task. The main findings were: (1) in 
HD, there were significant 12 month declines in self-paced eye and hand movements in contrast 
to a minimal change in performance in controls over time; (2) in contrast to the saccade-only 
temporally-cued tasks, in which the HD group had little reduction in eye latencies (a measure 
of saccade prediction), there was a greater reduction of eye latencies (albeit smaller compared 
to controls) in the eye-hand variants of the same task; and (3) there were striking differences 
between controls and the HD group in terms of the predictive behaviour of the eye and hand 
across the four ISIs. In controls, the reduction in eye latency was greatest at longer ISIs whereas 
there was initially a shortening of hand latency, which progressively became longer with longer 
ISI. By contrast, in the HD group, the predictive behaviour of the eye and the hand movements 
were relatively similar across ISIs.  
 
V.4B.1. Eye and hand movements in the self-paced task 
Overall, the findings of a reduction in the number of rhythmical eye and hand movements in 
the HD group in a self-paced task compared to controls on cross-sectional analysis were in line 
with previous studies (Andrich et al., 2007; Antoniades et al., 2010; Collins et al., 2014; 
Delmaire et al., 2010; Michell et al., 2008; Winograd-Gurvich et al., 2003). Such findings were 
not unexpected because the basal ganglia, which house the motor circuitry for the control of 
oculomotor and somatic movements (Alexander, 1994), are the primary site of HD pathology. 
The selective degeneration of the striatum in the basal ganglia might have in general, affected 
the functionality of the motor circuits, resulting in a reduced ability to generate self-paced 
rhythmical movements in HD. It is well-established that there is a greater loss of striatal neurons 
in the indirect (inhibitory) pathway of the basal ganglia than the direct (excitatory) pathway in 
early HD (Albin et al., 1990; Reiner et al., 1988). Based on this, it can be speculated that 
movement initiation should be relatively preserved in early HD. Conversely, the findings of the 
current study showed that relative to controls, there was a reduction in the number of self-paced 
rhythmical eye and hand movements even in patients with early HD. This implies that a decline 
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in self-paced rhythmical movements might not be directly related to the degenerative changes 
of the striatum in HD.   
 
The posterior parietal cortex has been implicated as a key communicating and processing centre 
for spatial and temporal information in the control of eye and hand movements (Hwang et al., 
2014; Vesia et al., 2010; Yttri et al., 2013). Several overlapping but functionally distinct areas 
within the posterior parietal cortex have been identified to have specific roles in the control of 
eye and hand movements (Vesia et al., 2010). Nevertheless, the different regions were found to 
interact with each other to support the coupling and decoupling of eye-hand movement 
(Battaglia-Mayer et al., 2006; Dean et al., 2012). Besides, the posterior parietal cortex is also 
involved in the control of attention (Colby & Goldberg, 1999). Thinning of the cerebral cortex, 
which is progressive in nature and occurs relatively early in HD (Rosas et al., 2002), is also a 
neuropathological hallmark of HD (Rosas et al., 2005; Tabrizi et al., 2009). Rosas et al. (2002) 
also showed that in comparison to other cortical regions, cortical thinning was most significant 
in the sensorimotor (parietal) region of the cortex. These findings might therefore explain the 
reduction in performance level in self-paced rhythmical eye-hand movement in early HD. 
Recent neuroimaging studies also found that there was a significant reduction in connections 
between the caudate nucleus of the basal ganglia and the posterior parietal cortex in HD 
compared to controls (Marrakchi-Kacem et al., 2013) and also a generalised loss of the region 
in the caudate nucleus specific for receiving neural inputs from the posterior parietal cortex 
(Bohanna et al., 2011). Taken together, these findings suggest that impairment in self-paced 
rhythmical eye and hand movements in HD patients can be attributed to HD pathology both in 
and outside the basal ganglia, thus explaining the marked reduction of self-paced eye and hand 
movements made in Stage 1 patients, as compared to controls. Given the number of self-paced 
eye-hand movements made decreases with increasing clinical severity in HD, a measurement 
of self-paced eye-hand movements may provide a useful global indication of underlying 
neuropathological changes in HD and also a progression marker for this disease.  
 
It is also noteworthy that both groups appeared to have made more self-paced eye movements 
in the eye-hand task than in the saccade-only task (refer to section V.3A.1). Such a finding 
might conceivably be explained by the physiological interactions between the neural 
mechanisms for the control of eye and hand movements. It has been consistently reported that 
in healthy controls, there is an improvement in oculomotor performance when eye movement 
is executed simultaneously with hand movement (Gauthier et al., 1988; Leist et al., 1987). 
Based on suggestions that the oculomotor control system relies on visual feedback (Lewis et 
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al., 1994) and the somatomotor control system is dependent on proprioceptive feedback (Barnes 
& Grealy, 1992), Barnes and Marsden (2002) posited that such an effect was likely to be 
contributed by a cross-modality transfer of feedback information between the two motor 
controls systems which resulted in the reinforcement of the behaviour of the oculomotor control 
system. The increase in the number of self-paced rhythmical eye movement in the HD group 
when eye movement is executed together with the hand implied that the cross-modality of 
transfer of feedback information appeared be relatively spared by the disease process in HD. 
The effective control of gaze behaviour is essential in monitoring and changing direction during 
locomotion (Hollands et al., 2002). There is evidence to support that the performance of 
locomotor movement can be improved with training of eye movement (Azulay et al., 1999; 
Crowdy et al., 2002). Taken together, it can therefore be speculated that the relatively intact 
ability to use multi-modal feedback information in HD might potentially be useful to improve 
motor control in HD patients.  
 
V.4B.2. Clinical correlates of eye and hand movements in the self-paced tasks 
In the current study, the results corroborated previous studies which showed that the 
performance level of hand movement was strongly correlated with the UHDRS motor scores 
of HD patients (Andrich et al., 2007; Michell et al., 2008; Saft et al., 2006). This was expected, 
as the UHDRS motor component primarily assesses the control of voluntary movement in HD. 
In addition to the hand, the performance of the eye in the eye-hand task was well correlated 
with UHDRS motor scores in HD.  According to Saft et al. (2006), the change in performance 
level in a hand tapping task was also related to the extent of caudate atrophy in HD patients. 
These findings show that self-paced rhythmical eye and hand movement might not only be a 
good indicator of the severity of motor impairment in HD but also of the underlying 
neuropathological changes in HD patients.   
 
Saft et al. (2006) showed that the reduction in hand tapping rate of HD patients was also 
associated with decline in performance in the cognitive tests of the UHDRS. However, it is 
known that the UHDRS cognitive component primarily provides a measure of executive 
function domain rather than global cognitive functioning (Toh et al., 2014). Therefore, I 
extended their work (Saft et al., 2006) by comparing the performance level of eye and hand 
movements to the global cognitive function of HD patients. Interestingly, it was revealed that 
the ability to generate self-paced rhythmical eye and hand movements was significantly 
correlated with the global cognitive scores of HD patients. This suggested that a decline in the 
ability to control self-paced rhythmical eye and hand movements in HD reflects an overall 
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deterioration of cognition. As discussed before, the control of eye and hand movements is 
dependent on the functional interactions between cortical and subcortical structures. Therefore, 
cerebral degeneration, which is a direct attribute of cognitive deterioration in HD (Rosas et al., 
2005), can also affect the control of self-paced rhythmical eye-hand movement in HD patients. 
Based on these findings, it can be suggested that the performance level in self-paced rhythmical 
eye and hand movements, in addition to having the potential to be a global disease progression 
marker, might also be an effective tool in providing an overall measure of motor disability and 
cognitive decline in HD.  
 
V.4B.3. 12 month changes in self-paced rhythmical eye-hand movement 
It is well-established that there is a systematic decline in hand tapping rate in HD over time 
(Andrich et al., 2007; Antoniades et al., 2010; Collins et al., 2014; Michell et al., 2008). 
However, there is conflicting evidence in terms of the annual changes in hand tapping rate in 
manifest HD, as Collins et al. (2014) demonstrated a decline in task performance after a year  
while others claimed that a change was only apparent after considerably longer follow-up 
intervals (Andrich et al., 2007; Antoniades et al., 2010; Michell et al., 2008). It is also 
noteworthy that many of these studies made the assumption of a systematic decline in the HD 
group in the absence of a control group. In contradistinction to the studies by Andrich et al. 
(2007) and Antoniades et al. (2010), in which they revealed that there were relatively negligible 
annual changes in rhythmical somatomotor movement, the present study demonstrated that 
relative to controls (who had negligible performance changes after 12 months), there was a 
significant decline in rhythmical self-paced eye and hand movements over time in all HD 
stages. Taken together, these findings suggest that there was a generalised and systematic 
decline in self-paced rhythmical movement across all stages of HD and that such a decline was 
measurable over a relatively short period of 12 months. 
 
Nevertheless, one might argue that the finding of a significant decline in the performance of the 
eye in the eye-hand task contradicted the finding of a minimal change in the number of self-
paced saccades generated after 12 months in the saccade-only task reported earlier in this 
chapter (refer to section V.3A.1). However, the neural pathways for the control of saccades 
made in isolation and those made during coordinated eye-hand movements, though sharing a 
similar fundamental neural circuit, involve different regions of cerebral cortex. The neural 
circuitry involved in the generation of self-paced saccades was discussed in detail in section 
V.4A.1. In contrast to the neural pathway for self-paced saccades, which primarily receives 
inputs from the frontal eye field and the supplementary eye field in the frontal cortex, the key 
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cortical area involved in the control of coordinated eye-hand movements is the posterior parietal 
cortex (Dean et al., 2012; Hwang et al., 2014; Vesia et al., 2010). Progressive degeneration of 
the cerebral cortex (Rosas et al., 2008; Tabrizi et al., 2010) in HD might have affected the 
functionality of the frontal and posterior parietal cortices and contributed to the poor 
performance of HD patients in the two variants of the rhythmical self-paced tasks when 
compared to controls. However, Rosas et al. (2008) demonstrated that there was great 
heterogeneity in terms of cortical degeneration in HD patients over time. These findings might 
conceivably explain the differences in the rate of decline in the performance level of the HD 
group in the two rhythmical self-paced tasks after 12 months. Rosas et al. (2002) reported that 
the sensorimotor region of the cortex was the most affected of all cortical regions. Taken 
together, it can be postulated that the neural control system for rhythmical self-paced eye and 
hand movements might be more susceptible to HD pathology than the neural system for 
controlling self-paced saccades over a relatively brief period of time and thus, making it an 
appealing tool for measuring short-term disease progression in HD. 
 
 
V.4B.4. Eye-hand movement prediction in the temporally-cued tasks 
The data of the control group in the present study can be compared with the results of Barnes 
and Marsden (2002), who studied the characteristics of eye-hand movement of healthy controls 
in tasks with repeated presentation of a target stimuli at a constant inter-stimulus interval (ISI). 
Barnes and Marsden (2002) reported that there was a progressive shortening of latency in the 
eye and the hand with increasing ISI from an ISI value of 480 ms up to 910 ms. However, it 
was shown that in contrast to the eye, which continued to show further reduction in latency in 
trials at the longest ISI (3740 ms), there was a gradual reversal of movement prediction in the 
hand beyond an ISI value of 910 ms (Barnes & Marsden, 2002). Despite variation in the ISIs 
used in the present study and the study by Barnes and Marsden (2002), the control group of the 
current study also demonstrated that there were differences in the predictive behaviour of the 
eye and hand movements with increasing ISI. That is, the latency of the eye was progressively 
reduced with longer ISIs, whereas the latency of the hand reduced initially and progressively 
increased as the ISI increased. The pattern of predictive behaviour of the hand in controls is 
consistent with the fact that humans, in general, are capable of instigating predictive 
somatomotor movement at an ISI value of 100 ms (Jeeves, 1961). However, such predictive 
behaviour would tend to cease when the ISI is longer than 2000 ms (Mates et al., 1994)., which 
coincides with the increase in hand latency in the control group at the 2050 ms ISI in the present 
study.   
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Based on a review by Gross et al. (1999), predictive behaviour in the somatomotor system –  
referred to by the authors as sensorimotor prediction –  is controlled by two partially distinct 
but parallel neural network loops, the cortico-basal ganglionic and cortico-cerebellar loops. The 
posterior parietal cortex, a key centre for integrating sensory information (Vesia et al., 2010), 
is thought to provide the secondary motor areas (the premotor cortex and supplementary motor 
area) with visual representations of the body in relation to the environment in real-time and also 
in a predicted state (i.e. if an anticipatory movement was to be performed) (Kosslyn & Sussman, 
1994). The secondary motor areas are actively involved in motor planning and these regions 
are thought to participate in sensorimotor prediction by constructing hypothetical movements 
based on associative memories and visual representations supplied by the posterior parietal 
cortex (Tsunoda et al., 1996). These hypothetical movements would then be projected to the 
striatum of basal ganglia for further processing. It was postulated that the striatal neurons of the 
basal ganglia are capable of selecting these suggested movements via an internal process that 
evaluates the sensory situations and the outcomes of these motor commands based on past 
experiences (Gross et al., 1999). There is compelling evidence to suggest that the cerebellum 
plays a significant role in the control of predictive behaviour (Barrera, 2010). As stated by Gross 
et al. (1999), the cerebellum uses sensory context from the sensory cortex to predict the sensory 
outcomes of the proposed motor commands from the secondary motor areas. Sensory prediction 
is then projected back to the primary motor areas via the thalamus to enable the suggested 
actions to be performed (Gross et al., 1999).  
 
Consistent with the findings in the saccade-only temporally-cued tasks (please refer section 
V.3A.2), in which there was minimal predictive behaviour in the eye in HD, the HD group, 
relative to controls, showed significantly less prediction in eye-hand movements. These 
findings suggest that there is a generalised change in the predictive behaviour in manifest HD. 
As previously discussed (refer section V.4A.2), in HD, there is strong evidence of progressive 
degenerative changes in various neural structures implicated in the control of predictive 
behaviour (Aylward et al., 1997; Aylward et al., 2011; Rosas et al., 2001; Rosas et al., 2008; 
Rub et al., 2013; Tabrizi et al., 2013). Taken together, it can be speculated that HD pathology 
in the cortical and subcortical structures might have in general, affected the normal functioning 
of neural systems involved in controlling predictive behaviour of motor movements. The 
finding of an altered predictive behaviour in stage 1 HD patients compared to controls in the 
present study is consistent with these neuropathological changes being evident even in early 
HD (Kipps et al., 2005; Rosas et al., 2005; Stoffers et al., 2010; Tabrizi et al., 2009).  
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V.4B.5. Differences in the predictive behaviour of the eye in the saccade-only 
and eye-hand variants of the temporally-cued tasks 
It is interesting to compare the results of the saccade-only (refer section V.3A.2 for a detailed 
description) and eye-hand variants of the temporally-cued tasks (refer section V.3B.3). The 
present study revealed that in controls, when saccades are performed in isolation in the 
temporally-cued tasks, the strength of prediction is inversely related to the length of the ISIs. 
That is, saccade prediction was found to be the strongest in trials with the shortest ISI and 
decreased with increasing ISI. Conversely, this relationship was reversed in the eye-hand 
variants of the same task. It is to be noted that the HD group, which failed to demonstrate 
significant saccade prediction in the saccade-only temporally-cued task, was found to exhibit 
certain degree of movement prediction in the eye and the hand in the eye-hand variants of 
temporally-cued tasks. Based on this, it can be speculated that the predictive behaviour of the 
oculomotor system could be enhanced when oculomotor movement is executed concurrent with 
somatomotor movement. Consistent with this interpretation is the fact that in healthy 
volunteers, ocular pursuit was found to be improved when ocular tracking was accompanied 
with hand tracking (Gauthier et al., 1988; Leist et al., 1987).   
 
There are several possible mechanisms by which hand movement may enhance the predictive 
behaviour of the eye. According to Barnes and Marsden (2002), the central initiation of hand 
movement might have the ability to accentuate the expectancy level of the central system, 
leading to the facilitation of eye movement execution. Based on the postulation that there is a 
constant exchange of information between the eye and the hand systems when executing 
coordinated eye-hand movements (Gauthier et al., 1988), Barnes and Marsden (2002) claimed 
that in the process of initiating the hand movement, the somatomotor control system might have 
provided the immediate kinematic information of the intended hand movement to the 
oculomotor system, thus eliminating the need for the oculomotor system to access the 
internally-stored information required to generate a predictive saccade.  
 
Feedback control systems may also have a role in strengthening the predictive behaviour of the 
eye in the temporally-cued eye-hand tasks. Lewis et al. (1994) demonstrated that visual 
feedback is the main form of feedback mechanism for the oculomotor system because 
proprioceptive feedback from the extraocular muscles primarily contributes to long-term (i.e. 
over several weeks or months) regulation of eye movement. By contrast, the somatomotor 
control system has the advantage of concurrently utilising both visual and proprioceptive 
feedback mechanisms (Barnes & Grealy, 1992). The availability of visual and proprioceptive 
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feedback information during a coordinated eye-hand movement might have provided additional 
feedback information for the oculomotor system to assess the eye performance, resulting in 
stronger predictive behaviour of the eye in the temporally-cued eye-hand tasks, as observed in 
both groups in the present study.  
 
The ability for the motor system to express predictive behaviour in motor planning and 
execution is integral to a smooth and efficient control of motor movement (Wexler & Klam, 
2001). This is because sensorimotor prediction enables the motor system to minimise reaction 
time delays by preparing the desired response well in advance of the anticipated situations 
(Schmidt, 1968). The finding that there was a synergistic effect in sensorimotor prediction in 
temporally-cued eye-hand movement in HD suggests that this effect may have utility in 
managing their motor symptoms. HD patients might benefit from motor training techniques that 
make use of one movement to facilitate the execution of another movement, i.e. using the eye 
to assist in the initiation of limb movement or vice versa, when performing self-paced or 
temporally-cued rhythmical movements.  
 
V.4B.6. ISI effect on the difference between eye and hand latencies in the 
temporally-cued tasks 
The presence of a significant ISI effect in the difference between eye and hand latencies (eye-
hand latency interval) in the control group (i.e. mean eye-hand latency interval was shorter than 
at the random phase at the shortest ISI and this progressively increased to being longer at longer 
ISIs) suggests that there is no strict temporal sequentiality in the coordination of eye and hand 
movement in a temporally-cued task. That is, in eye-hand coordinated movements, the eye does 
not necessarily have to lead or precede the hand movement. Consistent with this idea is the fact 
that the pattern of human eye-hand coordination in a natural environment can vary according 
to the task in context (Pelz et al., 2001). The current study also showed that there was a 
significant effect of ISI in eye-hand latency interval in the HD group. That is, eye-hand latency 
interval changes in the HD group, albeit smaller in magnitude than controls, when target motion 
becomes predictable. This indicates that in a temporally-cued task, HD patients could 
accordingly adjust the temporal sequencing of eye-hand coordination to meet the demand of 
the task, suggesting a relative preservation of flexibility in the temporal sequentiality of eye-
hand movements in manifest HD.  
 
It is however, important to highlight that there was a greater increase in eye-hand latency 
interval, i.e. eye movement was initiated well in advance of the hand, in controls compared to 
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the HD group with increasing ISI. Based on these findings, it is tempting to suggest that HD 
patients might have a more efficient control of temporal coordination of the eye and hand 
movement in a temporally-cued task, because there was a reduced period of dormancy between 
the initiation of eye and hand movements. This may, however, not be the case. It is well-
established that there are two distinct types of fixation in naturalistic tasks, ‘guiding’ fixation 
and ‘look-ahead’ fixation (Lehtonen et al., 2013; Mennie et al., 2007; Pelz et al., 2001). It was 
suggested that ‘guiding’ fixations are closely coupled to the ongoing movement whereas ‘look-
ahead’ fixations aim at objects that are relevant in the future but not in the current ongoing 
subtask (Lehtonen et al., 2013). Khan et al. (2011) posited that the rationale for directing 
fixation to locations relevant for future actions is to enable the motor system to process the 
properties of the objects that will be manipulated for setting internal goals for future motor 
actions. Mennie and colleagues (2007) provided evidence to support that look-ahead fixations 
are indeed involved in gathering spatial and temporal information relevant for future actions 
and have direct influences on the accuracy of subsequent motor actions. Taken together, the 
findings in the present study might possibly suggest that in controls, there was a greater 
flexibility in selecting gaze strategies for motor planning which might be reduced in the HD 
group.  
 
It can be speculated that in HD, the reduced flexibility in the selection of gaze strategy is related 
to a greater reliance on visual guidance in movement execution in HD. An increased reliance 
upon visual cues to guide movement in HD was reported in a study by Georgiou et al. (1995), 
in which they showed that HD patients had difficulty in executing sequential responses with 
the reduction of advanced visual information in a button pressing task. The authors postulated 
that an increased reliance on external cues is likely an effect of HD. Given that the basal ganglia 
provide internal cues for movement generation, the degeneration of basal ganglia in HD might 
have affected the ability of HD patients to use internal cues to control their movements 
(Georgiou et al., 1995). Besides, Pelz and colleagues (2001) demonstrated that hand movements 
in healthy controls are usually initiated close to or concurrently with the eye, in tasks that require 
high level of visual guidance. They also posited that this strategy of eye-hand coordination 
eliminates the need for the motor control system to separately initiate the eye and the hand 
movement at different times (Pelz et al., 2001). Based on this evidence, it can be posited that 
manifest HD patients have likely selected a gaze strategy with relatively constant eye-hand 
latency interval, because this ensures that the eye is always available or near to the hand for 
guiding the movement. Further, such a strategy does not place additional burden on an already 
compromised motor control system. 
Chapter V Rhythmical movement 
135
In summary, the findings in the temporally-cued tasks conceivably suggest that in HD, there 
was greater reliance on visual guidance in movement control and having a relatively fixed 
temporal coupling of eye-hand coordination (compared to controls) ensures that the eye can be 
readily called upon to guide the hand during movement execution. 
 
V.4B.7. Clinical correlates of eye and hand movements in the temporally-cued 
tasks 
The current study revealed that in the HD group, eye-hand movement parameters in the 
temporally-cued tasks were weakly correlated with UHDRS motor scores and global cognitive 
scores (Figure V.8). These findings suggest that eye-hand coordination performance in the 
temporally-cued tasks in general, do not closely reflect the disease status of HD patients. One 
possible explanation for the weak associations was that the UHDRS motor component primarily 
assesses motor movements that are under the direct influence of the cortico-basal ganglia 
pathway. As discussed previously, the predictive behaviour of the human motor system is 
governed by two partially distinct neural pathways, the cortico-basal ganglia and the cortico-
cerebellar neural loops (refer to section V.4A.2 for a detailed discussion). Although the 
degeneration of the basal ganglia co-exists with cerebellar atrophy in HD, the extent of cell loss 
in the basal ganglia was independent of the atrophic changes in the cerebellum (Rub et al., 
2013). Given the disparity in the degeneration of the two neural structures, it can be implied 
that there might be a non-uniform decline in the normal function of the two neural pathways 
involved in the control of sensorimotor prediction in HD. This results in deficits in sensorimotor 
prediction being unrelated to the clinical severity of HD patients, in terms of the degree of motor 
or cognitive impairment. These findings though valuable for understanding the behaviour of 
eye-hand movements in manifest HD, diminish the value of eye-hand movement measurement 
in a temporally-cued task as a potential disease biomarker for HD.  
 
 
V.5. Chapter summary 
In summary, the present study extended the current literature on the characteristics of 
rhythmical saccades in HD (Tian et al., 1991; Winograd-Gurvich et al., 2003) to show that 
deficits in rhythmical saccades – self-paced and predictive – were evident in early manifest HD 
and worsened with increasing disease severity, as measured using HD clinical staging, UHDRS 
motor component, and global cognitive level. In addition, there was demonstrable short-term 
progression in saccadic latency but not in the number of self-paced saccades or predictive 
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behaviour of the eye in the temporally-cued tasks after 12 months. It is therefore proposed that 
for saccade assessment, the measurement of reactive saccadic latency might be useful 
progression marker for following short-term disease changes, i.e. over 12 months, in manifest 
HD whereas rhythmical self-paced and predictive saccade paradigms may be valuable for 
longer-term follow-up. Given the close association between the main pathological site of HD 
and the neural circuits for eye movement control, and the evidence of objectively measured 
longitudinal changes in saccades, the use of saccadic measures in general might be helpful 
adjuncts for monitoring the effects of putative neuroprotective therapies in both manifest and 
premanifest HD. An improvement, or stable saccade measurement, would potentially translate 
to the therapy as having an effective neuroprotective effect.  
 
Despite having a small sample, data from the present study provided compelling evidence of a 
longitudinal decline in rhythmical eye-hand movement in a self-paced task and also of a change 
in the predictive behaviour of eye-hand movement in HD patients, compared to controls. 
Findings in rhythmical saccadic and eye-hand movements were discussed in relation to the 
neuropathological changes in HD. The presence of a significant decline in rhythmical eye-hand 
movement in the self-paced tasks over a brief period of 12 months substantiated previous claims 
(Andrich et al., 2007; Antoniades et al., 2010; Saft et al., 2006) that a simple motor task might 
be more effective than complex tasks in demonstrating disease progression in HD over time. 
This also indicates that the measurement of concurrent self-paced eye and hand movements 
may potentially be useful progression marker of HD for monitoring short-term longitudinal 
disease changes. Given the relative simplicity of the task, it can be easily translated for use in 
research trials or clinical practice.  
 
In addition, concurrent control of the eye and hand movements in the temporally-cued tasks 
appeared to have strengthened the predictive behaviour of the eye in the HD group. Future study 
is warranted to examine if concurrent control of multiple motor control systems is beneficial 
for the improvement of motor control in manifest HD. If this claim is substantiated by a larger 
study, motor training that focusses on using one movement to guide another may serve as 
















In general, human saccades can be broadly categorised as either visually-guided or complex 
volitional saccades.  The execution of visually-guided saccades is dependent on an external cue 
and some relatively simple sensorimotor transformation processes in the saccade generating 
system (McDowell et al., 2008). By contrast, complex volitional saccades, which are generated 
based on contextual cues and instructions, often require the concurrent inhibition of a reflexive 
saccade and involvement of various complex cognitive processes in multiple cortical regions 
(McDowell et al., 2008; Munoz & Everling, 2004; Pierrot-Deseilligny, 1991; Pierrot-
Deseilligny et al., 2004). Despite the differences, both type of saccades share a final common 
motor pathway for saccade generation (Leigh & Zee, 2006).  
 
Complex volitional saccades have been widely-used in the study of various behavioural and 
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neurological disorders (Anderson & MacAskill, 2013; Landgraf et al., 2008; van Stockum et 
al., 2012). Memory-guided saccade and anti-saccade tasks are the most commonly used 
complex volitional saccade paradigms in functional neuroimaging studies (McDowell et al., 
2008). Although there are slight variations in the complex volitional saccade paradigms used 
across studies, all of them consisted of pro-saccade inhibition and a spatial working memory 
processing component. In a memory-guided saccade task, for example, participants should 
remember the location of a briefly presented target without making a saccade to it, and a saccade 
should only be made to that remembered location after a brief delay. Meanwhile, in an anti-
saccade task, a saccade should be directed to the mirror – opposite – location of a peripheral 
target upon fixation target offset.  
 
The hallmarks in HD are involuntary hyperkinetic movements, saccadic function abnormalities 
(Anderson & MacAskill, 2013; Lasker & Zee, 1997) and cognitive impairment (Paulsen, 2011). 
Complex volitional saccades have been extensively studied in previous cross-sectional studies, 
in which it was found that there was a significantly increased saccade disinhibition in HD 
patients and authors have suggested that performance in complex volitional saccades may 
potentially reflect the underlying neuropathology in HD (Becker et al., 2009; Blekher et al., 
2009b; Lasker et al., 1987; Peltsch et al., 2008; Tabrizi et al., 2009; Tsai et al., 1995). Despite 
the findings of cross-sectional studies, there has, however, been conflicting evidence of the 
utility of various types of complex volitional saccade tasks in the longitudinal monitoring of 
disease progression in HD (Rupp et al., 2010; Tabrizi et al., 2010).  
 
The control of somatic movement calls upon the concerted interactions of a schema (a control 
system that specifies the current tasks and plans the overall sequence of actions), gaze, visual, 
and motor systems (Land, 2009). In manifest HD, there was evidence of a stronger reliance of 
visual guidance in the control of motor performance (Georgiou et al., 1995). It was also 
suggested that in HD, there are great similarities between eye and arm movement abnormalities 
(Berardelli et al., 1999). Despite that, there is no literature on a direct comparison of the 
longitudinal changes in saccadic and eye-hand coordination performance in various complex 
movement tasks in HD. Wolf et al. (2008) found that in premanifest HD, there was a stronger 
disease effect on the functional abnormalities of motor control in tasks with higher cognitive 
load, i.e. complex movement tasks. Therefore, one of the objectives of the present study was to 
examine and compare the utility of various complex movement tasks for monitoring 12 month 
disease progression in HD and also to probe the eye-hand coordination of HD patients in 
complex volitional movements.  
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VI.2.  Methods 
Please refer to Chapter II for a detailed description of study procedures. 
 
VI.3.  Results 
VI.3A. Complex volitional saccades (Delayed, memory-guided, and anti-saccades) 
VI.3A.1. Saccade disinhibition and pro-saccade correction 
Between-group differences, group-by-time interactions, and disease stage effect on saccadic 
disinhibition in the three voluntary saccadic tasks were determined by fitting generalised linear 
mixed-effect models for binary data to the number of disinhibited saccades and the total number 
of saccadic responses made.  
 
The HD group (Baseline Mean % [SD] : Delayed: 46.1 [32.4]; Memory-guided: 55.8 [30.3]; 
Anti-saccade: 71.5 [30.7]) had a significantly higher proportion of disinhibited saccadic 
response than controls (Baseline Mean % [SD] : Delayed: 6.9 [11.0]; Memory-guided: 9.7 [9.0]; 
Anti-saccade: 19.7 [11.3]) in all three complex movement tasks (z > 6.0, p ≤ 0.003) at baseline 
and at 12 month follow-up. The mean effect sizes ranged from d = 1.6 in the delayed task to d 
= 2.0 in the anti-saccade task. There were no significant differences between the two groups, in 
terms of the proportion of pro-saccade correction (proportion of saccades made to the peripheral 
target which were subsequently corrected to the mirror position of that target) in the anti-
saccade task (z = -1.8, p = 0.09).  
 
There was a strong linear effect (z ≥ 6.3, p ≤ 0.001) of disease stage on the rate of disinhibited 
saccadic response in the delayed and anti-saccade tasks and a strong non-linear disease stage 
effect (z = -2.9, p ≤ 0.001) in the memory-guided task. That is, in all three tasks, saccadic 
disinhibition increased with worsening disease severity in HD (Figure VI.1). The corrected pro-
saccade error rate in the anti-saccade task (z = -2.5, p = 0.01)  was relatively high from controls 
through Stage 1 and 2, with a substantial decline observed in Stage 3 HD (Figure VI.1). 
 
There was a significant group × time interaction in the memory-guided task (z = 3.0, p = 0.002) 
and the anti-saccade (z = 2.5, p =0.01) task. This was contributed by a significant improvement 
in performance (i.e. reduction in disinhibited saccades) by controls in the presence of a minimal 
change in HD patients in these complex saccade tasks. This interaction however, was not 





Figure VI.1 Proportion of disinhibited saccades (expressed in percentages) for controls and the three sub-groups 
of HD patients in the delayed (top panel), memory-guided (second from top), and anti-saccade (third from top) tasks. 
Corrected pro-saccade error rate (percentage) in the anti-saccade task is shown in the bottom panel. Baseline and 12 
month data are shown. Error bars shown are 95% CIs. *NB: The only stage 4 HD patient (S08) in the present study was analysed 
together with stage 3 patients. 
 
 
VI.3A.2. Saccade disinhibition in the memory-guided task 
A linear mixed effect model was fitted to the differences between the proportions of disinhibited 
saccade at peripheral target (flash) offset and at fixation target offset to determine if there were 
any changes in the proportions of disinhibited saccade between the two time points in all three 
fixation intervals (1500 ms, 2000 ms, and 2500 ms) in the memory-guided task. In both the 
control and the HD groups, there was about an 8% increase in the proportion of disinhibited 
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saccade from fixation target offset to peripheral target offset in trials with the shortest fixation 
interval (1500 ms). The increase in the proportion of disinhibited saccades during fixation 
period (peripheral target offset and fixation target offset) was relatively stable across the three 
fixation intervals in either group (p ≥ 0.1) (Figure VI.2). There was no overt HD effect (p = 0.3) 
on the increase in the proportion of disinhibited saccades between the two time points across 
the three fixation intervals.  
 
Figure VI.2 The cumulative frequencies of saccadic latencies in memory-guided trials with 1500 ms, 2000 ms, 
and 2500 ms fixation intervals. The green lines indicate the peripheral target (flash) offset time (400 ms) and the green dotted 
lines are the fixation target offset times (1900 ms, 2400 ms, and 2900 ms). The duration of the fixation interval is shaded in 
pink in each panel. Changes in the proportions of disinhibited saccade during fixation period are the differences between the 
proportions of disinhibited saccade at peripheral target offset and at fixation target offset. 
 
 
VI.3A.3. Saccadic latency of correct and corrected responses  
Linear mixed-effect models were fitted to saccadic latencies in the ‘Step’ condition of the 
reflexive 1D (horizontal only) paradigm (refer section IV.3A.1) and latencies of correct 
saccadic responses in the three complex movement tasks to determine between-task and 
between-group differences, and the longitudinal changes within each complex task.  
 
In the control group, the delayed, memory-guided, and anti-saccade tasks had longer latencies 
than the reflexive task by 137 ms [95% CI: 112 ms – 161 ms; p < 0.001], 145 ms [95% CI: 123 
ms – 166 ms; p < 0.001], and 157 ms [95% CI: 138 ms – 175 ms; p < 0.001], respectively 
(Figure VI.3). There was no evidence of a group effect (p ≥ 0.6) on the increase in eye latencies 
in complex tasks in relative to the reflexive task (Figure VI.3), suggesting both control and HD 
groups shared a similar profile of increase in eye latency in complex movement tasks.  The HD 
group, however had a significantly longer latency (t = 4.6, p < 0.001) than controls for pro-
saccade correction in the anti-saccade task (Control: Mean = 196 ms, SD = 61 ms; HD: Mean 
= 360 ms, SD = 140 ms). 
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In controls, there were no significant changes (p ≥ 0.3) in latency in all three complex tasks at 
12 month follow-up. There was however, an overt time effect in latency in the memory guided 
and anti-saccade tasks in the HD group, in which there was an estimated increase of latency by 
67 ms [95% CI: 13 ms – 121 ms; p = 0.02] and 51 ms [95% CI: 12 ms – 90 ms; p = 0.01], 
respectively in the follow-up session (Figure VI.3). A significant group × time interaction was 
observed in the memory guided task only (p = 0.04). 
 
 
Figure VI.3 Mean saccadic latencies in the reflexive (‘Step’ task) and complex movement tasks for controls and 
the HD group at baseline and at 12 month follow-up. Filled circles are the LMEM-estimated group mean latencies and 
unfilled circles, means for individual subjects.   
 
 
VI.3A.4. Clinical correlates of saccades in the complex movement tasks 
VI.3A.4.1.  Saccade disinhibition and corrected pro-saccade error rates 
It was revealed that in general linear regressions did not provide a good fit for the relationships 
between the proportions of disinhibited saccade and corrected pro-saccade error, and current 
disease status (UHDRS motor scores and working memory domain z-scores). Thus, nonlinear 
regressions were used to assess the relationships (Figure VI.4).  
 
The proportion of disinhibited saccades in all three complex tasks generally increased with an 
increase in UHDRS motor scores (Figure VI.4A) and decrease in working memory domain z-
scores (Figure VI.4B). There was a much smaller range of pro-saccade correction rate in the 
anti-saccade task and a decline in pro-saccade correction rate was observed in participants with 
either a very high motor score (Figure VI.4A) or a very poor working memory domain z-score 
(Figure VI.4B) 
Saccadic task 
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Figure VI.4 Relationships between the proportions of disinhibited saccade in the three complex tasks and the 
proportions of corrected pro-saccade error in the anti-saccade task, and (A) UHDRS motor scores, and (B) working 
memory domain z-scores. 
 
 
VI.3A.4.2. Saccadic latency of correct and corrected responses 
Simple correlations were used to examine the relationships between mean latencies of correct 
saccadic responses and pro-saccade correction in the complex tasks, and UHDRS motor scores, 
and working memory domain scores.  
 
Large deviations from a linear fit resulted in low r values in the relationships between mean 
latencies of correct saccadic response in all three tasks and UHDRS motor scores (Figure 
VI.5A), and working memory domain scores (Figure VI.5B). Mean latencies of corrected pro-
saccade errors, however, showed strong positive correlation (r = 0.8, p < 0.001) with the UHDRS 
motor scores (Figure VI.5A) and strong negative correlation (r = -0.6, p = 0.007) with working 
memory domain scores (Figure VI.5B), suggesting that an increase in corrected pro-saccade 
error latency is associated with higher motor scores and lower working memory domain scores. 
Further, bootstrapping procedure revealed that latencies for corrected pro-saccade errors had 
greater association with UHDRS motor scores than the scores pertaining to working memory 





Saccadic parameters in all three complex tasks showed weak correlations (0 < r < 0.3, p > 0.2) 
to CAG repeat number, indicating that changes in saccadic performance are progressive and 
not related to CAG repeat size.   
 
 
Figure VI.5 Correlations between saccade latencies in the three complex tasks and (A) UHDRS motor scores, and 
(B) working memory domain z-scores. r [95% CIs] and p values are shown.   
 
VI.3B. Eye-hand coordination in the delayed task 
V.3B.1 Movement disinhibition  
Latency distributions from the combined eye-hand delayed task are shown in Figure VI.6. In 
contrast to controls, who showed a unimodal eye latency distribution, the HD group 
demonstrated a bimodal distribution, at baseline and at 12 month follow-up assessments (Figure 
VI.6A. That is, the HD group had an increased eye movement disinhibition rate in the delayed 
task. For hand movement, the HD group had a much wider latency distribution compared to 
controls, indicating a high variability in hand latencies (Figure VI.6B). 
 
A binomial family generalized linear mixed-effect model was fitted to the number of 
disinhibited responses and total number of responses made, to establish the between-group 
differences and the effect of time on eye and hand disinhibited responses. At baseline, there 
was a significant increase (p < 0.001) in disinhibited eye and hand responses in the HD group 
B 
r = 0.5 [0.1 – 0.8], p = 0.03 
 
r = -0.2 [-0.6 – 0.2], p = 0.4 
0.003 
 
r = 0.2 [-0.2 – 0.6], p = 0.3 
 
r = 0.03 [-0.4 – 0.5], p = 0.9 
 
r = 0.8 [0.6 – 0.9], p < 0.001 
 
r = -0.1 [-0.5 – 0.4], p = 0.7 
 
r = 0.3 [-0.2 – 0.7], p = 0.2 
 
r = -0.6 [-0.8 – -0.2], p = 0.007 
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Chapter VI Complex movement 
145
compared to controls (Table VI.1). There was an effect of time in eye movement disinhibition 
in both groups, with the disinhibited eye response rate dropping by 5% (p < 0.005) in controls 
and increasing by 10% (p < 0.03) in the HD group in the follow-up session. These contrasting 
effects in the two groups contributed to a strong group × time interaction (z = 3.5, p < 0.001). 
By contrast, there was no overt time effect in hand movement disinhibition in either group (p ≥ 




Figure VI.6 Latency distribution of the eye (A) and hand (B) in controls and the HD group in the combined eye-
hand movement delayed task. The blue dashed lines indicate fixation target offset while the red dashed lines are the cut-off 
times (Eye: 80 ms; and hand: 120 ms) for correct responses. Disinhibited responses are responses made in the time frame 





Table VI.1 Mean rate (SD) of disinhibited eye and hand responses in the combined eye-hand movement 
delayed task 
 Rate of disinhibited responses (%)  z, p value 
 Control group  HD group  HD vs. Control 
 Baseline 
Change after 
12 months  Baseline 
Change after 




at 12 month 
Eye  8 (14) 
-5 (11), 
 p < 0.005 
 43 (35) 
10 (23), 
p < 0.03 
 3.5, p < 0.001 3.5, p < 0.001 
Hand  2 (5) 
-1 (4), 
 p = 0.4 
 8 (11) 
5 (18),  
p = 0.1 
 2.6, p < 0.001 1.4, p = 0.2 
 
A linear mixed effect model was fitted to the proportions of disinhibited eye and hand responses 
at fixation offset to determine if there is any differences in the percentages of disinhibited 
responses between the eye and hand at fixation offset. In controls, the proportion of disinhibited 
responses in the eye was not significantly higher than the hand at fixation offset (10% vs. 3%), 
with an estimated increase of 7% [95% CI: -1% – 15%; p = 0.07]. The HD group, relative to 
controls, showed a significantly higher response disinhibition in the eye than the hand (40% vs. 
17%), with an estimated increase of 23% [95% CI: 12% – 35%; p = 0.001] greater than the 
increase observed in the control group. Despite there being no evidence of a time effect in 
controls (p = 0.1), the HD group demonstrated an additional increase of 9% [95% CI: 0.3% – 
18%; p = 0.04] in disinhibited eye response compared to the hand in the follow-up session, 
which resulted in a significant group × time interaction (t = 2.3, p = 0.03).  
 
Figure VI.7 Disinhibited response rates in controls and the three sub-groups of HD patients in the delayed task. 
Error bars shown are 95% CIs. *NB: The only stage 4 patient (S08) was analysed together with the stage 3 patients. 
 
Figure VI.7 shows the disinhibited response rate of the eye and hand for controls and the three 
sub-groups of HD patients in the combined eye-hand delayed task. There was a significant 
linear effect of disease stage on the disinhibited response rate of the eye (p < 0.001) and also 
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the hand (p < 0.001), suggesting that the proportion of disinhibited eye and hand responses 
increased with increasing disease stage in HD. There was a strong disease stage × time effect 
in eye movement disinhibition (χ2 = 13.4, p < 0.001) but this effect was not significant in the 
hand (χ2 = 6.2, p = 0.2). That is, there was a significant increase in disinhibition rate across 
disease stages in the eye but not the hand in HD in the follow-up session.   
 




Figure VI.8 Eye and hand latencies in the visually-guided reflexive task and delayed task. Filled circles are the 
LMEM-estimated group means and unfilled circles, mean latencies for individual subjects.  
 
Linear mixed effect models were fitted to eye and hand latencies of the visually-guided 
reflexive and of the delayed task to determine the differences in latencies across tasks and the 
effect of time on latency. In controls, eye and hand latencies were longer by 187 ms [95% CI: 
167 ms – 207 ms; p < 0.001] and 313 ms [95% CI: 270 ms – 356 ms; p < 0.001] respectively 







demonstrated similar profile of latency changes (Eye: Mean = 209 ms; 95% CI: 166 ms – 252 
ms; p < 0.001; Hand: Mean = 225; 95% CI: 185 ms – 264 ms; p < 0.001) in the delayed task as 
controls (Figure VI.8B) with the exception of a lesser increase in hand latency by 88 ms [95% 
CI: 29 ms – 146 ms; p = 0.004] than controls (Figure VI.8B). In general, there was an effect of 
time on eye latency across tasks, with an estimated increase of 19 ms in the follow-up session 
(p < 0.001). Such effect was however, not apparent in the hand (p = 0.1). 
 
VI.3B.3. Eye-hand latency interval: Delayed task vs. reflexive task 
A linear mixed effect model was fitted to eye-hand latency intervals (time intervals between 
the initiation of eye and hand movements when reaching for a target) in the visually-guided 
reflexive task and in the delayed task to assess the behavioural pattern of the two movements 
in different eye-hand tasks. 
 
In controls, eye-hand latency interval in the delayed task was larger than the reflexive task by 
76 ms [95% CI: 24 ms – 127 ms; p = 0.005]. By contrast, in the HD group, there was no 
significant increase in eye-hand latency interval in the delayed task, with the estimated eye-
hand difference in the delayed task likely being 3 ms [95% CI: -61 ms – 68 ms; p = 0.9] longer 
than the reflexive task (Figure VI.9).   
 
Figure VI.9 Differences in eye-hand latency intervals across tasks.   Filled circles are the LMEM-estimated group 
means and unfilled circles are means for individual subjects.  
 
There was an effect of time on eye-hand latency interval across tasks in controls, with an 
estimated increase of 104 ms [95% CI: 26 ms – 179 ms; p = 0.007] in the delayed task over the 
change in the reflexive task in the follow-up session (Figure VI.9). This effect was however, 
not apparent in the HD group as there was likely only a small increase of 25 ms [95% CI: -66 
Task 
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ms – 117 ms; p = 0.6] in eye-hand latency interval in the delayed task over the change in the 
reflexive task at follow-up.    
 
VI.3B.4. Clinical correlates of eye-hand parameters in the delayed task  
Simple correlations were used to determine if eye-hand coordination performance is associated 
with changes in motor and cognitive functioning of HD patients.  
 
Figure VI.11 Correlations between disinhibited response rates in the eye-hand delayed task, and UHDRS motor 
scores, and working memory domain z-scores in the HD group.  r [95% CIs] and p values are shown. 
 
Disinhibited response rates of the eye showed strong positive correlations (p < 0.001) with 
UHDRS motor scores and strong negative correlations (p < 0.001) with working memory 
domain scores of HD patients (Figure VI.11), indicating that higher proportions of disinhibited 
eye responses are associated with higher motor scores and lower scores of working memory 
domain. In contrast to the disinhibited response rates of the eye, there was a much smaller range 
of disinhibited hand response rates. The disinhibited hand response rates showed moderation 
correlations to the two clinical measures of HD (Figure VI.11).  
 
Mean latencies of correct eye and hand responses showed statistically significant positive 
correlations to UHDRS motor scores (Figure V.12, p < 0.001) and not working memory domain 
scores (p = 0.2). This provides the impression that an increase in eye and hand latencies in the 
delayed task is associated with an increase of motor scores only.  
 
r = 0.8 [0.5 – 0.8], p < 0.001 r = -0.7 [-0.9 – -0.3], p < 0.001 




Figure VI.12 Correlations between mean latencies of correct responses in the eye-hand delayed task, and UHDRS 




VI.4.  Discussion  
The present study provided novel findings on 12 month longitudinal changes in manifest HD 
in three types of complex movement task – delayed, memory-guided, and anti-saccade tasks – 
and also the relationships between eye-hand measurements in complex tasks and disease status 
of HD patients. The key findings in this section were: (1) HD patients, irrespective of disease 
stage, had an increased saccade disinhibition in all three saccade-only complex tasks, whereas 
impairment of anti-saccade error correction was only evident in advanced HD; (2) The HD 
group, relative to controls, had a prolonged latency for initiating complex volitional saccades; 
(3) Saccade inhibition (but not saccadic latency) was in general associated with clinical severity 
of HD patients, as measured using the UHDRS motor component and working memory domain 
testing; (4) Despite there was a reduction in saccade disinhibition in controls at follow-up, the 
proportion of disinhibited saccades in the HD group was relatively unchanged. The HD group, 
unlike controls who showed minimal 12 month changes in saccade latency across tasks, 
demonstrated an increase in latency in the memory-guided and anti-saccade tasks at follow-up; 
and (5) In terms of eye-hand movement measurements, the HD group had higher proportions 
of disinhibited eye and hand response than controls at baseline but there was only an overt 
increase in eye movement disinhibition in the follow-up session.  
r = 0.5 [0.1 – 0.8], p = 0.03 r = -0.3 [-0.6 – 0.2], p = 0.2 
r = 0.5 [0.1 – 0.8], p = 0.02 r = -0.3 [-0.6 – 0.1], p = 0.2 
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VI.4A. Complex volitional saccades (Delayed, memory-guided, and anti-saccades) 
VI.4A.1. Saccadic performance in complex tasks 
The findings in this study (refer Figure VI.1) were consistent with previous studies which 
demonstrated that in HD, there is increased saccade disinhibition in complex tasks (Lasker & 
Zee, 1997; Lasker et al., 1987; Tabrizi et al., 2009). It is well-established that the frontal cortex 
and the basal ganglia, via their direct projections to the superior colliculus, contribute to the 
planning and generation of volitional saccades (Hikosaka et al., 2000; McDowell et al., 2008; 
Pierrot-Deseilligny et al., 2004; Pierrot-Deseilligny et al., 2005). An increase in saccade 
disinhibition in HD is therefore posited to be associated with neurodegenerative changes in the 
indirect pathway of the basal ganglia and also degeneration of the frontal cortex, which in 
combination results in an impairment in saccadic activity control by the superior colliculus 
(Lasker & Zee, 1997; Lasker et al., 1987). In addition to increased saccade disinhibition, the 
present study showed that saccade disinhibition increased with worsening of UHDRS motor 
scores and working memory domain scores, and an increase in disease stage (refer Figure VI.1). 
Given that there were close associations between saccade disinhibition and clinical progression 
in HD, findings from the present study reaffirm the hypothesis from previous studies that 
performance in volitional saccades can potentially be a marker of disease progression in HD 
(Blekher et al., 2009a; Blekher et al., 2004; Turner et al., 2011).  
 
However, it can be argued that the increased saccade disinhibition in the HD group may simply 
indicate the failure of HD patients to understand the task demands of the complex movement 
tasks. The present study provided evidence to refute such an argument. Subjects were given 
practice trials for each of the complex task to gauge their understanding of the tasks and actual 
trials were initiated only if they were able to perform the task during the practice trials. All 
subjects showed that they were capable of performing all three complex saccade tasks during 
practice trials.  
 
The current study also revealed that in manifest HD, there was an inverse relationship between 
corrected pro-saccade errors and disease stage, such that the proportion of corrected errors 
declined with an increase in disease stage. Two processes – failure of inhibition (termed as 
‘weakness in the fixation control system’ in several previous studies) and deficits in working 
memory function – have been linked to cause pro-saccade errors (corrected and uncorrected) in 
an anti-saccade task (Barton et al., 2008; Bowling et al., 2012; Unsworth et al., 2011). As 
discussed above, the main trigger for corrected and uncorrected errors is a failure of the 
movement gating mechanism in the basal ganglia, which results in the impairment of movement 
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inhibition. However, intact working memory functioning, which is responsible for maintaining 
task goals, facilitates rapid correction of errors (Bowling et al., 2012). Uncorrected errors are 
closely associated with the level of cognition and are primarily caused by the failure to maintain 
the task goal in working memory (Fischer et al., 2000). In line with this argument is that 
uncorrected errors are commonly observed in individuals with dementing conditions or with 
frontal lobe lesions (Bowling et al., 2012).  
 
Taken together, it can therefore be concluded that in early HD, the high proportion of corrected 
errors is driven primarily by weakness in the basal ganglia movement inhibitory network. On 
the other hand, an increase in uncorrected errors in higher disease stages is linked to a decline 
in working memory capacity. These findings are consistent with the underlying pathological 
changes in HD. In early HD, there is selective degeneration of the indirect pathway of the basal 
ganglia (Albin et al., 1992; Glass et al., 2000; Reiner et al., 1988). This results in an increased 
GPe inhibition on downstream structures, and in turn leads to a reduction of inhibitory signals 
from the SNr to the saccade generating neurons in the superior colliculus (Galvan et al., 2012). 
An outcome of this cascade of events is a generalised impairment of the movement gating 
mechanism of the basal ganglia, which in this study, translated to increased saccade 
disinhibition. However, the relative preservation of working memory function in early HD 
(Papoutsi et al., 2014; Scheller et al., 2014) enabled the task goal to be maintained in working 
memory and thus, most errors were corrected in early disease stages (refer Figure VI.1). The 
progressive deterioration in cognitive functioning in HD (Lemiere et al., 2004; Peavy et al., 
2010; Stout et al., 2012) would eventually lead to an impairment in working memory function, 
and hence, a decrease in corrected errors in patients in the highest disease stage (Figure VI.1). 
However, it is worth noting that in the HD group, the decline in the proportion of corrected pro-
saccade errors was not in tandem with the decline in working memory function score (Figure 
VI.4B). That is, there was an overt decline in corrected pro-saccade errors only in participants 
having the lowest working memory scores. This suggests that the ability to correct pro-saccade 
errors, though influenced by working memory capacity, appeared to be maintained in the HD 
group until there was a severe impairment in the working memory function.  
 
Previous studies attributed the high saccade disinhibition in HD to a deficit in the fixation 
control system (Bollen et al., 1986; Lasker et al., 1987; Rubin et al., 1993). In the present study, 
fixation control in HD was assessed in the memory-guided tasks, which comprised of trials with 
varying-duration fixation intervals (1500 ms, 2000 ms, and 2500 ms). The HD group, despite 
having higher proportions of disinhibited saccade than controls at peripheral target offset, 
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demonstrated a similar increase in the proportions of disinhibited saccade during the fixation 
interval (i.e. from peripheral target offset to fixation target offset) to controls in all three fixation 
intervals. As proposed by Munoz et al. (2003), there are two components – exogenous and 
endogenous – in the control of fixation. In exogenous control of fixation, the presence of an 
exogenous fixation target leads to a greater activation of fixation neurons and concurrently the 
inhibition of saccade generating neurons in the superior colliculus and FEF. Given that the 
fixation target was illuminated throughout the fixation period in the memory-guided task, it can 
be concluded that exogenous control of fixation is preserved in manifest HD. The dlPFC and 
the SNr, which have direct inhibitory influence on saccade generating neurons in the superior 
colliculus and FEF (Hikosaka & Wurtz, 1983), are the two key neural structures implicated in 
the endogenous control of fixation (Funahashi et al., 1993; Hikosaka & Wurtz, 1983). In HD, 
impairment in the indirect pathway of the basal ganglia (Galvan et al., 2012) and progressive 
thinning of the dlPFC (Rosas et al., 2002; Selemon et al., 2004; Sotrel et al., 1991) may disrupt 
the neurophysiology of the SNr and dlPFC, and subsequently result in a deficit in endogenous 
control of fixation. The fixation control system may well have a role in saccade inhibition. 
However, the relative preservation of exogenous fixation control in manifest HD suggests that 
increased saccade disinhibition in HD is not a generalised failure of the fixation control system 
per se but rather a poor control over the endogenous component of fixation, caused by a 
dysfunctional frontal-striatal network.  
 
In summary, in early HD, high saccade disinhibition, with a correction rate that was comparable 
to controls, is suggestive of a weakness in saccade inhibition, caused by a failure in the basal 
ganglia movement gating mechanism. However, as disease progresses, there is progressive 
decline in cognitive functioning, which consequently affects the cognitive aspect of movement 
control, especially the task goal maintenance aspect of working memory function, resulting in 
high proportion of uncorrected errors in the anti-saccade task in advanced HD.  
 
VI.4A.2. 12 month changes in saccade disinhibition in complex tasks 
The 12 month data in the volitional saccade tasks of the present study confirmed and extended 
the finding of a multi-modality study that investigated longitudinal changes of various potential 
disease markers in premanifest and early HD (Tabrizi et al., 2010). The Tabrizi et al. study, 
which assessed only the proportions of disinhibited saccade in the anti-saccade task, showed 
that there were minimal changes in premanifest and early HD in terms of the proportions of 
disinhibited saccade after 12 months and hence suggested that there was no apparent worsening 
of saccade disinhibition in these sub-groups of HD patients over time. In spite of a step-wise 
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increase in saccade disinhibition with increasing disease severity in HD in the anti-saccade task 
at baseline (refer Figure VI.1), the present study demonstrated that there was relatively no 
change in saccade disinhibition in the delayed and memory-guided tasks at 12 month visit. One 
postulation for these contrasting results, albeit unlikely, is that there are negligible 
neuropathological changes in HD over a short time interval of 12 months. A more compelling 
explanation for this would be that saccade disinhibition does deteriorate with disease 
progression in HD, but a measurement of saccade disinhibition is not sensitive to short-term 
disease changes, such as over 12 months. Nevertheless, the lack of 12 month changes in saccade 
disinhibition would certainly limit the utility of this measure as a potential short-term 
progression marker or pharmacodynamics marker for HD.   
 
Another possible explanation for the minimal change in saccade disinhibition is that neural 
plasticity could have temporarily compensated for short-term neuroanatomical degeneration 
changes in HD. A study on brain activity during performance monitoring showed that in 
patients with basal ganglia and cortical lesions, despite the abnormal electrophysiological 
findings, these patients were still capable of monitoring their performance level (Ullsperger & 
von Cramon, 2006). A functional MRI (fMRI) study reported that in Tourette’s syndrome, a 
disease that is caused by abnormalities in the fronto-striatal circuits, normal performance in 
self-regulatory tasks was achieved by increasing the activation of fronto-striatal circuits (Marsh 
et al., 2009). It was also shown that neural circuits within the motor cortex can be modified by 
corticostriatal signals to facilitate movement control (Nudo et al., 1996). Together, these 
findings indicate that brain plasticity may potentially have subserved short-term compensatory 
mechanisms to counteract for the neuropathological damages in HD. One implication of this 
argument is that short-term disease changes in HD, at least over a 12 month period, may not be 
reflected in changes in the saccade disinhibition in the complex movement tasks.  
 
An interesting finding revealed in this study was that, in contrast to the HD group (which had 
relatively no change in saccade disinhibition after 12 months) the control group demonstrated 
significant improvement – i.e. decline – in saccade disinhibition over time. Earlier studies have 
revealed that cognitive strategies and experience can influence eye movement performance 
(Nodine et al., 1996; Yarbus, 1967). As described in a review by Schall et al. (1999), visual 
strategies, which can be influenced with prior training, can modify the neural selection process 
in the FEF during a visual search task. The authors based their hypothesis on a report that 
macaques, previously trained to ignore a distractor by exposing a specific type of visual search 
array, could suppress the activation of visually-guided cells in the FEF to the learned distractor 
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(Schall & Thompson, 1999). The authors further posited that the ability to alter the efficacy of 
inter-synaptic communications in the brain is likely the key neural mechanism in the 
modulation of neural selection process in the FEF (Schall & Thompson, 1999). Based on their 
findings, it can be implied that in the present study, controls had in general developed effective 
visual strategies on repeated testing of the same volitional saccade tasks, resulting in an 
improvement in their performance in those tasks. Several imaging studies showed that 
degenerative changes in the connectivity and structural integrity of white matter in various 
regions of the brain, which are evident in premanifest HD, continue to occur in manifest HD 
(Novak et al., 2014; Poudel et al., 2014; Rosas et al., 2010). Abnormalities in the connectivity 
and structural integrity of the white matter networks may interfere with the selection processes 
in the FEF and thus, affecting the ability of HD patients to develop effective visual strategies 
to improve their performance in saccade inhibition in the follow-up session.  
 
Although saccadic performance in complex volitional tasks deteriorated as clinical severity 
worsened on cross-sectional analyses, longitudinal changes in complex volitional saccades may 
assume a slow course, and not be revealed over the relatively short period of 12 months. The 
involvement of various cognitive and sensorimotor processes in the generation of complex 
volitional saccades, the heterogeneous nature of neurodegeneration in HD, and also short-term 
neurophysiological compensations, may have implications for the utility of behavioural 
performance for monitoring disease progression in HD, especially over short time intervals.  
However, these inferences are made in the absence of neurophysiological and imaging studies 
comparing complex volitional saccade performance and brain activity in HD patients. Studies 
with parallel approaches – i.e. concurrent saccade and neural activity measurements, and brain 
imaging – may enlighten the understanding of short-term disease changes in HD and also their 
effects on the performance in complex volitional saccade.   
 
VI.4A.3. Saccadic latency in complex tasks 
The present study extended previous ones (Becker et al., 2009; Lasker et al., 1987) that have 
investigated the latency of correct saccadic responses in complex tasks. A major distinction 
between this study and previous ones was that here, mean latencies for complex saccades in the 
HD group [memory-guided saccade mean = 384 ms; anti-saccade mean = 376 ms] appeared to 
be shorter than in previous studies [memory-guided saccade mean = 491 ms (Lasker et al., 
1987) ; anti-saccade mean = 461 ms (Becker et al., 2009)]. This disparity in mean latencies 
could be attributed to experimental design and technical variations in eye movement assessment 
between studies. Nevertheless, the present study revealed that similar to controls, there was a 
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task effect in saccade latency in complex movement tasks in the HD group. That is, latencies 
for complex volitional saccades were significantly longer than visually-guided saccades. The 
longer latencies in complex volitional saccades represent the additional time taken to modify 
the neural activity in the basic saccade circuitry and also to recruit additional cortical regions 
which are generally in idle mode during reflexive saccade execution (Everling & Fischer, 1998; 
McDowell et al., 2008; Sweeney et al., 2007). In contrast to controls, who demonstrated 
minimal change in latencies of complex volitional saccades over time, the HD group had 
significant prolongation in latencies in the memory-guided and anti-saccade tasks after 12 
months. This suggests that a measurement of complex saccade latencies might be a sensitive 
marker of disease progression in manifest HD over a relatively short time interval.  
 
In the current study, it was found that latencies of corrected pro-saccade errors in the anti-
saccade task were significantly correlated with the UHDRS motor scores and working memory 
domain scores (Figure VI.5). As discussed in section VI.4A.1, uncorrected errors are caused by 
a failure in movement inhibition and also an impairment in working memory function. Given 
that the UHDRS motor component primarily provides an assessment of impairment in voluntary 
movement, this may explain the close association between latencies of corrected pro-saccade 
errors and UHDRS motor scores. Unsworth et al. (2004) posited that working memory capacity 
is reciprocally associated with disinhibition rates and latencies in an anti-saccade task because 
cognitive factors are the basis in the maintenance of task goals in complex tasks hence, the 
significant correlation between the latencies of corrected pro-saccade error and working 
memory capacity in manifest HD.  
 
It was also revealed in this study that the correlation of corrected pro-saccade error latency with 
the UHDRS motor score was actually stronger than with the working memory function score. 
This is perhaps linked to a two- step sequential process involved in the correction of pro-saccade 
errors. That is, the first step involves recognising the pro-saccade error via the working memory 
function and the second, relates to the saccadic system initiating the anti-saccade. Although the 
latency of corrected pro-saccade errors is likely an overall temporal representation of the two 
events – error recognition and anti-saccade initiation – in the two-step process, the motor 
component might contribute more than the cognitive component to the overall latency. 
Therefore, changes in the latency of corrected pro-saccade errors were more closely associated 
with changes in the UHDRS motor scores than the working memory function scores. This 
hypothesis can only be validated with electrophysiological data of the separate events, which 
were not measured in this study. The close associations between latency of corrected pro-
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saccade errors and cognitive and motor impairment in HD suggest that this measure is useful 
for reflecting patients’ current disease status and might potentially also be helpful for tracking 
longitudinal disease changes. However, the longitudinal utility of this measure could not be 
assessed because it was an additional parameter measured at 12 month follow-up, and not at 
baseline. An assessment of the utility of this measure as a biomarker of HD is definitely 
warranted in future studies.  
 
In the HD group, despite mean latencies of pro-saccade error correction in the anti-saccade task 
being well-correlated with two standard measures of disease status (UHDRS motor component 
and working memory domain testing), mean latencies of correct saccadic response in the three 
tasks showed poor correlations to UHDRS motor scores and also working memory domain 
scores (refer Figure VI.5). As described earlier, the control of complex volitional saccades 
consists of a multitude of complex motor and cognitive processes (McDowell et al., 2008). It is 
likely that in the control of correct complex volitional saccades, the motor and cognitive 
processes involved occur in parallel to one another. Thus, the latency of correct responses in a 
complex task is directly related to neither the severity of motor nor cognitive impairment in 
HD. It can be concluded that the latency of correct responses in complex tasks is not a sensitive 
indicator of the current disease status of HD patients. However, there is evidence of progression 
in the latency of complex volitional saccades (memory-guided and anti-saccades) over a brief 
interval of 12 months. This suggests that latency measurement in complex tasks may potentially 




VI.4B.  Eye-hand coordination in the delayed task 
VI.4B.1. Eye and hand movements in the delayed task 
The finding of a high eye movement disinhibition rate in the eye-hand delayed task 
complemented the finding in the saccade-only delayed task (refer section VI.3A.1). In HD, a 
higher hand movement disinhibition rate compared to controls (refer Figure VI.7), was in line 
with previous studies, in which it was shown that both premanifest and manifest HD had poorer 
upper limb somatomotor response inhibition compared to controls in masked prime responses 
(Aron et al., 2003) and ‘Go/ No go’ tasks (Beste et al., 2011; Beste et al., 2008; Beste et al., 
2010).  
 
It is well-established that the basal ganglia act as a gating mechanism to minimise the 
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interference of competing motor mechanisms during the execution of a desired movement 
(Mink, 2003). In an fMRI study by Aron and colleagues (2003), it was shown in healthy controls 
that there was a significant deactivation of the caudate and thalamus during response inhibition. 
Aron and colleagues (2003) suggested that the deactivation of the caudate and thalamus is 
consistent with an accepted model of the basal ganglia thalamocortical circuitry in which a 
reduction in neural activity within the caudate leads to a reduced suppression of the globus 
pallidus interna via the direct pathway and in turn results in an enhancement of inhibition on 
the thalamus. In HD, there is progressive degeneration of the striatum (Rosas et al., 2001; 
Vonsattel et al., 2011). Degenerative changes in the striatum may compromise the basal ganglia 
in suppressing unwanted saccadic and somatic movements alike, contributing to a generalised 
impairment of movement inhibition in HD, which in the present study results in an increase in 
disinhibition rates in the eye and hand. 
 
Another possible mechanism for the higher rate of somatic movement disinhibition in the 
delayed task in HD could be a deficit in information integration in the basal ganglia. Neural 
synchronisation processes are processes related to action selection and they are heavily 
dependent on the inter-connectivity of neurons (Kitano & Fukai, 2004; Lago-Fernandez et al., 
2001). It has been suggested that neurodegeneration in the striatum, which is evident even in 
premanifest HD (Tabrizi et al., 2009), has an impact on the functional connectivity of the striatal 
medium spiny neurons (Cepeda et al., 2007; Mitchell et al., 1999). In an EEG study, Beste et 
al. (2011) demonstrated that deficits in response inhibition in premanifest HD patients became 
progressively more apparent as the complexity of action selection increases. The authors 
attributed such findings to failure of a functionally-compromised striatum at integrating 
conflicting contextual information and sensory inputs to inhibit undesired responses. It may 
appear that there are two distinct mechanisms affecting somatic movement disinhibition in HD 
but these two processes are unlikely to be separable in a real life situation. This is because the 
basis of movement control that involves conditional responding (such as in the present study) 
is comprised of motor inhibition and also a cognitive component. Therefore, it may be posited 
that both impaired inhibition and impaired cognitive integration in the basal ganglia have roles 
in influencing movement inhibition in HD.  
 
The control of movement inhibition also involves the participation of various cortical structures, 
which provide cognitive influences upon the limb control system. In healthy controls, several 
fMRI studies have shown that there is concurrent activation of various cortical structures, such 
as the rostral supplementary motor area and the right inferior frontal gyrus, during response 
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inhibition (Aron & Poldrack, 2006; Rao et al., 2014). Further, these cortical structures were 
found on a diffusion tensor imaging study to be structurally connected to each other and also to 
the basal ganglia (Aron et al., 2007). Several theories of action control posited that the rostral 
supplementary motor area and the right inferior frontal gyrus have distinct roles in attentional 
monitoring and the preparation of inhibitory responses (Rushworth et al., 2004; Swann et al., 
2009; Swann et al., 2012). Therefore, it appears that the implementation of inhibitory control is 
dependent upon a concerted effort of basal ganglia and cortical structures, with different 
structures contributing to different aspects of movement inhibition control.  
 
In line with this, Rao and colleagues (2014) found in an fMRI study that, relative to controls, 
there was significant reduction in brain activation in various cortical inhibition centres, such as 
left angular/supra-marginal and right superior/middle temporal gyri, in premanifest HD during 
somatic movement inhibition. The authors also revealed that these changes were closely related 
to response inhibition in premanifest HD (Rao et al., 2014). In addition, other studies 
(Bartenstein et al., 1997; Beste et al., 2008) showed that in manifest HD, there was an 
association between a decline in movement inhibition and a decline in neural activity in the 
anterior cingulate cortex, a cortical area involved in rational cognitive function (Botvinick et 
al., 2004). Based on these findings, it can therefore be hypothesised that similar to saccade 
inhibition (refer section VI.4A.1), there are also two components – motor inhibition and task-
goal maintenance by working memory function – in somatic movement inhibition. Therefore, 
increased movement in inhibition in HD appears to be caused by two sources of error: (1) poor 
movement inhibition, an outcome of a deficit in movement gating mechanism in the basal 
ganglia; and (2) a decline in working memory capacity, which compromises task goal 
maintenance ability. Naturally, a question arising from such a hypothesis is which source of 
errors has a greater influence in causing somatic movement disinhibition in HD. Unfortunately, 
the measurement of movement disinhibition is the combined outcome of impairment in 
movement inhibition and impairment in cognitive integration. Thus, without 
neurophysiological data, it is difficult to determine if one mechanism contributes more than the 
other in causing movement disinhibition.  
 
It is clear that a decline in somatic movement disinhibition in HD is a consequence of 
impairment in motor and cognitive components of the limb control system caused by HD effects 
on subcortical and cortical structures. Therefore, a measurement of somatic movement 
inhibition may potentially be a useful HD global biomarker, i.e. it monitors the global changes 
in subcortical and cortical structures functioning in HD.  
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VI.4B.2. Differences in eye and hand movement disinhibition rates 
The current study extended the findings of previous studies, which investigated either only 
saccadic (Becker et al., 2009; Blekher et al., 2006; Tabrizi et al., 2009) or only somatomotor 
(Beste et al., 2011; Beste et al., 2008; Rao et al., 2014) movement in complex movement tasks, 
by comparing the behavioural performance of both eye and hand movements simultaneously in 
a complex (delayed) task. Intriguingly, relative to controls, who demonstrated minimal 
differences in movement disinhibition between the eye and hand movement in the delayed task, 
the HD group demonstrated a significantly higher disinhibition rate in the eye compared to the 
hand (refer Figure VI.7). An intuitive explanation of this finding was that there was a greater 
reliance on visual information for coordinating somatic movements in HD compared to 
controls. Indeed, this was demonstrated in a study by Georgiou and colleagues (1995), who 
found that a reduction in advanced visual information had an effect on motor performance in a 
sequential button-pressing task in manifest HD but not in controls. Similar findings of a greater 
reliance on visual information in somatomotor movement control were also reported in 
Parkinson’s disease, another degenerative disease of the basal ganglia (Georgiou et al., 1994; 
Jones et al., 1992), thus supporting the postulation that visual reliance is influenced by the 
overall integrity of basal ganglia. Basal ganglia and supplementary motor areas are integral in 
providing internal cues for the motor system especially during the execution of motor sequences 
(Brotchie et al., 1991a, 1991b). Georgiou et al. (1995) posited that in HD, degeneration of the 
basal ganglia and supplementary motor areas may affect the internal representation of 
movement and to overcome this, patients would have to constantly update the internal mapping 
system by using externally-derived information, i.e. visual information. This compensatory 
mechanism, likely to have developed to preserve somatomotor movement control, might lead 
to the eye being more susceptible to making a disinhibited response than the hand in manifest 
HD.  
 
The conventional concept of the basal ganglia-thalamocortical circuitry in the control of motor 
movement describes the basal ganglia as intermediaries for the cortical association areas, in 
which they integrate inputs from various cortical association areas to the motor cortex (Allen 
& Tsukahara, 1974). Subsequent physiological and anatomical evidence suggested that the 
basal ganglia-thalamocortical circuitry can be segregated into two distinct pathways, i.e. a 
‘motor’ loop, which transmits the influences from the sensorimotor cortex to the premotor 
areas, and an ‘association’ loop that projects influences of the association areas to the prefrontal 
cortex (Alexander et al., 1986). In addition to the two neural loops, Alexander et al. (1986) 
posited that there are additional circuits, one of them identified as the ‘oculomotor’ loop for the 
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control of eye movement, in the basal ganglia and all these neural circuits are organised in 
parallel with the ‘motor’ loop. The authors argued that the circuits are not completely separated 
per se, as the structures within the circuits may receive inputs and send outputs to the same 
cortical and subcortical structures but certain portions of each circuit engage with specific 
regions of the cortex or structures in the basal ganglia that are not shared by other circuits 
(Alexander et al., 1986). Their argument was supported by the findings in a later review by Joel 
et al. (1994). The key difference between ‘motor’ and ‘oculomotor’ loops is that the cortical 
terminus of the former circuit is the supplementary motor area (Kunzle, 1978) whereas the latter 
engages with the frontal and supplementary eye fields of the cortex (Kunzle, 1977). Due to the 
segregated functional pathways in the control of somatic and oculomotor movements, the 
presence of a significantly higher rate of disinhibited eye movement compared to the hand in 
the delayed task might indicate that the ‘oculomotor’ loop might be more susceptible to HD 
pathology than the ‘motor’ loop. 
 
 
The supplementary motor area and the supplementary eye field are part of the supplementary 
motor complex of the cortex and that the boundaries of the two areas are defined only in relative 
terms (Nachev et al., 2008). Further, it was found in a non-human primate study (Fujii et al., 
2002) that the supplementary eye field contains neurons involved in the control of saccades and 
also non-effector specific neurons that could influence hand movement in eye-hand coupled 
reaching tasks. These findings appear to refute the arguments that the ‘oculomotor’ and ‘motor’ 
loops are mutually exclusive and that HD pathology may have different effects on the two loops. 
Despite the findings in primates, human case reports suggest otherwise. In one case report, it 
was shown that a patient with a highly discrete lesion of the supplementary eye field showed 
great difficulty in learning to associate a novel stimulus and the required response in eye 
movement but not in somatomotor movement (Parton et al., 2007). It was demonstrated in 
another case report that a patient with a lesion of the pre-supplementary area, it was the hand 
movement rather than the eye that was affected (Nachev et al., 2007). These findings suggested 
that although there are no definitive boundaries between these subregions, they are functionally 
distinct from one another. Besides, the fact that there was evidence of a heterogeneous decline 
within the same gyrus in the cerebral cortex in manifest HD (Rosas et al., 2008), this indicates 
that the cortical terminus of the two basal-ganglia thalamocortical pathways, though located in 
close proximity to one another, might show heterogeneity in degenerative changes in HD. This 
might therefore translate to a disparity in movement disinhibition rate between the eye and the 
hand in manifest HD in the delayed task.   
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VI.4B.3. Differences in eye and hand movement latencies across tasks 
In healthy controls, eye and hand latencies increases in tandem with the complexity of the task 
(de Boer et al., 2013; Sailer et al., 2000). The delay in the initiation of the eye and hand 
movements in complex tasks is a representation, measured in time duration, of underlying 
synchronising processes involved in coordination the two movements (de Boer et al., 2013; 
Sailer et al., 2000). Given that movement synchronising might be a factor in delaying movement 
initiation, one might expect that HD patients would show a greater delay in movement initiation 
than controls. However, this was not supported by the findings in the present study, in which it 
was shown that in terms of the relative increase in eye and hand latencies from reflexive task 
to delayed task, there were minimal differences between the HD and control groups (Relative 
differences in latencies (ms) across tasks between the control and HD groups: Eye: 28 [95% 
CI: -38 – 95]; Hand: -49 [95% CI: -131 – 33]). That is, both groups demonstrated similar 
increase in eye and hand latencies across tasks. It is tempting to speculate based on this finding 
that the movement synchronising processing in HD is as efficient as in controls. However, there 
is evidence to discredit such an argument. Previous reports showed that HD had poorer 
performance in bimanual movements than in unimanual movement (Brown et al., 1993; 
Thompson et al., 2010). That is, HD patients had greater difficulty in performing a task with 
both hands simultaneously than with one hand. This suggests that there is indeed impairment 
in the automisation and synchronisation of movements in HD. The minimal difference in eye-
hand latency interval between groups may therefore be explained by the relative simplicity of 
the delayed task used in the current study which was not challenging enough to reveal deficits 
in movement automisation and synchronisation in manifest HD. This finding is undoubtedly 
going to limit the utility of eye-hand movement measurement in the delayed task as a potential 
progression marker in HD.  
 
It is well-established that human motor processes can be influenced by how the sensory 
information is perceived. Sensory information can lead to two potential outcomes: (1) provide 
triggers or guide an action; or (2) result in perception (Neumann, 1990). It was posited by 
Neuman that sensory information that is subconsciously perceived, can influence the motor 
system through a process called the ‘direct parameter specification’. That is, there are 
tendencies for the direct parameter specification mode of sensorimotor control, which are not 
under voluntary control, to partially activate the signal for motor responses. However, to 
prevent the activation of motor responses instigated by the direct parameter specification, an 
inhibitory process, called the ‘activation-followed-by-inhibition’ process would have to be 
activated to reverse this response tendencies (Eimer & Schlaghecken, 1998). Based on this 
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model of perceptuo-motor interactions, it could be posited that in the delayed task, although the 
participants were asked not to respond to the peripheral targets while the fixation target was 
illuminated, these targets would still be identified subconsciously by the sensory system. In 
order to maintain the behaviour in context (i.e. to maintain fixation at fixation target), the 
‘activation-followed-by-inhibition’ process would have to be activated to inhibit a response to 
the peripheral target. However, the main implication of this ‘activation-followed-by-inhibition’ 
process is that a longer reaction time is required for triggering a response that is already 
subjected to inhibition by the system (Eimer, 1999; Eimer & Schlaghecken, 1998). Hence, the 
prolongation of latencies in controls across tasks (visually-guided reflexive vs. delayed task) 
might conceivably reflect the extra time needed to terminate this ‘activation-followed-by-
inhibition’ process. As previously discussed in section VI.4A.1, response disinhibition is a 
hallmark of HD. Given this, it can be speculated that there might also be an impairment in the 
‘activation-by-inhibition’ process in HD, which inadvertently reduces the reaction time needed 
to trigger a response that was initially inhibited. It is possible that in the delayed task, the 
duration for movement synchronising in HD was indeed longer than controls. However, in the 
delayed task, the longer duration in movement synchronising might have been counteracted by 
the reduced reaction time for triggering a response that was initially inhibited. Hence, there 
were minimal between-group differences in the prolongation of eye and hand latencies across 
tasks.  
 
Another possible explanation for this finding might be related to HD pathology in the 
supplementary motor area. The supplementary motor area has been implicated to be involved 
in movement planning and the coordination of complex movements (Deiber et al., 1991; 
Halsband et al., 1993). Chen et al. (2010) suggested that the state of responsiveness in the motor 
system, which is constantly being adjusted by an internal control mechanism, is integral in 
determining the reaction time of any motor response. The authors provided evidence that the 
supplementary motor area, possibly together with an extended neural network, modulates the 
state of responsiveness by setting the response threshold in the primary motor cortex, which 
ultimately generate the output signals for movement initiation (Chen et al., 2010). Due to there 
being neurodegeneration of the supplementary motor area in manifest HD (Rosas et al., 2008), 
this may affect the level of motor readiness of the primary motor cortex resulting in 
bradykinesia in HD. Taken together, it could be proposed that slower reactions in the visually-
guided task in HD patients was contributed to by a reduced motor responsiveness. However, 
given that there were similar increase in latencies across tasks (visually-guided reflexive vs. 
delayed) between the two groups, this suggests that HD patients might be able to utilise the 
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delay in the delayed task to allow the disease-compromised supplementary motor cortex to 
elevate the level of motor readiness in the primary cortex to initiate the movement. Besides, it 
has been demonstrated by Phillips et al. (1994) that movement execution was relatively 
preserved in the presence of motor programming deficits in manifest HD. If this is proven to be 
true, this might potentially be useful in the management of motor symptoms in HD, in which 
patients might be able to capitalise on this effect to improve their motor performance in 
activities of daily life. That is, to overcome deficits in motor programming, HD patients can be 
taught specific motor training techniques to allow them to thoroughly plan the desired 
movement by focussing on the goal of the movement rather than the speed of movement 
initiation.  
 
Interestingly, the HD group, unlike controls who demonstrated longer eye-hand latency interval 
in the delayed task than in the visually-guided task, had minimal differences in the eye-hand 
latency intervals between the two tasks. Visuomotor control in human, which involves the 
intricate interactions of cognition, perception, and motor processes, is highly adaptable (Sims 
et al., 2011). In the present study, the finding of a longer time delay in hand movement initiation 
in the delayed task in controls corroborated previous studies that showed timings in eye and 
hand movement initiation vary according to the cognitive demand of the task involved 
(Deconinck et al., 2011; Land et al., 1999; Pelz et al., 2001). It was postulated that by prolonging 
the interval between the initiation of the eye and hand movements, this allows the visuomotor 
control system to plan a specific movement (Pelz et al., 2001). Besides, personal goals can 
influence the temporal sequentiality of movements (Wu et al., 2009; Yarbus, 1967). In the study 
by Wu et al. (2009), healthy controls were found to slow down the execution of movement 
sequences when accuracy in motor performance was awarded with incentives. This suggests 
that in the present study, the longer delay in hand movement initiation in the delayed task in 
controls is indicative of a greater demand for task accuracy, which may be lacking in the HD 
group. However, as task accuracy was not measured in the current study, there was no 
quantitative data to support this claim.  
 
On the other hand, the minimal change in eye-hand latency intervals across tasks in the HD 
group may reflect a deficit in the adaptability of visuomotor coupling in HD. Previous works 
have consistently reported that HD patients were found to have poor ability at developing 
movement strategies and manipulating hand forces based on task demands (Gordon et al., 2000; 
Quinn et al., 2001; Serrien et al., 2002). The integrity of white matter microstructure has been 
found to be crucial in the control of condition-based visuomotor somatic movement (Reuter-
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Lorenz & Stanczak, 2000; Sullivan & Pfefferbaum, 2006). In HD, there is evidence to support 
that white matter atrophy is linked to the disturbances in the white matter connections of the 
sensorimotor cortex (Dumas et al., 2012). A direct consequence of this is the interference in the 
control of condition-based visuomotor somatic movement, which sequentially restricts the 
ability of HD patients to efficiently adjust the underlying visuomotor control mechanisms for 
modifying visuomotor performance based on task demands. Hence, this may explain for the 
HD group having relative stable eye-hand latency intervals across tasks with different level of 
task demands in the present study.  
 
VI.4B.4. Clinical correlates of eye-hand movement parameters in the delayed 
task 
The strong correlation between UHDRS motor scores and eye movement disinhibition rates 
was in line with the current understanding that normal functioning of motor control centres is 
integral in the control of inhibition (Aron et al., 2003). However, a lower r value between motor 
scores and hand movement disinhibition rates in HD was likely to be contributed to by the 
restricted range of disinhibition rates in the hand compared to the eye. Response disinhibition 
rates of the eye and the hand in HD were found to be strongly correlated with the working 
memory domain scores, thus supporting the argument posited by McDowell et al. (2008) that 
working memory is required to maintain contextual cues in complex tasks. Response inhibition 
is often argued to be a component of executive function (Barkley, 1997; Miyake et al., 2000) 
but it has been demonstrated in a hypothetical model of cognitive processes that there is a close 
relationship between working memory and executive functions (Miyake & Shah, 1999). 
Nevertheless, these findings suggest that eye and hand movement disinhibition rates in general 
reflect patients’ current disease status, more specifically, the level of motor and cognitive 
impairment in HD patients.   
 
The present study also revealed that mean latencies of the two movements were significantly 
correlated with the UHDRS motor scores but not with the working memory domain scores. 
These findings are likely to be explained by the fact that bradykinesia is a direct effect of HD 
pathology on the motor system (Berardelli et al., 1999). In addition, the UHDRS motor score 
is a direct measure of voluntary movement capability in HD (Huntington Study Group, 1996), 
thus it is expected that the scores of such a measure would be closely associated with the 
latencies of the eye and the hand. Despite the moderately strong correlations between latencies 
and the clinical severity of motor impairment, there was large within-group variability in motor 
performance in manifest HD (refer Figure VI.12). Therefore, mean latencies may not 
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necessarily provide an accurate estimation of the level of motor and cognitive impairment in 
HD. Due to this, mean eye and hand latencies in a complex task might have limited utility as 
an assessment tool for determining the current disease status of HD patients. However, given 
that in HD, there is prolongation of eye and hand latencies over time, the measurement of eye 
and hand latencies may still be a valuable long-term progression marker for HD.  
 
In addition, the current study demonstrated that the time intervals between the initiation of eye 
and hand movements were weakly correlated with the working memory domain scores and the 
UHDRS motor scores. As discussed in sections VI.4B.1 to VI.4B.3, several factors – cognitive, 
motor, and motivational – are involved in the temporal sequencing of eye and hand movements 
in complex tasks. Hence, eye-hand latency interval is not a direct measure of either motor or 
cognitive impairment in HD.  
 
VI.4B.5. 12 month changes in eye and hand movements in the delayed task 
In terms of the 12 month longitudinal changes in eye and hand movements in the delayed task, 
controls had a significant improvement (i.e. reduction) in eye and hand disinhibition rates in 
the follow-up session. These findings support the earlier argument that after 12 months, controls 
might have developed effective strategies to improve movement inhibition on repeated testing 
of the same task (refer section VI.4A.2 for a detailed discussion). As stated earlier, motor 
performance can be influenced by individual goals and motivation (refer section VI.4B.3). 
These factors might have also contributed to a generalised improvement in movement inhibition 
in controls at 12 month follow-up. 
 
The present study also revealed that in HD, there was a significant worsening of movement 
inhibition control (i.e. an increase in movement disinhibition) in the eye but not the hand in the 
follow-up session. It could be argued that these findings contradict the finding of a relatively 
stable saccade disinhibition in the saccade-only delayed task at one year follow-up (refer section 
VI.3A.1). It could however, be posited that these findings are instead complementary to each 
other. As shown by Kloppel et al. (2009), there were minimal differences, in terms of motor 
performance in a paced button pressing task, between premanifest HD patients and controls. 
The authors attributed this to a complex pattern of motor compensation through the modulation 
of brain activity in various cortical regions. In an fMRI study, Wolf et al. (2008) found that in 
premanifest HD, the functional connectivity of the prefrontal cortex was abnormal when 
performing a task with high cognitive demand. The key difference between the saccade-only 
delayed task and the combined eye-hand delayed task was that the latter required the 
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participants to control eye movement in synchrony with the hand. As discussed before, the 
control of visuomotor somatic movement involves the interactions of multiple processes. 
Concurrent control of eye and hand movements might therefore imposed extra burden on the 
already compromised visuomotor control system in HD, resulting in a decline in task 
performance in the eye in the eye-hand delayed task but not in the saccade-only variants.  
 
Innate compensatory mechanisms, as discussed previously, might have protected the 
functionality of the saccadic system in complex tasks (refer section VI.4A.2) from short-term 
neurodegenerative changes in HD, when the system is operated in isolation. However, these 
mechanisms may be inefficient in supporting concurrent operations of multiple control systems 
(i.e. saccadic, somatomotor, and cognition). These findings have implications for short-term 
longitudinal research studies. Due to compensatory mechanisms, movement inhibition 
performance in saccade-only complex tasks of HD patients over short-time intervals might be 
relatively preserved when the oculomotor control system is operated in isolation. Therefore, to 
better highlight the underlying short-term changes in HD patients, it is recommended for short- 
to medium-term longitudinal studies to include motor tasks that involve simultaneous control 
of multiple motor and cognitive processes. It is also worth mentioning that there was a 
significant worsening of eye movement inhibition compared to the hand at fixation target offset 
in the delayed task at 12 month follow-up. This suggests that the oculomotor control system, 
comparatively, might be more susceptible to HD pathology than the somatomotor control 
system over a short-time interval.  
 
Interestingly, latencies of the eye and hand, and the temporal coordination of eye and hand 
movements (eye-hand latency interval) of HD patients in the delayed task were relatively stable 
after 12 months. There are several possible explanations for such findings. Rao et al. (2014) 
suggested that the successful implementation of somatomotor response inhibition is dependent 
on the interactions of the classic inhibition network, ventral attention network, and motor 
control system. The authors demonstrated that functional changes were observed in all three 
networks in premanifest HD. Although functional changes in the inhibitory control and the 
ventral attention networks were found to be associated with the level of genetic exposure of 
premanifest HD patients, reduction in the flexibility of the motor control network was not (Rao 
et al., 2014). Besides, neurodegenerative changes in the cortex of manifest HD patients were 
found to be regionally specific but heterogeneous (Rosas et al., 2002). Taken together, it can be 
postulated that the three neural networks, at least over a 12 month period, showed heterogeneity 
in longitudinal deterioration which likely results in a greater deterioration in the inhibitory 
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control and ventral attention networks than the motor control network over a short-time interval. 
Heterogeneity in the degenerative changes of the various neural networks may account for the 
mixed results of an overt decline in movement inhibition control and minimal changes in the 
kinematics of eye and hand movements in the delayed task at follow-up assessment.  
 
The effects of motor compensation might also have contributed to the relative stability of eye 
and hand movement latencies and of the temporal coupling of eye and hand movements in HD 
in the follow-up session. It is well-established that the human brain can potentiate compensatory 
mechanisms by recruiting additional brain areas when faced with cognitive challenges (Stern, 
2009). There is evidence to support that compensatory mechanisms can also be activated in the 
somatomotor control system. In HD, Bartenstein et al. (1997) demonstrated that there was 
enhanced activation of the parietal cortex of HD patients compared to controls when performing 
motor tasks. They found that patients with higher levels of parietal cortex activation had better 
performance than those with lower level of activation. Besides parietal cortex, increased 
activations in caudal and dorsal parts of the supplementary motor area were also observed in 
different HD stages (premanifest and manifest) and these changes in brain activation were 
postulated to contribute to the preservation of somatomotor performance in HD (Gavazzi et al., 
2007; Kloppel et al., 2009; Rao et al., 2014). These findings suggested that multiple 
compensatory mechanisms could be activated in HD to maintain motor performance of HD 
patients, leading to the relative stability of eye-hand movement performance in HD at 12 month 
follow-up. Although it has been claimed that motor compensation in HD is likely to weaken 
with disease progression (Beste et al., 2007; Rao et al., 2014), the presence of various 
compensatory mechanisms would undoubtedly pose a challenge to the utility of measured 
kinematics of eye-hand movement as progression or pharmacodynamics markers for HD, 
especially over a short follow-up period.  
 
In addition, it should be highlighted that measurement of hand movement latency is filled with 
difficulty because a simple reaching movement is a concerted effort of a variety of muscles in 
the upper limb and the trunk (Lacquaniti & Soechting, 1982) and also multiple factors may 
influence how the movement is performed (Georgopoulos, 1986). These factors may be 
significant confounders in recording of hand movement and may have an effect upon 12 month 
longitudinal changes on hand movement in HD patients and controls. A more accurate measure 
of latency would derive from rectified EMG activity recorded from agonist and antagonist 
muscles. These factors may not be as significant confounders in measurement of eye movement 
because of its relative simplicity, which is dictated by the reduced degrees of freedom to move 
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and also the relative inconsequentiality of the elastic force in the orbit compared with inertia in 
the hand.  
 
 
VI.5. Chapter summary 
Despite a strong disease-stage effect in saccade disinhibition and saccadic latency in the 
saccade-only complex tasks, there were measurable 12 month longitudinal changes in HD only 
in the latency of memory-guided saccades and of anti-saccades. Study findings were discussed 
in relation to the complexity of complex movement control, short-term neural compensation, 
and heterogeneity in longitudinal neural degenerative changes in HD.  
 
However, the present study revealed that there was significant worsening of inhibitory control 
(i.e. increase in movement disinhibition rate) in the eye and hand in the eye-hand delayed task 
after 12 months. These findings perhaps highlighted the inadequacy of short-term 
compensatory mechanisms for assisting an already disease-compromised motor control system 
in the concurrent operations of multiple motor and cognitive processes. Motor tasks that assess 
only a specific motor control system (e.g. oculomotor) might not be effective in detecting short-
term longitudinal disease changes in HD. Therefore, it is recommended for short- to medium- 
term longitudinal studies to include complex movement tasks that involve the simultaneous 
control of multiple motor systems.  
 
Minimal changes in the kinematics of the eye-hand movement in manifest HD over a 12 month 
period suggest that these measures might have limited utility for detecting short-term disease 
changes in HD and thus, not useful as short-term progression markers. However, given the 
progressive nature of eye and hand latencies, these measures may still be useful as long-term 
progression markers for HD. Nevertheless, further studies on the usefulness of complex eye-


















VII.1. Study highlights 
In this study, the utility of saccadic and eye-hand movement measures in detecting short-term 
disease progression in HD was evaluated, concurrently with existing standard disease 
measures. Novel findings on 12 month longitudinal changes in HD patients in saccadic and 
eye-hand measures, and also predictive behaviour of saccadic and eye-hand movements, were 
revealed. There were large effect sizes of HD on all of the cognitive measures, and saccadic 
and eye-hand parameters on cross-sectional analysis (i.e. baseline). The decline over 12 months 
in HD patients was confined to a more limited number of parameters, such as measurement of 
reflexive saccades and measurement of rhythmical eye and hand movements.  
 
VII.1.1. Cognitive, motor, and behavioural measures 
Table VII.1 provides a summary of the effect sizes (reported in Cohen’s d values) for between-
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group differences, relative changes in the HD group as compared to controls at 12 month 
follow-up, and 12 month within-HD group changes for cognitive, motor, and behavioural 
measures. On cognitive measures, those that assess executive function were the most sensitive 
to 12 month disease progression. That is, there is within-HD group and relative to controls 
decline at 12 month follow-up. Global cognition and the learning and memory domain 
meanwhile, showed modest deterioration only when compared to controls (i.e. there is a 
significant relative to controls decline but no significant within-HD group changes in score at 
12 month follow-up). The three brief cognitive tests (MMSE, MoCA, and the UHDRS 
cognitive component) were similarly useful in cross-sectional analysis but the UHDRS 
cognitive component was superior in documenting cognitive decline in HD over 12 months. 
Motor function, as measured using the UHDRS motor component, deteriorated over 12 months 
but no change was observed in most behavioural measures (except for the AES, in which there 
was a decline after 12 months).    
 
Table VII.1 Cohen’s d effect sizes for baseline difference and change at 12 month follow-up in cognitive, motor, 
and behavioural measures 
 Magnitude of Cohen’s d 
 HD vs. Control  HD 
Cognitive/ Motor/ Behavioural measures Baseline  
Relative change at  
12 month follow-up 
 
Within-group change at 
12 month follow-up 
Global cognition 2.4  0.2  0.02 
Executive function domain 2.7  0.2  0.2 
Working memory domain 1.8  0.1  0.09 
Processing speed domain 2.4  0.08  0.01 
Learning & memory domain 1.5  0.4  0.04 
Language domain 1.4  0.02  0.4 
Visuospatial domain 2.4  0.03  0.08 
MMSE 1.2  0.2  0.2 
MoCA 1.8  0.1  0.09 
UHDRS cognitive score 2.4  0.1  0.1 
UHDRS motor score -  -  0.4 
UHDRS behavioural measures -  -  0.04 
BAI 0.8  0.3  0.08 
BDI 1.0  0.003  0.1 
AES 1.6  0.4  0.6 
Legends: The magnitude of Cohen’s d and r effect sizes (Cohen, 1988) are colour-coded: (1) ‘green’ indicates a small effect size (0.2 ≤ d < 
0.5); (2) ‘blue’ indicates a medium effect size (0.5 ≤ d < 0.8); (3) ‘purple’ indicates a large effect size (0.8 ≤ d < 1.5); and (4) ‘red’ indicates a 
very large effect size (d ≥ 1.5). Parameters that were not assessed are marked with ‘-’. 
 
VII.1.2. Saccadic measures 
A summary of the effect sizes for baseline differences, relative changes in the HD group as 
compared to controls at 12 month follow-up and 12 month longitudinal changes in the HD 
group is shown in Table VII.2 together with the correlations (reported in r correlation 
coefficients) between saccadic parameters and clinical measures of disease status (cognitive 
scores and UHDRS motor scores). The HD group generally showed deficits in reflexive, 
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rhythmical (self-paced and temporally-cued), and complex volitional saccades. Most saccadic 
measures – especially rhythmical and complex saccades – showed strong correlations to the 
disease status of HD patients. However, only reflexive saccade measures showed overt 12 
month longitudinal changes (within-HD group and relative to controls decline) in the follow-
up session. One explanation for this is the superior within-group consistency and lower 
variability of measurements after 12 months in this relatively simple saccadic task compared to 
the more complex tasks, which require the involvement of multiple cognitive processes and 
various neural networks.  
 
Table VII.2 Cohen’s d effect sizes for baseline difference and relative change at 12 month follow-up, and of r 
effect sizes for clinical correlates of saccadic parameters 
 Cohen’s d   r 
 HD vs. Control  HD  Within-HD Correlation 
Saccadic measures Baseline  
Relative change at 
12 month follow-up  
Within-group change at 
12 month follow-up  Motor Cognition 
Reflexive (2D)         
Horizontal         
Latency 0.5  0.4  0.6  0.3 -0.4 
Peak velocity 0.4  0.4  0.4  -0.4 0.6 
Primary gain 0.4  0.5  0.5  -0.4 0.5 
Saccade count 1.1  0.002  0.02  - - 
Vertical         
Latency 0.7  0.1  0.6  0.5 -0.6 
Peak velocity 0.4  0.2  0.3  -0.4 0.5 
Primary gain 0.6  0.5  0.7  -0.3 0.4 
Saccade count 0.7  0.3  0.1  - - 
Rhythmical         
Self-paced         
Horizontal 2.0  0.01  0.04  -0.8 0.8 
Vertical 2.0  0.09  0.05  -0.8 0.8 
Temporally-cued         
Predictive saccade 1.9  0.07  0.3  - - 
Reduction in saccadic latency in the predictable 
phase  
1.8  0.2 
 0.3  
0.6 -0.4 
Complex         
Disinhibition rate         
Delayed 1.6  0.07  0.2  0.8 -0.6 
Memory-guided 1.8  0.3  0.04  0.7 -0.6 
Anti-saccade 2.0  0.2  0.02  0.7 -0.5 
Correction rate         
Anti-saccade 0.7  0.07  0.1  -0.4 0.8 
Latency: correct response         
Delayed 0.3  0.3  0.2  0.5 -0.2 
Memory-guided 0.6  0.5  0.6  0.3 0.03 
Anti-saccade 0.3  0.3  0.4  -0.09 0.2 
Legends: The magnitude of Cohen’s d and r effect sizes (Cohen, 1988) are colour-coded: (1) ‘green’ indicates a small effect size (0.2 ≤ d < 
0.5; 0.1 ≤ r < 0.3); (2) ‘blue’ indicates a medium effect size (0.5 ≤ d < 0.8; 0.3 ≤ r < 0.5); (3) ‘purple’ indicates a large effect size (0.8 ≤ d < 
1.5; 0.5 ≤ r < 0.8); and (4) ‘red’ indicates a very large effect size (d ≥ 1.5; r ≥ 0.8). Parameters that were not assessed are marked with ‘-’. 
 
VII.1.3. Eye-hand movement parameters 
Key findings (reported in Cohen’s d and r effect sizes) in eye-hand movement parameters are 
summarised in Table VII.3. One unexpected and particularly interesting finding was an 
 
174 
increased number of self-paced eye movements generated when eye movements were made 
concurrently with the hand (i.e. in the eye-hand self-paced task), in controls (saccade-only 
horizontal self-paced task: 64; eye-hand horizontal self-paced task: 80) and HD (saccade-only 
horizontal self-paced task: 35; eye-hand horizontal self-paced task: 50). The HD group, relative 
to controls, showed reduced predictive behaviour in oculomotor and somatomotor movements. 
Further, in HD, oculomotor prediction in the temporally-cued tasks was different when eye 
movements were performed in isolation (i.e. in the saccade-only variants) compared to when 
performed in synchrony with the hand (i.e. in the eye-hand variants). Despite a strong disease 
effect and correlations to disease status in most eye-hand measures on cross-sectional analysis, 
only self-paced rhythmical eye-hand movements and eye movement disinhibition rate in the 
eye-hand delayed task were sensitive to a 12 month progression.  
 
Table VII.3 Cohen’s d effect sizes for baseline difference and relative change at 12 month follow-up, and r effect 
sizes for clinical correlates of eye-hand movement parameters 
 Magnitude of Cohen’s d  Magnitude of r 
 HD vs. Control  HD  Within-HD Correlation 
Eye-hand movement measures Baseline  
Relative change at 
12 month follow-up  
Within-group change at 
12 month follow-up  Motor Cognition 
Reflexive movement         
Reaching: Latency         
Eye 1.2  0.07  0.5  0.5 -0.7 
Hand 1.4  0.1  0.2  0.5 -0.7 
Return: Latency         
Eye 1.5  0.05  0.07  0.5 -0.6 
Hand 1.4  0.07  0.2  0.2  -0.3 
Eye-hand latency interval         
Reaching 1.3  0.2  0.04  0.4 -0.6 
Return  0.5  0.03  0.2  0.09 -0.2 
Rhythmical movement         
Self-paced         
Eye: Horizontal 1.9  0.3  0.4  -0.8 0.7 
Eye: Vertical 1.9  0.3  0.4  -0.8 0.8 
Hand: Horizontal 1.9  0.3  0.5  -0.7 0.7 
Hand: Vertical 2.0  0.1  0.4  -0.8 0.8 
Temporally-cued         
Eye-hand latency interval 1.1  -  -  0.03 0.02 
Reduction in eye latency in the predictable phase 1.1  -  -  0.4 -0.5 
Reduction in hand latency in the predictable phase 1.0  -  -  0.3 -0.3 
Complex movement (Delayed)         
Disinhibition rate         
Eye 1.3  0.5  0.3  0.8 -0.7 
Hand 0.7  0.3  0.3  0.4 -0.6 
Latency         
Eye 0.2  0.06  0.2  0.5 -0.3 
Hand 0.5  0.3  0.07  0.5 -0.3 
Legends: The magnitude of Cohen’s d and r effect sizes (Cohen, 1988) are colour-coded: (1) ‘green’ indicates a small effect size (0.2 ≤ d < 
0.5; 0.1 ≤ r < 0.3); (2) ‘blue’ indicates a medium effect size (0.5 ≤ d < 0.8; 0.3 ≤ r < 0.5); (3) ‘purple’ indicates a large effect size (0.8 ≤ d < 
1.5; 0.5 ≤ r < 0.8); and (4) ‘red’ indicates a very large effect size (d ≥ 1.5; r ≥ 0.8).  Parameters that were not assessed are marked with ‘-’. 
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VII.2. Study implications 
Findings in this study have implications for longitudinal clinical research HD studies, especially 
those of short- to medium-term, and also for clinical practice.  
 
VII.2.1.  Cognitive measures and UHDRS 
There was clear evidence in the control group of some practice effects on repeated assessment 
of cognitive tests. Such practice effects have implications for comparative assessments of a HD 
group. The conclusions from repeat-testing of the HD group alone would have been different 
(i.e. an apparently lower degree of deterioration over 12 months) if there had been no control 
group. It is therefore, important to include a control group in short- to medium-term longitudinal 
HD research studies involving cognitive measures to assess longitudinal changes in cognition 
in manifest HD.  
 
In line with previous studies (Bachoud-Levi et al., 2001; Snowden et al., 2001), the executive 
function domain was found to be the most sensitive cognitive domain to short-term (i.e. 12 
month) longitudinal decline in HD. This finding implies that cognitive function monitoring of 
HD in health care settings – especially during routine clinic follow-ups – should emphasize, or 
at minimum include, testing of executive function. Further, the results of the study suggest that 
the UHDRS cognitive component is the most appropriate brief assessment tool – superior to 
the MoCA and MMSE – for monitoring 12 month cognitive changes of HD patients in the 
clinic. Although the UHDRS has been criticized for its subjectivity (Weir et al., 2011), data 
from the present study indicates that its motor and cognitive components are actually sensitive 
tools for demonstrating disease progression in the short-term. This reaffirms the utility of the 
UHDRS, especially the motor and cognitive components, as useful markers of progression in 
HD, at least over a short follow-up interval of 12 months.   
 
VII.2.2.  Measurement of reflexive movements 
Based on the results herein, the measurement of reflexive saccades, especially in a 2D 
(horizontal and vertical) task, may provide an objective and sensitive marker for detecting and 
tracking longitudinal HD disease changes in research and clinical treatment trials. Given the 
magnitude of 12 month longitudinal changes in reflexive saccades was unlikely to be detected 
through conventional clinical examination, the utility of this disease monitoring technique in 
clinics is debatable. It is however, noteworthy to mention that a portable eye-tracking system 
like the saccadometer, which is capable of providing automated and immediate analysis of 
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saccade measurements, is commercially available, suggesting that saccade measurement can be 
easily translated for use in clinics. In addition, the saccadometer was found to be a reliable tool 
for saccade measurement in HD (Turner et al., 2011).  
 
VII.2.3.  Measurement of rhythmical movements 
There was a strong disease stage effect on the number of self-paced saccades. That is, self-
paced saccade performance diminished with increasing clinical severity. This indicates that this 
eye movement measure might be the most useful saccadic markers for objective assessment of 
disease status. The absence of significant deterioration in self-paced saccade generation after 
12 months suggests, however, that this measure is not a sensitive marker of short-term disease 
progression in HD.  
 
There was a significant 12 month decline in self-paced rhythmical eye-hand performance in the 
HD group. This underscores the proposal that simple movement tasks (such as this) might be 
better for monitoring HD progression than tasks involving complex movement (Collins et al., 
2014). The results indicate that the measurement of self-paced eye-hand movement would be 
very appropriate for objectively measuring HD motor status and short- to medium-term 
progression in clinical research and treatment trials. In the temporally-cued tasks, there were 
differences in the predictive control of eye movement, both when performed in isolation 
(saccade-only) and when executed in combination with hand movement. The HD group did not 
reduce saccadic latency as much as controls in the predictable phase, indicating that in HD, 
there is impairment (though not abolition) of predictive mechanisms, as noted by Tian et al. 
(1991).  
 
VII.2.4.  Measurement of complex movements 
The application of cognitive strategies by controls might have led to their improvement in 
saccade inhibition in complex volitional saccade tasks at 12 month follow-up. Similar to 
cognitive testing, this had implications for the comparative assessment of the HD group. 
Therefore, with the measurement of saccade disinhibition as a measure of disease progression, 
it is essential to include a control group especially in short- to medium-term longitudinal HD 
research studies. Another interesting finding in complex saccades was that there was overt 
longitudinal increase in latency in HD over 12 months, suggesting that the measurement of 
complex saccade latency is potentially useful for tracking disease changes in HD. Nevertheless, 
a recommendation for this measure should be reserved until a longitudinal study with larger 
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sample size and longer follow-up interval is conducted to further assess the utility of this 
measurement.     
 
In the delayed task, there was a significant deterioration in eye movement inhibition in the eye-
hand, but not the saccade-only, variants of the task. These findings have implications for the 
longitudinal assessment of changes in behavioural performance of HD patients, such that the 
assessment of a specific movement in isolation in a task may not provide the full picture of the 
underlying pathological effect in HD, and that more ‘naturalistic’ paradigms combining eye 
and hand movements may be more rewarding. These findings highlight one unique strength of 
the present study; that is, it involved the investigation of eye movement performance in both 
saccade-only and eye-hand variants of both simple and complex movement tasks. 
 
There is currently insufficient evidence to support the use of physical therapies for improving 
motor performance of HD patients (Bilney et al., 2003). However, the results herein, showing 
differences in oculomotor prediction between the saccade-only and eye-hand variants of the 
temporally-cued tasks, suggest that it might be productive to explore whether one could induce 
positive transference of movement performance (e.g. movement prediction) from the combined 
eye-hand task to the saccade-only task with repetitive training in HD. A positive finding might 
open up a novel therapeutic avenue for improving motor performance in HD.  
 
VII.2.5.  An emerging theme from this study 
The present study has revealed that though performance in complex movement tasks is 
significantly associated with the disease status of patients, many of these tasks did not appear 
to be sensitive in tracking or detecting short-term longitudinal disease changes in manifest HD. 
By contrast, there were quantifiable longitudinal changes over a 12 month period in simple 
movement tasks, such as reflexive saccades and rhythmical eye-hand movement. It is clear that 
there is an emerging theme from this study. That is, contrary to the belief that “complex might 
be better”, simple movement measurements may potentially have greater as progression 
biomarkers for HD, especially for short-term disease monitoring.  
 
As discussed in previous chapters, complex movement control often comprises of: (1) a motor 
component, that controls movement inhibition and initiation; and (2) a cognitive component, 
that provides cognitive influences, such as task-goal maintenance and prediction. These 
components are regulated by various subcortical structures and higher cortical centres in the 
central nervous system. The commonly used measurements in complex movement tasks, such 
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as disinhibition rate and latency of correct responses, are the combined outcomes of all the 
components in the complex movement control system. Without supporting neurophysiological 
data, it is difficult to determine if one component plays a greater role than another in influencing 
the control system. 
  
In HD, there is heterogeneity in the longitudinal progression of structural pathology, i.e. one 
neural structure may not degenerate at the same rate as another over time. This may 
inadvertently result in an unsynchronised decline in the functioning of the different components 
involved in the control of complex movement. In addition, the human brain is capable of neural 
compensation. Therefore, it can be hypothesised that a deficit in one component, e.g. the motor 
component in the complex movement control system, might be counteracted, albeit 
temporarily, by the cognitive component, thus resulting in no measurable changes in complex 
movements over a short 12 month follow-up period.  In line with this, the present study found 
overt changes in UHDRS motor scores in the presence of subtle changes in global cognition in 
the HD group at 12 month follow-up. This reaffirms the hypothesis that in manifest HD, motor 
function declines at a faster rate than global cognition over 12 months.  
 
By contrast, the control systems for simple movements and rhythmical movements are usually 
dependent on the motor component only and involve less active participation of the cognitive 
component. It is likely that due to the relative simplicity of the simple movement control 
system, it is more susceptible to HD effects (because there is perhaps less involvement of 
compensatory mechanisms than the complex movement control system) over a short period of 
time and hence the measurable changes in simple movements at 12 month follow-up. Despite 
this, one should not consider the measurement of complex movement as obsolete. This is 
because the effect of neural compensation is not permanent and, with time, a decline in 
cognition will eventually lead to the collapse of such compensatory mechanisms (Papoutsi et 
al., 2014) and subsequently a measurable performance decline in complex movement.  
 
Based on these findings, it can therefore be hypothesised that the measurements of simple 
movement and complex movement have different utility in monitoring disease progression in 
HD. Simple movement measurement that appears to be more susceptible to short-term HD 
effects, may potentially be a sensitive progression marker for HD. By contrast, there are motor 
and cognitive components to the control of complex movement, and thus measurement of 
complex movement may be a useful global marker (i.e. provides an overview of global disease 
changes) for HD in long-term disease monitoring.   
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VII.3. Study limitations 
The relatively small sample size is a key limitation of this study. I initially intended to have at 
least 25 HD patients but due to the limited patient population in the Canterbury region of New 
Zealand and that many potential patients failed to meet the inclusion criteria, only 22 patients 
were recruited. Nevertheless, the study was still able to demonstrate significant disease effects 
at baseline and also 12 month changes in the HD group in a majority of the measures evaluated. 
It is both a strength and weakness of this study that patients at various stages of HD were 
included. Whilst on one hand, this allowed disease stage-specific analyses to be performed, it 
also resulted in an increased variance in the HD group, weakening the statistical power of the 
study and increasing the chance of Type II errors (i.e. failing to reject the null hypothesis when 
it was not true).  
 
Normal aging effects are unlikely to be a contributing factor for the decline in performance in 
the control group, especially when the follow-up interval was just 12 months. It is often 
suggested that ‘healthy’ controls may not always be completely normal as hoped for, which can 
affect the interpretation of results in the patient group. The main criterion used for control 
selection was the absence of neurological disorder on recruitment. Cardiovascular status and 
other medical problems, such as musculoskeletal disorders, were not considered during 
selection process and may have affected the motor performance of controls. This may have led 
to unexpected deterioration in certain measures (particularly in reflexive eye-hand movement). 
A more stringent protocol for health evaluation in controls might reduce such confounding 
factors.  
 
The loss of 12 month data in the temporally-cued eye-hand movement task, due to an 
unforeseen software error, prevented the determination of the utility of this measure in 
monitoring changes over 12 months. It would also have been desirable to assess eye-hand 
movement in the memory-guided and anti-saccade/reaching tasks but these were not included 
due to time constraints for the patients (i.e. so as to avoid excessive participant fatigue). Finally, 
from a statistical point of view, it would have been better to counterbalance the order of the 
four ISI trial blocks in the temporally-cued tasks to minimize ‘order effect’ but at least this was 
consistent across both patient and control groups.  
 
The measurement of hand latency is undoubtedly fraught with difficulty and multiple 
confounders may have interfered with data interpretation. A more accurate measure of hand 
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latency would derive from a measurement of rectified EMG activity in the agonist and 
antagonist muscles involved in reaching movements. This is not as significant a confounder in 
eye movement recording, as eye movement is relatively simple, due to the reduced degrees of 
freedom to move and also relative inconsequentiality of the elastic force in the orbit as 
compared to the inertia of the hand.   
 
 
VII.4. Recommendations for future research 
This study has established a strong foundation for the utility of cognitive, saccadic, and eye-
hand movement measures for monitoring 12 month changes in HD patients. A more extended 
longitudinal assessment would be warranted to characterize the medium- and long-term 
changes of these measures over a more prolonged follow-up period. A larger sample, with 
patients of various HD stages (premanifest and manifest), would enable wider inferences of the 
longitudinal changes of the various measures evaluated in the present study to be made and 
might permit the identification of disease measures that are sensitive to changes specific to a 
particular disease stage in HD. As discussed in earlier sections on neuroimaging, there is 
evidence of global longitudinal changes on cortical and subcortical structures in premanifest 
and manifest HD. Therefore, correlation of longitudinal changes in saccades with neuroimaging 
progression might be an aspect worth investigating for future studies.  
 
It would also be of considerable value to examine the performance of eye and hand movements 
in the temporally-cued task to discern the longitudinal changes in sensorimotor prediction in 
HD patients. Similarly, a logical extension of the present study would be the investigation of 
eye-hand movement in a memory-guided and anti-saccade/reaching task in order to better 
understand the relationship of the eye and the hand in tasks that require greater cognitive 
demand. A rectified EMG recording of opposing muscles provides a more objective 
measurement of hand latency and could potentially eliminate some of the confounding factors 
in the present study. 
 
A previous study by Khan et al. (2011) showed that combined eye-hand performance in healthy 
controls is considerably different from separate eye and hand only movements. The present 
study showed that in the HD group, eye movement performance in the rhythmical tasks (self-
paced and temporally-cued) was different when eye movement was performed in isolation (i.e. 
the saccade-only variants of the task) and concurrently with the hand (i.e. the eye-hand variants 
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of the task). A detailed study to investigate the performance of the eye and the hand in isolation 
and in combination would be relevant and might possibly extend the findings in the present 
study. Findings from such a study could then be extended to determine whether in HD, 
repetitive training of one movement (e.g. eye) has a positive transference effect on improving 
movement of another (e.g. the hand) in a multi-movement task.  
 
Innate compensatory mechanisms might contribute to the short-term preservation of 
behavioural performance in HD in the face of true underlying pathological progression. As 
there is evidence to support preclinical neural compensation in premanifest HD (Kloppel et al., 
2009; Scheller et al., 2013; Scheller et al., 2014), it would be useful to perform a longitudinal 
functional MRI or neurophysiological study to examine how these compensatory mechanisms 
may evolve over time to cope with the burden of pathology in premanifest and manifest HD, 
when performing complex tasks. Such knowledge may potentially lead to the use of enrichment 
or other brain function enhancement therapies as an intervention to maintain motor performance 
or as an adjunct to future disease-modifying treatments in HD.  
 
 
VII.5. Chapter summary 
The lack of sensitive disease markers poses a challenge for monitoring disease progression in 
HD. Neuroimaging studies are thus far the most sensitive in showing longitudinal changes in 
HD. However, such techniques may not be practical for use in clinical practice where medical 
resources are limited. This study has identified several potentially useful, relatively cheap and 
safe progression markers for monitoring HD changes over 12 months that could be easily 
adapted for use in research studies and clinical trials. Eye-hand movement assessment in this 
study has provided novel perspectives on eye-hand coordination in HD and could be a 
springboard for the design of motor training therapies to improve motor performance in 

































Table S1 Scores (mean, SD, and range) in the control and HD groups at baseline and 12 month follow-up 
assessments.  Neuropsychological tests raw scores were converted to standard z-scores using test-specific 
norms. Global cognitive and domain scores were shown in z-scores. The MMSE and MoCA were scored 
out of 30 points. The UHDRS motor and behavioural components were scored in points while individual 
tests within the cognitive component were reported in z-scores.  
 
 
* The UHDRS motor and behavioural components were assessed in the HD group only 
  














Global cognitive level (z-score)         
Executive function (z-score) 
Working memory & attention (z-
score) 
Processing speed (z-score) 










-0.2 – 1.1 
-0.3 – 2.1  
-0.5 – 0.7 
-0.1 – 1.8 
-0.8 – 2.0  
-0.7 – 0.9  
-0.4 – 0.8  
0.7 (0.3) 






0.0 – 1.2 
0.1 – 1.9  
-0.0 – 0.9  
0.2 – 1.7 
-0.2 – 2.2  
-0.3 – 0.8  
-0.2 – 0.8  







-2.7 – 0.2 
-2.9 – 0.5 
-3.0 – 0.2 
-3.0 – 0.8 
-2.8 – 1.5 
-2.8 – 0.9 








-2.7 – 0.5 
-3.0 – 0.8 
-3.0 – 0.5 
-3.0 – 1.2 
-2.8 – 0.8  
-2.8 – 0.1 
-2.1 – 0.8 
MMSE (point) 
with WORLD item 





26 – 30 





29 – 30 






19 – 30 





17 – 30 
17 – 30 
MoCA (point) 27.8 (1.4) 24 – 30 28.3 (1.6) 24 – 30  21.5 (4.9) 11 – 28 21.0 (5.8) 10 – 30  
UHDRS  
Motor component* (point) 
Cognitive component (z-score) 
Letter fluency (z-score) 
SDMT (z-score) 
Stroop Reading (z-score) 
Stroop Naming (z-score) 
Stroop Interference (z-score) 












-0.4 – 1.7 
-2.0 – 3.0 
-0.8 – 1.7 
-1.0 – 1.5 
-0.7 – 1.5 













-0.3 – 1.5 
-0.7 – 3.0 
-0.6 – 1.7 
-0.7 – 1.7 
-0.7 – 1.3 













11 – 82  
-2.9 – 0.8 
-3.0 – 1.0 
-3.0 – 1.0 
-3.0 – 0.5 
-3.0 – 0.5 
-3.0 – 1.0 











14 – 80  
-3.0 – 1.1 
-3.0 – 1.7 
-3.0 – 1.2 
-3.0 – 1.7 
-3.0 – 1.0 
-3.0 – 1.3 





Table S2 Mean (SD) standardised z-scores for the six cognitive domains and neuropsychological battery 
component tests in the control and HD groups at baseline and 12 month follow-up. 
 Mean (SD) 
 Control group HD group 
 Baseline 12 month Baseline 12 month 
     
Global cognitive level           0.4 (0.3) 0.7 (0.3) -1.2 (0.9) -1.1 (0.9) 
     


























     
Working memory 0.2 (0.3) 0.4 (0.3) -1.0 (0.8) -0.9 (0.9) 

























     
Processing speed 0.7 (0.4) 0.9 (0.4) -1.4 (1.2) -1.4 (1.3) 
Stroop - reading 
Stroop - naming 
Trails A 

















     
Learning memory & attention 0.5 (0.7) 1.1 (0.7) -1.0 (1.2) -1.0 (1.0) 
CVLT-II: recall  



















     











     
Visuospatial function 0.3 (0.5) 0.3 (0.3) -1.4 (0.8) -1.5 (0.8) 
JOL 









     
 
 
Table S3 Mean (SD) standardised z-scores for global cognitive level and the six cognitive domains in controls 
and the three sub-groups of HD patients at baseline and 12 month follow-up. 
 
Mean (SD) 
Control group  HD – Normal    HD – MCI   HD – Dementia  
Baseline 12 month  Baseline 12 month  Baseline 12 month  Baseline 12 month 
Global cognitive level 0.4 (0.3) 0.7 (0.3)  -0.1 (0.4) 0.1 (0.3)  -1.4 (0.6) -1.3 (0.6)  -2.1 (0.4) -2.0 (0.5) 
Executive function 0.8 (0.6) 1.0 (0.5)  -0.2 (0.5) 0.2 (0.6)  -1.5 (0.7) -1.9 (0.6)  -2.6 (0.3) -2.6 (0.4) 
Working memory  0.2 (0.3) 0.4 (0.3)  -0.3 (0.4) 0.1 (0.3)  -1.1 (0.8) -1.0 (0.6)  -1.7 (1.0) -1.6 (0.9) 
Processing speed 0.7 (0.4) 0.9 (0.4)  -0.03 (0.9) 0.5 (0.9)  -1.7 (0.8) -1.7 (0.7)  -2.5 (0.5) -2.6 (0.6) 
Learning memory & 
attention 
0.5 (0.7) 1.1 (0.7) 
 
0.3 (0.7) 0.3 (0.5) 
 
-1.3 (0.9) -1.2 (0.8) 
 
-2.0 (0.5) -1.8 (0.6) 
Visuospatial 0.3 (0.5) 0.3 (0.3)  -0.5 (0.9) -0.7 (0.6)  -1.6 (0.5) -1.7 (0.7)  -2.1 (0.4) -1.8 (0.7) 
Language 0.1 (0.4) 0.5 (0.4)  0.07 (0.6) 0.3 (0.5)  -1.0 (0.7) -0.5 (0.7)  -1.7 (0.8) -1.5 (0.6) 
  










































Figure S1 Change in neuropsychological battery component tests scores over 12 months.  Baseline and 12 
month scores for control (circle) and HD (triangle) groups in overall executive domain score (Overall: Ex); letter fluency 
(LF); action fluency (AF); category switching (CS); Trail Making Test – Part B (Trl.B); Stroop-Interference test (Strp.I); 
overall working memory domain (Overall: WM); digit forward, backward and sequencing combined score (DF.B.Sq); digit 
backward (DB); digit sequencing (Dsq); Symbol Digit Modalities Test (SDMT); Ruff 2 &7 Cancellation Test – Accuracy 
(R27.TotA); overall processing speed domain score (Overall: PS); Stroop –Reading test (Strp.WR); Stroop – Naming test 
(Strp.CN); Trail Making Test – Part A  (Trl.A); Ruff 2 & 7 Cancellation Test – Speed (R27.TotS); overall learning memory 
& attention domain score (Overall: LM); CVLT - Recall score (CV.Recall); CVLT - Long delayed score (CV.LongD); 
BVMT – Learning score (BVMT.Learn); BVMT – Delayed recall score (BVMT.Delayd); overall visuospatial domain score 
(Overall: Vs); Judgement of line (JOL); Rey complex figure copying test (RCF.Copy); overall language domain score 










Figure S3 Eye and hand latencies by stimulus number in controls at the 750 ms ISI trial block. Missing data 
points for either movements are due to unforeseen technical failure with the motion tracker system that was discovered during 
data analysis.  
  







Figure S4 Eye and hand latencies by stimulus number in controls at the 1000 ms ISI trial block. Missing data 
points for either movements are due to unforeseen technical failure with the motion tracker system that was discovered during 









Figure S5 Eye and hand latencies by stimulus number in controls at the 1400 ms ISI trial block. Missing data 
points for either movements are due to unforeseen technical failure with the motion tracker system that was discovered during 
data analysis.  
  







Figure S6 Eye and hand latencies by stimulus number in controls at the 2050 ms ISI trial block. Missing data 
points for either movements are due to unforeseen technical failure with the motion tracker system that was discovered during 









Figure S7 Eye and hand latencies by stimulus number in the HD group at the 750 ms ISI trial block. Missing 
data points for either movements are due to unforeseen technical failure with the motion tracker system that was discovered 
during data analysis.  
  







Figure S8 Eye and hand latencies by stimulus number in the HD group at the 1000 ms ISI trial block. Missing 
data points for either movements are due to unforeseen technical failure with the motion tracker system that was discovered 









Figure S9 Eye and hand latencies by stimulus number in the HD group at the 1400 ms ISI trial block. Missing 
data points for either movements are due to unforeseen technical failure with the motion tracker system that was discovered 
during data analysis.  
  







Figure S10 Eye and hand latencies by stimulus number in the HD group at the 2050 ms ISI trial block. Missing 
data points for either movements are due to unforeseen technical failure with the motion tracker system that was discovered 









C. Supplementary data 
 
  




Spreadsheet A  Participant demographics at baseline 
 
Abbreviations: HD (HD group); Ctrl (Control group); Edu. (Years of formal education); Eth. (Ethnicity - EU: NZ European; MO: NZ Maori; 
SA: South African Indian); CAG (CAG repeat size); FRS (Shoulson-Fahn staging system); Motor (UHDRS motor score); Behav. (UHDRS 
behavioural score); Func. (UHDRS functional score); Indp. (UHDRS independence score); TFC (UHDRS total functional capacity score); Cog 
(Cognitive status: HD-N, HD-Normal; HD-M, HD – Mild cognitive impairment; and HD-D, HD-Dementia); ‘?’ indicates unconfirmed but 
likely mode of HD inheritance. 
  
ID no. Group Age Gender Edu. Eth. CAG  Inheritance FRS Motor Behav. Func. Indp. TFC Cog 
S01  HD 61 M 10 EU 41 Maternal 2 44 16 20 75 9 HD-M 
S02  HD 36 F 17 EU 47 Paternal 3 82 2 11 60 4 HD-D 
S03  HD 56 M 15 EU 42 Paternal 2 47 27 18 70 7 HD-M 
S04  HD 43 M 13 EU 47 Paternal 3 47 7 17 70 3 HD-M 
S05  HD 62 M 10 EU 41 ?Maternal 2 35 11 22 85 9 HD-M 
S06  HD 35 F 16 EU 41 Paternal 1 46 7 23 85 11 HD-M 
S07  HD 38 M 15 EU 41 Maternal 1 17 45 24 95 11 HD-N 
S08  HD 53 M 15 EU 45 Paternal 4 77 30 13 60 1 HD-D 
S09  HD 24 F 15 MO 45 Maternal 1 11 28 25 90 13 HD-N 
S10  HD 53 F 12 SA 50 Maternal 3 50 32 13 70 5 HD-M 
S11  HD 45 M 11 MO 46 Maternal 2 34 41 22 80 9 HD-N 
S12  HD 67 F 11 EU 43 Maternal 3 63 28 12 60 3 HD-M 
S13  HD 56 M 14 EU 43 Paternal 1 41 0 24 90 12 HD-M 
S14  HD 77 M 11 EU 39 ?Paternal 1 29 28 24 75 12 HD-M 
S15  HD 35 F 13 EU 53 Paternal 3 64 48 16 60 3 HD-D 
S16  HD 71 F 10 EU 41 ?Paternal 2 49 36 15 70 7 HD-D 
S17  HD 40 F 13 EU 43 Maternal 1 14 11 25 100 13 HD-N 
S18  HD 72 F 10 MO >40 Maternal 2 52 16 17 70 7 HD-M 
S19  HD 27 M 12 EU 51 Paternal 1 17 46 24 90 11 HD-N 
S20  HD 62 F 12 EU 40 ?Maternal 2 45 15 19 80 7 HD-M 
S21  HD 37 F 14 EU 47 Paternal 2 53 34 20 80 8 HD-M 
S22  HD 44 F 13 EU 43 Maternal 1 13 6 25 100 12 HD-N 
C01  Ctrl 62 M 11 EU - - - - - - - - Normal 
C02  Ctrl 39 F 16 EU - - - - - - - - Normal 
C03  Ctrl 58 M 16 EU - - - - - - - - Normal 
C04  Ctrl 48 M 12 EU - - - - - - - - Normal 
C05  Ctrl 63 M 10 EU - - - - - - - - Normal 
C06  Ctrl 37 F 16 EU - - - - - - - - Normal 
C07  Ctrl 44 M 18 EU - - - - - - - - Normal 
C08  Ctrl 56 M 15 EU - - - - - - - - Normal 
C09  Ctrl 25 F 15 EU - - - - - - - - Normal 
C10  Ctrl 51 F 12 EU - - - - - - - - Normal 
C11  Ctrl 41 M 12 EU - - - - - - - - Normal 
C12  Ctrl 67 F 13 EU - - - - - - - - Normal 
C13  Ctrl 52 M 15 EU - - - - - - - - Normal 
C14  Ctrl 77 M 10 EU - - - - - - - - Normal 
C15  Ctrl 34 F 11 EU - - - - - - - - Normal 
C16  Ctrl 69 F 12 EU - - - - - - - - Normal 
C17  Ctrl 41 F 12 EU - - - - - - - - Normal 
C18  Ctrl 71 F 11 EU - - - - - - - - Normal 
C19  Ctrl 23 M 13 EU - - - - - - - - Normal 
C20  Ctrl 63 F 12 EU - - - - - - - -  Normal 
C21  Ctrl 30 F 12 EU - - - - - - - - Normal 



















Spreadsheet C  Patient medication list at 12 month follow-up 
 
  
ID no. Group Time Medication(s) 
S01 HD Y0 None 
S02 HD Y0 Risperidone; Tetrabenazine 
S03 HD Y0 Venlafaxine 
S04 HD Y0 Citalopram 
S05 HD Y0 Venlafaxine; Verapamil 
S06 HD Y0 Citalopram 
S07 HD Y0 Moclobemide 
S08 HD Y0 Fluoxetine 
S09 HD Y0 None 
S10 HD Y0 Citalopram; Tetrabenazine 
S11 HD Y0 None 
S12 HD Y0 Citalopram; Tetrabenazine 
S13 HD Y0 Citalopram; Clonazepam; Quetiapine 
S14 HD Y0 None 
S15 HD Y0 Ubidecarenone 
S16 HD Y0 Tetrabenazine; Alendronate 
S17 HD Y0 Citalopram 
S18 HD Y0 Haloperidol 
S19 HD Y0 None 
S20 HD Y0 Citalopram; Amitriptyline; Zopiclone; Enalapril; Omeprazole; Premarin 
S21 HD Y0 Citalopram; Sodium Valproate 
S22 HD Y0 None 
ID no. Group Time Medication(s) 
S01 HD Y1 None 
S02 HD Y1 Risperidone; Tetrabenazine 
S03 HD Y1 Venlafaxine; Quetiapine; Olanzapine 
S04  HD Y1 None 
S05 HD Y1 Venlafaxine; Aspirin; Carvedilol; Cilazapril; Amiodarone 
S06 HD Y1 Citalopram; Solifenacin Succinate 
S07 HD Y1 Clonazepam 
S08 HD Y1 Fluoxetine 
S09 HD Y1 None 
S10 HD Y1 Citalopram; Tetrabenazine 
S11 HD Y1 Tetrabenazine 
S12 HD Y1 Quetiapine; Mirtazapine; Tetrabenazine; Quinalapril; Metoprolol; Aspirin 
S13 HD Y1 Citalopram; Clonazepam; Quetiapine 
S14 HD Y1 None 
S15 HD Y1 Zopiclone; Ubidecarenone 
S16 HD Y1 Tetrabenazine; Nortriptyline 
S17 HD Y1 Citalopram 
S18 HD Y1 Tetrabenazine 
S19 HD Y1 Nortriptyline 
S20 HD Y1 Citalopram; Zopiclone; Enalapril 
S21 HD Y1 Citalopram; Sodium Valproate 
S22 HD Y1 None 
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